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CHAPTER 1 
PREFACE 
Abbreviations 
Throughout the work the abbreviations CO (carbon monoxide), NO (nitric 
oxide) and NO (nitrogen dioxide) are used. 
2 
i) Purpose of the study 
This first paragraph is a concise summary of the state of knowledge at 
the end of 1981. Nitric oxide (NO) and carbon monoxide (CO) are two of 
the principle components of the gas phase of cigarette smoke. CO yields 
are now available for most contemporary UK cigarettes and also for a 
limited range of cigarettes from previous decades. No similar figures 
are avail able for NO. NO does not exist in fresh smoke but is formed as 
2 
the smoke ages. It is believed that inhaled NO is absorbed from the lung 
into the blood to form methaemoglobin. NO, on the other hand, when 
2 
inhaled in low concentrations reacts with the lung to cause lung damage 
(including emphysema) and may cause lung cancer by nitrosamine formation. 
Inhaled CO combines with haemoglobin to form carboxyhaemoglobin which may 
reduce oxygen delivery to the heart. It might also contribute to 
arterial and lung disease in smokers. 
The purpose of the study was to establish whether NO or CO cause heart or 
lung disease in smokers. The following approaches were used. 
7 
i) Analyse cigarette NO concentrations and yields. Confirm that fresh 
c i garette smoke does not contain NO and determine how rapidly NO 
2 2 
i s formed as the smoke ages. Construct a "league table" of NO 
yields for contemporary cigarettes and establish the effect of 
fi lters, country of manufacture, CO and tar yield on NO delivery. 
ii ) By experiments on volunteers determine how quickly and hence by what 
mechanism NO is taken up into the lung. 
i i i ) Determine whether cigarette smoke elevates methaemoglobin in the 
blood i n vitro and in smokers. 
From (i), (ii), and (iii) average smokers' alveolar NO and NO 
2 
concentrat ions could be calculated and toxicity predicted. 
i v) Use data from a large prospective epidemiological study of published 
CO y i elds t o relate smokers' c igarette CO exposure to heart and lung 
disease . 
v) Use t he cigarette NO data from (i) and published mortality 
statistics to relate smokers' NO exposure to heart and lung disease 
risk. 
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iv) Chief Findings 
1 ) Analysis of cigarettes confirms that NO is not present in the fresh 
2 
s moke. The rate of disappearance of NO in whole smoke occurs at a 
similar rate to its oxidation to NO in air. The rate of 
2 
disappearance in the gas phase occurs faster by first order kinetics 
with a half life of 4.3 minutes. The mechanism of this rapid 
disappearance is likely to be oxidation by free radicals. It is 
unlikely to occur in the respiratory tract in smokers since whole 
s moke rather than gas phase is inhaled. 
Analysis of contemporary cigarettes shows that the yield of NO is in 
, 
general independent of tar or CO yield or cigarette design. The 
major determinant of NO yield is the country of origin by way of the 
variety of tobacco used in manufacture. US and French cigarettes 
yield on average 3 fold higher than UK cigarettes. In general NO 
deliveries are at least an order of magnitude lower than CO 
deliveries . Ce llulose acetate filters do not affect NO yield. Venti-
lated filters reduce NO yield for UK and perhaps for US cigarettes. 
2 ) Analysis of alveolar NO shows that there is normally a negligible 
back tension (even in smokers) in contrast to CO. The disappearance 
of NO from the alveolus is a first order process with a half life of 
2 seconds. The rate of this reaction considerably exceeds the rate 
of reaction of NO with oxygen or reactive oxidant species. It 
exceeds the rate of alveolar uptake of CO by 4 - 5 fold. The rate of 
uptake (expressed as D , the diffusing capacity) for NO showed close 
L 
correspondence but exceeded 4 fold that for CO in a group of 13 
13 
normal individuals. D NO appeared to increase with exercise (to a 
L 
lesser degree than D CO) and with lung volume (to a greater degree 
L 
than D CO). It appeared less dependent on posture. Unlike D CO, 
L L 
D NO appeared independent of alveolar oxygen tension. Conversely, 
L 
D CO and D NO both decreased exactly proportionately with a reduction 
L L 
in haemoglobin concentration in 12 subjects. These results are 
consistent with a rapid removal of NO into the blood from the 
alveolus. As for CO the rate of uptake (measured as D NO) appears to 
L 
reflect the rate of combination with the red cell rather than 
alveolar capillary membrane diffusion. The poor correlation between 
D NO and alveolar oxygen tesnion probably reflects a difference in 
L 
t he kinetics of combination of NO with haemoglobin compared to CO. 
3 ) I n a survey of 672 subjects methaemoglobin concentrations were no 
greater in 336 smokers than in the non-smokers. This is in contrast 
t o carboxyhaemoglobin. In fact, smokers' methaemoglobin 
concentrations were statistically significantly lower. However, 
passing cigarette smoke gas phase through whole blood produced a 
linear rise in both COHb and metHb. The rise in metHb was an order 
of magnitude lower than for COHb. This is in accord with the NO 
delivery of the cigarette being an order of magnitude below its CO 
delivery. It is suggested that NO from cigarette smoke causes metHb 
forma tion but the concentrations are too low to detect and certainly 
insufficient to impair oxygen carriage by the blood. 
4) Reanalysis of a study of 18,000 Civil Servants to explore the 
relationship between smokers' cigarette CO exposure and the risk of 
cardjorespiratory diseases showed no evidence for a reduction in 
mortality with lower CO yield. There was a suggestion of increased 
bronchi al carcinoma mortality with increased CO yield but lower 
i ncidence of coronary heart disease and prevalence of chronic air 
flow obstruction. Among self reported inhalers the negative 
associat ion of reduced CO yield for mortality became statistically 
signi ficant. 
5 ) Comparison of the es t imated cigarette NO exposure of smokers in 21 
i ndustrialised countries showed no relationship between NO exposure 
and mortality from carcinoma of the bronchus, chronic air flow 
obstruction or coronary heart disease . However, t he estimated life 
t ime cigarette exposure and rates of disease appeared related (and 
for CHD the relationship was significant). 
Over all it appears t hat inhaled NO in cigarette smoke is not 
converted to t he toxic NO but is rapidly removed in the blood 
2 
apparently without causing harm. The dilution of smoke during 
i nhalati on, the intermittent nature of smokers' cigarette smoke 
ex posure and the rapid blood removal all limit alveolar NO concen-
t ration and the rate of conversion to N02 . The estimated alveolar con-
centrations of oxides of nitrogen are therefore below those shown to 
ca use lung damage f rom animal work. 
Conversely, the blood concentrations of methaemogoblin 
r esulti ng from NO absorption are too low to be harmful. There is no 
evidence that despite the three fold higher NO yields in French and 
I~ 
US cigarette types they are more "dangerous". 
There is no evidence that smokers who choose a lower CO yielding 
cigarette reduce their risk of heart or lung disease. 
Key words: Nitric oxide, carbon monoxide, diffusing capacity, 
cigarette smoking, heart disease, lung disease. 
II, 
v) Directions for Further Work 
1) Cigarette NO analysis should be extended to confirm my findings and 
to establish how yields have changed over the years. It is important 
to verify my classification into "high" and "low" NO countries by 
surveying NO yields from countries apart from those that I analysed. 
Kinetic experiments might further elucidate the mechanism of 
disappearance of NO in gas phase and whole smoke. The behaviour of 
inhaled whole smoke could be studied to see whether separation into 
gas and particulate phase occurs in vivo. 
2) There is an urgent need for measurements of the rate and mechanism of 
r eaction of NO with the red cell. This is essential for interpreting 
the meaning of D NO. It would also be useful to obtain measurements 
L 
of D NO under different circumstances such as hypoxia, high altitude 
L 
and to study a range of patients with lung disease. If a rapidly 
reacting NO analyser were developed, measurements could be made on 
animals so that comparative data could be obtained. 
3 ) It would be interesting to repeat the methaemoglobin analyses on 
smokers perhaps studying a population who choose higher NO yielding 
brands. It would also be interesting to further study the metabolism 
of metHb in smokers and non-smokers. 
" 
4) There is a need for further work on the effects of CO. Following the 
retraction of Astrup's work on atheroma and the doubt about Aranow's 
coronary artery disease studies, the CO exposure experiments need to 
be re-evaluated. The possibility that my work suggested of a link of 
CO with bronchial carcinoma needs further study. Further 
epidemiological studies are needed to examine associations between 
cigarette CO exposure and cardiorespiratory disease. 
5) Extension of cigarette analyses would help validate the assumptions 
made in relating contemporary NO yields to disease occurrence. It 
would be of benefit to carry out nitrosamine analyses to confirm that 
their concentrations may be predicted from NO yields. 
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CHAPTER 2 
INTRODUCTION 
i) History of Cigarette Use 
Smoking the dried leaf of the tobacco plant (Nicotiana tobacum) was 
widespread in North America at the time of Columbus and the plant was 
brought back to Europe by the early explorers. It was initially 
(paradoxically!) grown for medicinal purposes (Ashton and Stepney 1982). 
During the 17th century pipe smoking gained in popularity in Europe and 
commercial growing for export was starting in Virginia. Growing was also 
started at that time in other parts of the world where the climate was 
suitable e.g. Turkey (Akehurst 1981). During the 18th century snuff 
became the most popular way of taking tobacco but the habit rapidly 
declined by the 19th century (Mackenzie 1957). Wrapping a length of 
tobacco in uncut tobacco leaf to produce a cigar and in paper to produce 
a cigarette were introduced into Europe from Spain in the early 19th 
century (Mackenzie 1957) but it was not until 1856 that John Gloag 
started machine cigarette production in London. This cheap and 
convenient way of smoking rapidly gained in popularity. 
In the late 19th century as cigarette smoking became widespread on both 
sides of the Atlantic a profound difference developed between the U.S. 
and U.K. in the varieties of tobacco used in manufacture which still 
prevails today (Colby, 1978). Initially in the U.K. low quality oriental 
t obacco was used in manufacture being the "mildest" available and hence 
most suitable for use in cigarettes. At that time, however, "Bright" 
20 
tobacco appeared on the market from Virginia. It was a tobacco grown on 
poor quality soil and "cured" (dried) by heating over a log fire rather 
than drying in air (Mackenzie 1957). This tobacco was milder than the 
air cured varieties and soon supplanted oriental tobaccos so that by the 
First World War virtually all the cigarette tobacco smoked in the U.K. 
was of flue cured Bright Virginia type. However, in the U.S. Bright 
tobacco was added to oriental tobacco for use in cigarettes. 
Subsequently a mild air cured variety "White Burley" was discovered (by 
accident, Mackenzie 1957) and incorporated together with Maryland tobacco 
to produce the "U.S. blended" style of cigarette. Commercial machine 
production in the U.S. was started by J.B. Duke in 1881 using an adapted 
French machine and by 1883 he had merged with two other tobacco companies 
to form the American Tobacco Company. 
In 1901 J.B. Duke attempted to "invade" the U.K. market and was resisted 
by seventeen British companies (including W.D and H.O. Wills, Lambert and 
Butler and John Player) who united to form the Imperial Tobacco Company. 
An agreement was reached in 1902 in which the American Tobacco Company 
was awarded sole selling rights in the U.S., Imperial Tobacco and the 
other British companies (notably Gallahers, Godfrey Phillips and 
Carreras) were awarded Britain and Ireland and a joint venture "British 
American Tobacco" to export to other countries (Mackenzie 1957). Most of 
the U. K. companies subsequently operated independently again. Within a 
decade the American tobacco company was dismembered under U.K. Government 
regulations into its constituent companies including R.J. Reynolds, 
Lorillard, Liggett and Myers and a smaller American tobacco company. 
Similarly the British companies free of American competition split up 
into constituents such as Wills and John Player. There were no further 
2.1 
TAB LE 1 CIGARETTE ~lOKING I N 2 I COUNTRIES ( Bee3 e DH 197 2l 
HAtIUFACTU RED 
TOBACCO - POUNDS CIGARETTES PER 
ADULT PER ADULT 
1935 1945 1955 1965 1970 1935 1945 1955 1965 1970 
Australia 450 600 1770 2680 2910 3.9 4.1 7.2 7.4 7.3 
Austria 860 480 1320 1930 2330 3.8 1.5 3.6 4.8 5.5 
Belgium 790 390 1250 1980 2380 6.8 3.2 6.2 7.3 7.5 
Canada 700 1660 2320 3310 3340 4.9 7.7 8.3 10. 1 9.8 
DenGlark 470 390 1150 1500 1690 6.5 3.9 7.2 8.2 8. 1 
Finland 1350 760 1970 1920 1850 2.7 1.1 3.9 4.5 4.8 
France 530 430 1170 1510 1830 3.8 2.3 4.4 5.2 5.8 
Germany 720 11210 1100 2100 2500 4.8 .. 1.6 5.0 6.2 6.7 • 1949 fi~re 
Greece 960 850 1560 1930 2260 2.4 2.1 3.9 4.9 5.7 
Holland 680 u490 1560 2020 1910 8.4 H4.0 1.8 9.3 8.9 H 1946 figure 
Ireland 1210 1550 2620 2690 3040 4.5 5.0 6.9 6.6 6.5 
... 
650t 970t t Five-year averae;e Italy 450' 1260 1680 1.9 2.1 2.6 3.2 3. 9 
Japan 880 310 1650 2350 2810 3.0 1.4 3.9 5.2 6.2 
New Zealand 530 980 1110 2280 2610 4.5 5.5 1.1 7.6 7.7 
Norway 300 220 570 520 630 3.2 1.8 4.4 4.1 5.0 
Portugal 430 150 1150 1210 1.8 2.0 2.1 2.9 
Spain 390 490 130 1160 2100 3.5 2.8 3.2 4.5 5.2 
Sweden 380 410 1010 1360 1620 3.6 3.8 4.2 4.1 4.5 
Switzerland 540 1110 1140 3050 3810 4.1 5.4 6.3 9.0 10.4 Average of '34-'36 
U.K. 1590 2600 2510 26CO 3050 4.8 6.9 6.3 6.1 5.9 
U.S.A. 1450 · 2560 3280 3820 3610 1.8 9.5 10.3 10.8 9.4 
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Fig 1 
incursions of the U.S. into the U.K . tobacco market until 1968 when the 
successor to American Tobacco (American Brands) purchased Gallaher in 
Northern Ireland. Philip Morris, orgininally a London based hand-rolled 
tobacco company, set up in New York in 1902 and grew from there. The 
Rembrandt group was started in South Africa after the second World War 
and became a tobacco giant by buying into the British market by 
purchasing Carreras and Rothman. Forty per cent of the world tobacco is 
thus sold by these six multinational giants: American Brands (including 
Gallahers), R.J. Reynolds and Philip Morris (Malboro') in the U.S., 
Bri t ish American tobacco and Imperial in the U.K. and Rembrandt 
(Rothmans ) in South Africa. State monopolies in the communist block and 
i n c erta in weste r n countr ies (eg France and Italy and Japan) (Taylor, 
1984 ) account f or most of the r emainder of world cigarettes sales. 
During t h is century in the U.K. there was a steady rise in smoking 
amongst men starting at the turn of the century and a later rise among 
women s t arting in the 1930s (see Table 1 and Fig. 1). The effect of the 
t wo World Wars on smoking are clearly apparent. In the 1950s filter 
cigar e ttes we re introduced initially not to produce a less hazardous 
cigarett e but to use less tobacco leaf in manufacture and to attract 
female s moke rs who might be put off by the soggy tip of a plain cigarette 
(Ashton and Stepney 1982). In the 1960s and ' 1970s as a result of 
Gov e rnme n t press ure in the form of "voluntary agreements" the tar yield 
of c i garettes was reduce d by changes in t h e t obacco used e.g. 
i ncorporat ion of tobacco stem and by the use of more effective filters 
i ncluding the ventilated variety. Sales of cigarettes have recently 
fallen du e to a c ombination of increased awareness of the health hazards 
and increases in t he Government revenue. 
The history of cigarette usage has been different in other countries 
(Tabl e 1) and these differences are important in understanding 
differences in the burden of cigarette related disease. Before the 
Second World War only the British Isles, Finland and America had 
consumptions greater than "1,000 per adult per year", (This figure is 
derived by divid ing cigarette sales by total adult population). The 
effect of the Second World War was to substantially increase consumption 
in the U.K., U.S. and Commonwealth nations but to drastically reduce 
consumption in Axis countries (with the exception of Italy) and those 
under Axis occupation. Consumption then continued to rise in all 
countries until the 1960s and 1970s when it began to tail off, 
particularly in Scandinavia. By contrast in the developing world the 
1970s and 1980s have seen a rapid rise in consumption (RCP 1983). The 
high values for "weight of tobacco per adult" compared to "manufactured 
cigarettes per adult" for Belgium, Holland and · Denmark reflects their 
high consumption of pipe tobacco, cigar tobacco and cheroots. 
With regard to the type of tobacco used in cigarette manufacture, in the 
U. K. and Commonwe a lth flue cured Virginia is used almost exclusively 
wher e as in Belgium, France and Spain dark air cured tobaccos are used. 
In Greec e and Turkey there is a preference for oriental tobaccos but in 
the rest of the developed countries U.S. blended varieties are 
predominantly smoked (Colby 1978). Thus a series of historical events 
has had a fundamental effect on how much and of what type of tobacco 
different countries smoke. 
23 
ii) Reasons for Smoking 
The spread in popularity of smoking and the difficulty most smokers have 
with stopping , despite the expense and health risks, testify to a 
power f ul motivation to smoke . It is apparent that smokers smoke for a 
variety of reasons but fundamentally to obtain the drug nicotine (Ashton 
and stepn ey 1982). Obviously the motives will vary for different smokers 
and a rat ional classification into seven motivating factors which may be 
assessed in an individual using a questionnaire has been developed 
(Russell, Peto and Patel 1974). These factors are: psychosocial (i~e. to 
increase social confidence), sensory-motor (to obtain oral and 
man ipulatory satisfaction), indulgent (smoking for pleasure alone), 
sedative (to calm the nerves), stimulant (to remain alert despite fatigue 
or boredom), addictive (to avoid withdrawal symptoms due to nicotine 
dependence) and automatic (to light up without noticing). 
iii) Health Risks of Smoking 
Though t here were isolated early reports of diseases occurring more 
commonly among s mokers , e.g. "cancerous swellings and excrescences in the 
nose" in 1761 (Surgeon General 1982) and lung cancer in cigarette factory 
workers in Nottingham i n the 1920s (Cuthbertson 1968) it was in 1938 that 
Pearl demonstrated the death rates (i,e. numbers of individuals in a 
defined population dying over a defined period) were higher in smokers 
than non-smokers (Pearl 1938). Many reports from different countries 
confirm this fact, both case control analyses (ie comparing the smoking 
habits of subjects with disease to those of healthy controls) and 
prospective studies (ie following the fate of a cohort of individuals 
whose smoking habits are known). 
The mortality among smokers is, below the age of 70, on average 2 fold 
greater than for a life long non-smoker of the same age and greater still 
in the younger age groups (Doll and Peto 1976). It is due to lung 
cancer, coronary heart disease, chronic obstructive lung disease (and the 
associated heart disease "cor pulmonale") cancer of the upper airways, 
oesophagus and bladder, peptic ulcer, hernia and vascular disease 
(notably cerebral thrombosis and non-syphylitic aortic aneurysm) · (Doll 
and Peto 1976). Peripheral vascular disease is considerably more common 
in smokers and there are some associations between smoking and carcinoma 
of the pancreas, carcinoma of the kidney, accidental death (Surgeon 
General 1979) and cirrhosis of the liver (Doll and Peto 1976). Smoking 
is synergistic with other risk factors for disease (e.g. occupational 
exposure, diabetes and oral contraceptive use) (Surgeon Generai 1979). 
Maternal smoking during pregnancy increases the risk of foetal death and 
increases perinatal mortality (Surgeon General 1979). Involuntary 
exposure to tobacco may cause lung cancer in non-smokers (Hirayama 1981). 
Three diseases, carcinoma of the bronchus, chronic obstructive lung 
disease and coronary heart disease together account for the majority of 
deaths in smokers. They have been chosen for this study. 
Lung Cancer 
Historically, lung cancer was the first disease to be convincingly 
associated with smoking and because the association is the strongest 
(Doll and Peto 1976) it is the easiest disease for which to refute other 
explanations. The risk of lung cancer increases with the "dose" both in 
terms of numbers of cigarettes (Doll and Peto 1976) and years smoked 
(Hammond 1966) . On stopping smoking the risk returns to that of a 
non-smoker after 10 years. The idea of lung cancer being due to a 
genetic susceptibility to both cancer and smoking is invaUdatedby the 
simi l ar risk ratios for smokers compared to non-smokers in mono and 
dizygot i c twins in the Swedish twins study (Cederlof, Finberg and 
Lundmann 1977) and by the reduced rates in racially similar groups that 
have lower smoking habits, e.g. (U.S. seventh day adventists) or British 
doctors (Doll and Peto 1976). Similarly, the consistency of the · many 
studies from many parts of the world and the close dose response 
relationship argue against another single environmental agent. 
The risk to an individual smoker of cancer may, however, be greatly 
modified by familial factors (Tokuhata 1964), occupational exposure (Doll 
and Pe to 1981) and perhaps vitamin deficiency, e.g. vitamin A (Mettlin, 
Graham and Swanson 1979). Alleged discrepancies to the smoking causing 
l ung cancer view such as the low rates for women and certain 
nationalities , e . g. the Japanese, become explicable if life time exposure 
is assessed (Doll and Peto 1981). Similarly the paradoxical effect of 
i nha l ation being associated with a lower risk of lung cancer in heavy 
smokers in s ome studies may be due to differences in tar deposition (Wald 
e t al 1983). The often quoted slogan of the U.S. tobacco industry "no 
ani ma l has yet been given lung cancer" conveniently ignores the increased 
rates of laryngeal tumours in smoke exposed Syrian golden hamsters and 
the difficulties of getting even primates to "smoke" in a manner similar 
to humans (Surgeon General 1982). 
The mechan ism whereby cigarette smoke causes cancer is believed due to 
carcinogen in the smoke (Surgeon General 1982) principally the tar 
fraction. Aromatic compounds and nitrosamines could interact with 
nucleic acids in the cells' (Surgeon General 1981) genetic material to 
induce mutation (Hayes 1968) and then neoplasia. The role of 
nitrosamines in carcinogenesis is very pertinent to this study. 
Chronic Air Flow Obstruction 
Smokers may suffer from a spectrum of respiratory disorders ranging from 
the near universal morning cough to respiratory failure. Much difficulty 
in understanding the natural history of these diseases results from the 
different terminologies in use . It is now clear that chronic bronchitis 
(that is continued or recurrent bronchial hypersecretion) though leading 
to freque n t infections does not, in the absence of airways obstruction, 
carry a substantial risk of death (Fletcher et al 1976). On the other 
hand , persistent air flow obstruction (as assessed by simple 
physiological testing, e.g. FEVI) carries a poor prognosis especially for 
the 20% that show a rapid decline with age (Fletcher et al 1976). The 
site of this obstruction is in the peripheral airways which are less than 
3 mm in size and it is due to bronchiolar inflammation and emphysema 
(Cosio, Hall and Niewohner 1980). 
Throughout life lung function deteriorates with age but the decline is 
proportional to t he amount smoked and duration of smoking (Fletcher et al 
1976). On stopping smoking bronchial hypersecretion disappears in 90% of 
smoke rs in a few months but lung function, rather than improving, 
continues to de c line at the same rate as non-smokers (Fletcher et al 
1976). 
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other factors in addition to smoking undoubtedly contribute to air flow 
obstruct ion in smokers as shown by the increased mortality for social 
clas s V compared to social class I for a given level of cigarette 
c onsumption (Rep 1983). This could be due to indoor air pollution but 
respiratory disease in childhood may affect later respiratory function 
( Burrows, Knudson and Lebvitz 1977). Similarly the decline in bronchitis 
mortality i n the U.K . in re c ent years which anteceded the decline in 
cigarette cons umption might, in addition, suggest an effect of outdoor 
pollution <md a beneficia l effect of the "Clean Air Acts". The marked 
internat ional differences in mortality and the high figures for the 
British I sles appear to be partly due to differences in classification 
and d i ffe rences in life time smoking consumption (see Table I) as well as 
to atmospheric pollution (Reid and Fletcher 1971) . Genetic 
s uscept ibility to obstructive lung disease, e.g. ex 1 antitrypsin 
deficiency (Kueppers and Black 1974) is well recognised but it affects 
only a s ma ll proportion of smokers. 
The rel ationship of asthma and chronic air flow obstruction is 
cont rovers ial: air flow obstruction that is reversibl e in some smokers 
( i.e . asthm a) later becomes irreversible and conversely bronchial 
hyperreacti vity (ie reversibility) c an be demonstrated in other patients 
with otherwise irreversible obstruction (Taylor et al 1983). In this 
ca....(~ 
study, the term chronic air flow obstruction (Pride/1984) will be used. 
The mech anisms whereby smoking causes chronic air flow obstruction are 
not understoo d but effects of lung immunity, mucociliary clearance and 
enzymat i c imbalance have been proposed (Surgeon General 1981). The 
proposed enzyme imbalance theory is particularly pertinent to this 
st ud y (see 4 (ii) disc ussion) 
Other factors in addition to smoking undoubtedly contribute to air flow 
obstruct ion in smokers as shown by the increased mortality for social 
class V compared to social class I for a given level of cigarette 
c onsumption (RCP 1983). This could be due to indoor air pollution but 
respi ratory disease in ch ildhood may affect later respiratory function 
( Burrows, Knudson a nd Lebvitz 1977 ). S imilarly the decline in bronchitis 
mort a li ty in th e U. K. in re cent years which anteceded the decline in 
c i garet.te cons umption might, in addi tion , suggest an effect of outdoor 
poll ution C'md a beneficial effect of t he "Clean Air Acts". The marked 
international differences in mortality and the high figures for the 
British Isles appear to be partly due to differences in classification 
and differences in life time smoking consumption (see Table I) as well as 
to atmospheric po llution (Reid and Fletcher 1971) . Genetic 
susceptibility to obstructive lung disease, e.g. a 1 antitrypsin 
defic iency (Kueppers and Black 1974) is well recognised but it affects 
only a s mall proportion of s mokers. 
The relat ionshi p of asthma and chronic air flow obstruction is 
controversia l: air flow obstruction that is reversibl e in some smokers 
(i.e . asthma ) later becomes irreversible and conversely bronchial 
hyperreactivity ( i e reve rs ibil ity) c an be demonstrated in other patients 
with otherwise irreversib l e obstruction (Tayl or et al 1983 ). In this 
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study, the te rm c hronic air flow obstruction (Pride/1984) will be used. 
The mecha n isms whe r eby smoking causes chroni c air fl ow obstruction are 
not understoo d but effects of lung immunity, mucociliary clearance and 
enzymat i c imbalance have been proposed (Surgeon General 1981). The 
propose d enzy me imbalance theory is particularly pertinent to this 
st ud y (see 4 (ii) disc ussion) 
Coronary Heart Disease 
The large prospecti ve studies s howed an increase mortality from coronary 
he art d isease (CHD) in smokers compared to non-smokers (Doll and Peto 
1976) (Surgeon General 1979). Indeed, this was both the largest cause of 
death among s mokers and the largest number of deaths due to smoking 
related diseases is due to CHD. The risk is increased with the number of 
cigarettes s moked and with inhaling (Doll and Peto 1976). However, the 
risk of hear t diseas e in non-smokers approximates to that in smokers by 
the age of 65 (Doll and Peto 1976). The excess risk in smokers declines 
towards t hat o f non-smokers within 5-9 years of stopping (Doll andPeto 
1976) perhaps suggesting that t he e ffect of smoking is on thrombosis or 
some other acute even t as we ll as on the development of atheroma. 
Undoubtedly o ther factors such as blood cholesterol, diabetes and 
hypertension affect CHD mortality in addition to smoking (and this makes 
interpretation of longitudinal changes in pattern of disease difficult) 
(Rep 1983) (Pooling project 1978). 
The exac t me c hanism whereby smoking causes heart disease remains unknown 
(BMJ Editoria l 1980) though an ability of tar, nicotine and carbon 
monoxide to modify atheroma and thrombosis have been postulated. 
iv) Ways of Reducing Smoking Related Disease 
Since bronc hial carcinoma is virtually incurable and chronic air flow 
obstruction and coronary hear t d i sease largely irreversible, it is 
importan t to prevent their development by reducing exposure to cigarette 
s moke. Since only about 1 in 4 smokers under the age of 60 succeeds in 
up smoking permanently, it is obviously better never to start (Rep giving 
1977 ) . Unfortunately despite 20 years of publicity about the hazards of 
smoking , roughly 20% of 14-15 year olds are regular smokers. Though 
there may have been a small decline among boys over the last 20 years the 
same is not true for girls (Bewley et al 1980). Simila~ly, for 
established adult smokers attempted intervention by advice, aversion, 
rapid smoking etc . do not achieve results better than 15-25% at one year 
and worse thereafter (RCP 1977). Claims for better results, as has 
recently been shown in the case of nicorette chewing gum (Russell, Raw 
and Jarvis (1980) are generally due to selected populations or early 
reporting and are not borne out when the method is applied to general 
populations (Russell et al 1983) or the studies repeated by other groups 
in a clinical setting (Campbell et al 1983). While starting to smoke and 
giving it up are related to an individual's personality (Ashton and 
Stepney 1982) there is some evidence that measures aimed at the 
population as a whole have an effect: declines (albeit temporarily) in 
consumption have been seen following publication of the various RCP 
reports and "Surgeon Generals" (see Fig. 1). Similarly it is probable 
tha t increases in taxation have contributed to the declines in 
consumption in the U.K. even though there has been an overall reduction 
in real cost (RCP 1983). 
"Less Hazardous Smoking" 
Changing the pattern of smoking 
For the majority of cigrette smokers who are unable to stop smoking 
permanently the risk of disease (apart from cancer of the upper 
respiratory tract and oesophagus) may be reduced"by changing to a pipe or 
cigar (Doll and Peto 1976) or even taking the tobacco chewed or as snuff. 
Whils t habits such as keeping the cigarette in the mouth between puffs 
and re l i ghting half smoked cigarettes are associated with an increased 
ri s k of di sease (RCP 1977) it is less clear whether dropping these habits 
whil e c ontinuing to smoke helps . With regard to inhaling the picture is 
even les s clear: the risk of CHD in smokers is apparently greater among 
i nha lers (Higenbottam, Shipley and Rose 1982) but that of lung cancer in 
he avy smokers may be lower among inhalers (Wald 1983). 
"Safe cigarettes" 
Not s urprising ly, there has been a demand for a cigarette that is "safe" 
and yet can b e smoked in the normal way . There are two theoretical 
approaches t o t he s e a rch for a "safe" cigarette: either to alter the 
composition of cigar ettes and observe the effect on the frequency of 
disease in smokers or to determine what components in the smoke cause 
disease and alter cigarettes accordingly. The reasons for reducing "tar 
yields " in the 1950s and 1960s were most certainly not to observe the 
effec t on disease in subsequent years. Nonetheless, it is likely that 
this unw i tting "experiment" will have yielded much information on how to 
make s mok i ng less hazardous. The process of identifying which component 
causes which disease and then altering the cigarette so that it is 
deficien t i n s uch substances is obviously a very difficult task. 
approaches could aid identification (Surgeon General 1981): 
Four 
Consti tuen t t oxicology: identify a component in the smoke , f i nd out 
how it r e a c t s wi th the body and hence what diseases it might cause. 
Identify the basic mechanism of the disease and establish how known 
agents i n t h e smoke cause disease at molecular level. 
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Bioassay methods: expose biological material (e.g. secretions, cells, 
whole animals or human volunteers) to fractions of smoke and determine 
the effect . 
Epidemiological methods: chemically analyse the cigarette smoked by a 
populati on and relate exposure to disease rates. 
The difficulty with the first approach relates to the large numbers of 
c hemi c als in the smoke (at least 3,600) (Green et al 1980) and the 
compl e x ity of their interactions with the human body. 
relatively simple chemical such as carbon monoxide (CO). 
Conside~ a 
CO has been 
known to be present in tobacco smoke since the last century (Wahl 1899) 
and i ts a bsorption into the blood via the lung has been understood for a 
similar length of time (Krogh 1914). However, we are still unable to say 
whether or not it represents a health hazard to smokers (Schievelbein 
1979 ). On the other hand, observations on a single ingredient are 
valuable if it is found not to be present, or in an inactive form or at 
sub-toxic levels. However, merely to isolate an ingredient in smoke that 
i s toxic in other circumstances does not prove its relevance to human 
disease: i ndeed it might even be beneficial: afterall "poisons in small 
doses are t h e best medicines" (Withering 1787). 
The second approach suffers from lack of understanding of the basic 
mechanism of disease. It is easy to conceive theoretical models based on 
limi t ed data eg Astrup's permeability theory of atheroma (Astrup 1972) or 
the oxidant theory of emphysema (Janoff et al 1983) but so far no 
mechani sm of cigarette related disease is understood. 
Bioassay methods with animal material suffer from the difficulty of 
arranging exposure to approximate to human smoking behaviour and of 
relat ing any changes induced to human disease. Looking at physiological 
indices i n humans, such as changes in sensitive lung function tests when 
cigar ette c omposition is changed, avoids the first difficulty but it is 
difficult to relate such changes to long-term disease. Measurements are 
necessarily made over short exposure periods, tolerance may develop and 
longer term changes could be different. It is difficult to know whether 
change s represent early disease, are protective responses or are 
i rrelevant. Examination of cytological (or histological) material . in 
humans for structural change might reveal "markers" for later disease but 
the t e chniques are invasive. In any case, since both lung cancer and 
disabl i ng chronic air flow obstruction only occur in a minority of 
smoker s, relevant markers might be over-looked . 
The major advantage of epidemiological studies is that they examine real 
diseases in real smokers over a prolonged exposure period. On the other 
hand, exposure is not controlled, subjects choose the cigarette they 
smoke rather than being assigned it at random and this choice may be 
influ enced by social class or other factors that independently influence 
disease risk; indeed, the presence of disease itself might influence 
brand c hoice, e.g. an ill smoker could change to a "safer" lower tar 
cigarette . In addition differences in smoking behaviour, which are 
difficult to accurately record in an epidemiological survey can 
drastically alter cigarette smoke delivery (Creighton and Lewis 1978). 
I t might be that those who smoke each cigarette less intensively or 
inhal e less deeply, also take more exercise, eat a better diet or have 
t heir b lood pressure checked more frequently. One might think that if 
the study were large enough such differences would not prevent a real 
effec t of an ingredient causing a disease being detectable. 
Unfort unately, as studies get larger the chances of a small but spurious 
as s ociation becoming statistically significant become greater (See 
Method s sec tion v). In an epidemiological study, it is many years 
be fore s uf ficient disease has occurred to draw conclusions about the 
c i garette smoked and by that t i me even if smokers remained loyal to one 
brand, its c omposition could well have changed (Lee and Garfinkel 1981). 
Similarly , over a long follow- up period changes in other risk factors 
s uc h as d i e t and atmospheric pollution might well have occurred. 
Which Agents in Smoke are Harmful? 
Despite t h e s hortcomings outlined in the previous section there is 
ev idenc e that "tar" plays a role in cardiorespiratory disease in smokers 
and t hat t he r eduction i n average tar yields in recent years has had a 
beneficia l effect . The association is strongest between tar and lung 
cancer . 
It has been known for many years that painting cigarette tar on to the 
s ki-n of mice causes skin cancer (Wynder and Hoffman 1967). The major 
case con t rol and prospective studies have shown a reduction in bronchial 
c arcin oma risk associated with lower tar yields (Lee and Garfinkel 1981 
and Chapter 3 , s ecti on iv). There has been an over all reduction in 
bronch i al c arcinoma mortality in the U.K . in recent years. It has been 
mos t ma rke d in younger cohorts (Coggon and Acheson 1983) in whom it is 
also obse r ved i n the U.S. (Doll and Peto 1981). Since this fall has 
occurre d despite little change i n the over all level of cigarette 
cons ump tion , i t would appear that the recent change to lower tar 
c i garettes has r educed mortality from this disease. Further evidence 
comes from post-mortem pre-malignant histological changes which were less 
effect of an ingredient causing a disease being detectable. 
Unfortunately, as studies get larger the chances of a small but spurious 
association becoming statistically significant become greater (See 
Methods section v). In an epidemiological study, it is many years 
before sufficient disease has occurred to draw conclusions about the 
cigarette smoked and by that time even if smokers remained loyal to one 
brand , its composition could well have changed (Lee and Garfinkel 1981). 
Similarly, over a long follow-up period changes in other risk factors 
such as diet and atmospheric pollution might well have occurred. 
Which Agents in Smoke are Harmful? 
Despite the shortcomings outlined in the previous section there is 
evidence that "tar" plays a role in cardiorespiratory disease in smokers 
and that the reduction in average tar yields in recent years has had a 
beneficial effect. The association is strongest between tar and lung 
cancer. 
It has been known for many years that painting cigarette tar on to the 
skin of mi ce causes skin cancer (Wynder and Hoffman 1967). The major 
case c ontrol and prospective studies have shown a reduction in bronchial 
carcinoma risk associated with lower tar yields (Lee and Garfinkel 1981 
and Chapte r 3, section iv). There has been an over all reduction in 
bronchial carcinoma mortality in the U.K. in recent years. It has been 
mos t marked in younger cohorts (Coggon and Acheson 1983) in whom it is 
also observed in the U.S. (Doll and Peto 1981). Since this fall has 
occurre d despite little change in the over all level of cigarette 
consumption, i t would appear that the recent change to lower tar 
c i garettes has reduced mortality from this disease. Further evidence 
come s from post-mortem pre-malignant histological changes which were less 
marked in s mokers in the 1970s compared to the 1950s in the United States 
(Auerbach, Hammond and Garfinkel 1979). 
The exact mechanism by which tar causes lung cancer is not known. 
Certainly this fraction of cigarette smoke contains many carcinogens 
(initiators , promoters and cocarcinogens) (Surgeon General 1979). 
Despite these encouraging trends interest in other agents has grown for 3 
reasons: 
A number of volatile smoke constituents have been shown to be toxic in 
low concentrations in animals, e.g. CO causing vascular damage (Astrup 
1972), oxides of nitrogen causing lung damage (Freeman et al 1968) and 
aldehydes, acrolein and hydrogen cyanide poisoning cilia (Kesler and 
Battista 1963). 
The epidemiological studies generally have failed to demonstrate a strong 
association between tar yield and CHD mortality (Lee and Garfinkel 1981; 
Wald 1976) and possibly tar yield and prevalence of chronic air flow 
obstruction (Higenbottam et al 1980). 
Smokers may compensate for a reduction in tar and nicotine delivery of a 
cigarette by smoking more intensively. (Ashton et al 1979). Since the 
yields of, e.g. CO in the U.K. has fallen less than the tar, compensation 
could increase exposure to other agents. 
Of these agents attention has been directed towards CO because of its 
sUspected link with heart and vascular disease and oxides of nitrogen 
because of their alleged role in respiratory disease and as possible 
precursors for carcinogenic nitrosamines. 
For these r easons CO and NO and been chosen for this study. 
v) Manufacturing Methods and Formation of' CO and NO 
The chemical compos i tion of the smoke and hence, intuitively its 
toxicity, are determined by the type(s) of tobacco used in manufacture 
and the design of the cigarette, in particular the paper used in 
construction and a filter if incorporated. Four tobacco types are . used 
in cigarette manufacture (Bright (Virginia), Burley, Maryland and 
Oriental). There are several major chemical differences in the tobaccos 
due t o diff erences in the genetic makeup of the plant itself, the soil it 
is grown in and the way in which it is "cured" (dried) (Akehurst 1981). 
Soil nitrogen is the major determinant of tobacco growth (Chaplin and 
Miner 1980 ) and determines the yield of nitrates and other nitrogenous 
substances (including nicotine). There is an inverse relationship 
bet ween nitrogen containing and carbon containing substances probably 
resulting from synthesis of complex molecules depending on nitrogen 
availabi li ty (Surgeon Genera l 1979) thus high nitrate tobaccos are low in 
sugars and aromatic agents and vice versa. 
"Curing " is achieved by heating the tobacco leaf to 30-80 o C for 5-7 days 
("flue curing" ) or by storing the tobacco leaf at ambient temperatures 
for 3-12 weeks (air curing) (Baker 1981). This results in loss of water 
and other volatile substances and a change from green to brown due to 
loss of chlorophyll. Decomposition reactions during curing produce the 
high molecular weight polyisoprenoids and turpinoids responsible for 
flavour and aroma (Chaplin and Miner 1981). Though many complex reactions 
OCCur during the growing and cur ing process, it is possible to make some 
generalisati ons. Burley tobacco and most other forms of air cured 
t obacco are h igh in nitrate and low in reducing sugars (Akehurst 1981) 
and yield s mok e o f high (i.e. alkaline) pH. Flue cured (i.e. Bright 
Virginia) tobacco (and Oriental tobacco which is sun cured) are of low 
nitra te content, h i gh sugar content and yield smoke of low pH (Surgeon 
General 1979) . 
Followi ng c ur ing the tobac co is aged for 1-2 years before cigarette 
manufactu r e . It i s then shre dded , different blends are made by adding 
diffe ren t t obaccos (e . g . U. S . type , s ee s e c tio n l)and the blend is he l d 
together by a syrup s olution to wh i ch flavouring may be added (Surgeon 
Gener a l 1979). Since the 1950s material other than t obacco leaf has been 
a dde d to c i garettes . Thi s is principally the tobacco stem reconstituted 
i n to a s heet ( RST ) and though the rea s ons for its addition were initially 
e c onomic t h e s hee t c an be c hem i ca l ly treated to change the flavour or to 
a l ter c igare t te tar yield . Such changes have raised the nitrate content 
(Surge on General 1979) . Recent attempts to add non-tobacco material to 
U. K. c i gar e t tes were a commercial fiasco (Ashton and Stepney 1982). 
Thre e types of filte r a r e in use: cellulose acetate, ventilated and 
c har c oal. Cel lulose acetat e i s t h e most common and this reduces delivery 
of pa r ticl e s and s ome volatile con s t i tuents including n i trosamines 
(Brunnema nn, Yu a nd Hoffma nn 1977), "Ventilated filters" consist of a 
s e r ies o f perforation s clos e to t he mouth e nd of a cigarette and dilute 
t he s moke a nd a s i milar e f fec t is achieved by increased cigarette pape r 
porosity . Ch a r coa l filte r s are us ed in t wo cigarettes on the U.K. market 
(Lark a n d Gi tane s I n t ernat iona l ) a nd modify the volatile agents by 
adsorbing soluble g a s es (Tigglebeck 1975) . 
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TABLE 2 S01-1E COrlTEHPORARY DATA ON LABORATORY DERIVED SHOKING BEHAVIOUR 
Mean SDS in brackets. 
;'10. of Puff Vol. Puff Duration Puff Interpuff Butt Len!:2th Inhaled Vol. Type of Environment Reference Subjects (ml) (SE) (s) No . I nterval (s) ( rrrn ) ( ml) CiGarette 
--- --- - -- - ---
( 1) 32 37 . 2 2.20 1 Lf. 3 27 . 4 30 . 6 not standard - UK i n EEG (Come r & Cre i Ghton 
ised Labora t ory 1978 ) 
32 33 . 4 2.16 12 . 0 39 . 7 29.2 
21 1. 92 9 . 1 52 . 7 28 . 2 Surreptitious (Comer & Creighton 
observat ion 1978 ) 
in lounGe 
( 2) 8 38 .5 1. 85 12 40 . 7 Usual c i g . rcrencil (Guillerm and 
sl'loKin;:s lab. Radzisevs~y 1978 ) 
( 3) 10 44 .2(12.7 ) 1. 88 ( 0 . 91 ) 25 . 9 ( 14 . 5) 6 14(358) Usual c i G. UI( lab . (Adams et al 1983) 
( 4) 10 52 ( 15) 84 1( 517) LT US lab . (Tobin & Sackner 
1982) 
10 39 ( 10) 748 (323) fIT US lab . (Tobi n I:: Sacker 
1982) 
( 5) 6 64 (21) 8 13( SC91) ;·; iddle t G.r m,: l ab . (Rees et al 1982 ) 
44 2 . 00 11. " 37 . 3 75 l t Overall Inean 
TABLE 3 
COt1POSITION OF' CIGARETTE S110KE 
(U.S. ciGarettes) (Norman 1978) 
l.fhole Smoke : 58% 
12% 
13% 
Particulates 8% 
Other Gas Phase AGents 
CO 3.5% 
0.5% 
Gas Phase: 
Group No. Largest Representative 
Aldehydes (saturated) 13 Acetaldehyde 
Alkanes 17 Methane 
Alkenes 41 Isoprene 
Ethylene 
Ketones (saturated) 14 Acetone 
Nitriles 13 HCN 
Acetonitrile 
Nitrogen compounds 15 NO 
Alcohols 7 Methanol 
Halogenated hydrocarbons 6 Methyl Chloride 
Sulphur compounds 37 H2S 
Aromatic hydrocarbons 17 Toluene 
Aldehydes (unsaturated) 5 Acrolein 
Heterocyclic 0 10 2-Methyl furan 
Ketones (unsaturated) 4 Butane 
Esters (s atura t ed ) 12 Methyl formate 
Alkynes 5 Acetylene 
Esters (unsatura ted) 2 Vinyl acetate 
Cyell c hydrocar bons 12 Cyclohexane 
QuantH:,: 
(meg/cigarette) 
1200 
800 
400 
160 
350 
300 
140 
300 
180 
160 
90 
80 
70 
50 
30 
30 
25 
4 
3 
TAUU: '1 
!.IUANTITATIVE DATA ON TilE PARTICULATE PHASE 
Group 
riumcctant 5 
Nicotine , flornicot i n e 
Leaf pigment 
Hydr ocarbons 
Carboxy l i c a" id s 
Waxes 
Phenol s 
Aldehydes 
Other PyrIdine" 
PhytosteroI~ 
Aminoaeids 
Amldes 
Metal s 
Aliphatic amines 
Lactams 
Cyclic amines 
Indoles 
PA H 
Naphthalene s 
Nitro compo und s 
Carbazole s 
Nltroamine s 
Aromatic :'\m ln e ~ 
Ketones 
Al co hol s 
Este r " 
~ a c t()ne ~. 
T o I.~ l J 
mg/ c ig 
3. 0 
1.6 
1.5 
1.5 
\ . 2 
1.12 
0.6 
0.5 
0.3 
0.2 
0.18 
0.1 
0.1 
0 . 065 
0.05 
0.04 
0 . 03 
0 .005 
0.004 
0.004 
0.002 
0 .0001 
12 . 1 
25.4 
13 .2 
12 . 4 
12 . 4 
9.9 
9.3 
5.0 
4. 1 
2.5 
1 . 7 
1.5 
0.8 
O.B 
1.7 
100.0 
Major Components 
glycerin, propylene glycol 
neophytadiene, Ilmonene 
acetic, linolenic, palmitic acids 
n-C31 
phenol, catechol, hydroqulnone 
furfural, benzaldehyde 
pyridine, methyl pyrldlnes 
stigmasterol 
a-alanine 
acetamide 
K 
methylamine 
cotlnlne 
pyrrolldlne 
Indole 
phenanthrene 
methylnaphthalenes 
nitroe thane, 2-nitropropane 
c arbazole 
N_nitrosonornicotine 
aniline 
a ce tophenon e 
many hydroxy acids 
many methyl and solanesyl este r s 
y -bu tyrol ac tone 
When a smoker takes a puff from a cigarette he takes about 40-50 ml of 
fresh smoke into his mouth, holds it there for about 2 seconds then draws 
in about 700 fI1l of fresh air through the mouth and inhales the diluted 
smoke into his lungs. This results in dilution of the smoke by 12-15 
fold by the time it reaches the alveoli (see Table 2). The duration of 
the inhalation is about 4-8 seconds (See Diagram 14.6, 14.7 and 28.4 in 
Guillerm and Radzizewski 1978). The smoke he takes in is known as the 
Ilmainstream il and what comes from the smouldering tip in between puffs is 
the "sidestream". The mainstream smoke consists of 60% air and 20% 
s imply gases formed by decomposition and combustion (CO, CO and H Y. The 
2 2 
remainder consists of 8% which are aerosol particles of mass median 
diameter 0.18 m (logarithmic sd 0.4 ~m (Baker 1981) and 5% agents that 
are volatile at room temperature. Conventionally the smoke is divided 
i nto the gas and the particulate phase, the latter being the material 
trapped when the smoke is passed through a Cambridge glass fibre filter. 
Table 3 shows quantitatively that CO is present in relatively large 
amounts (approximately 3-5% of the smoke) and oxides of nitrogen form 
quantitatively the largest amount of the nitrogen containing species in 
the gas phase. The remainder of the gas phase consists of low molecular 
weight (and therefore volatile) hydrocarbons, alcohols, aldehydes, 
ketones , esters, and nitrogen and sulphur containing species. The 
particulate matter consists of a very large number of compounds, many in 
minute quantities (Norman 1978). It can be seen from Table 4: that 
nicotine is the second most abundant compound by weight and most 
attention has been directed toward it. 
It is customary to subdivide the two phases into classes of compound with 
different biological activities based on animal exposure experiments. 
The gas phase contains agents which are toxic to cilia (volatile 
3S 
aldehydes, hydrogen cyanide and acrolein) (Battista 1963), carcinogens 
(volatile nitrosamines) (Surgeon General 1982) and a miscellaneous toxic 
group of which CO and NO are the most important members. The particulate 
matter contains the vast majority of cancer producing activity. This is 
divided into initiators (e.g. benzapyrene, polyaromatic hydrocarbons an9 
tobacco specific nitrosamines) which induce cancer development, 
promotors, (e.g. volatile phenyls) that accelerate induced tumour growth 
and co-carcinogens (e.g. pyrene) which enhance the activity of initiators 
and promoters (Surgeon General 1982; Surgeon General 1981). 
Formation of CO and NO 
When a cigarette burns heat is given out by combustion. This heat is 
used to drive three heat requiring (endothermic) processes: "mass 
transfer" (distillation of liquids into vapour and sublimation of solids 
into vapour) , "pyrolysis" (breaking down of complex molecules into 
simpler ones), and "pyrosynthesis" (recombination of molecules generated 
by the other two processes). All the compounds in cigarette smoke are 
produced by one or more of these processes and recent work using mass 
spectrometry, radiolabelling and thermocouple "probe techniques" has 
helped characterise some of them (Baker 1981). 
When a puff of smoke is taken air is drawn by the path of least 
resistance which is just behind the burning paper. This becomes hottest 
and "advances" towards the smoker conducting heat in front and promoting 
distillation and pyrolysis. These processes leave the familiar black 
carbon rich residue in the centre of the coal which between puffs becomes 
the hottest region as the periphery cools down. The hottest zones have 
been shown to have a temperature of 900 o C, to be rich in hydrogen and to 
be virtually devoid of oxygen which is rapidly consumed in combustion. 
Carbon monoxide i s believed to be formed by 3 processes: 
Incomplete combusti on of carbon rich material. 
Thermal decompos ition of high molecular weight molecules. 
Reduction of carbon dioxide (C + CO 2CO) • 
2 
The contributions of each of these 3 processes is not known but smoking a 
cigarette in air containing labelled oxygen results in over half the · CO 
being labelled (i.e. most is derived from 1 and possibly 3). 
Nitric oxide i s formed by thermal decomposition of inorganic nitrate in 
the tobacco. If a cigarette is "spiked" with labelled nitrate the label 
is found in NO (Johnson et al 1977). Nitrogen dioxide was reported in 
earlier studies (Bokhoven and Niessen 1961; Haagen-Smit, Brunelle MF and 
Hara 1959 ) but this was probably due to smoke ageing prior to analysis. 
Later studies report only NO (Barkemeyer and Seehofer 1968; Norman and 
Keith 1965) . This is to be expected since NO is completely broken down 
2 
into NO and oxygen above 600°C (Cotton and Wilkinson 1980). 
Knowledge of the processes of formation allows explanation and prediction 
of how changes in cigarette manufacture will affect delivery. Adding a 
cellulose acetate filter removes particles and hence should reduce tar 
and nicotine but will not affect CO delivery (Baker 1981). Increasing 
air entry by increasing paper permeability or using a ventilated filter 
will reduce all constituents by dilution of the mainstream smoke (Baker 
1981). Because more of the puff drawn is derived from the side of the 
Cigarette, less air is drawn through the burning tip which then becomes 
COHb 
74% 
60% 
50% 
30% 
20% 
18% 
15% 
9% 
2 .8% 
Notes 
1. 
TABLE 5 
BIOLOGICA L EFFECTS OF CARBON 
CO Duration Species ( ppm) 
2400 40- 100 days Mice 
(0.24%) (10 day 
run - in) 
800 45 mins. Rabbits 
Man 
minutes Man 
Man 
Pregnant 
Mice 
170 10 weeks Rabbits 
100 6 hours Monkey 
50 2 hours Man 
1% = 10,000 parts per million 
MONOXIDE 
Effect Reference 
tBlood vol. t Hb. Zebro, 1976 
t Lung permeability Fein et al, 1980 
Coma 
Headache, confusion 
• Mental ability Turino, 1981 
• Birth weight Turino, 1981 
Atherogenesis Astrup, 1972 
• Threshold for VF de Bias, 1974 
post induced myo-
cardial infarct. 
• Ex. tolerance in Aronow (Turino 1981) 
patients with angina, 
leg claudication and 
airflow obstruction 
2. % COHb~ 3 x %CO x exposure time in minutes (Turino 1981) 
3. Max. Los Ange l es air pollution 14 ppm (Turino 1981) 
4. A U.K . middle tar cigarette yielding 19 mg. CO contains 4.6% CO in a puff 
(Rothwell & Gr ant 1974). 
cooler as less oxygen is drawn through it. Consequently distillation, 
pyrolysis and pyrosynthesis are reduced and the delivery of all 
constituents is correspondingly less . Increased paper permeability also 
a llows i ncreased diffusion of low molecular weight gases like NO and CO 
from the side of the cigarette. A charcoal filtershouldnot affect CO and 
NO yield bec ause they are both insoluble (Tigglebeck 1975). In the case 
of NO the over-riding consideration appears to be the quantity of nitrate 
in t h e tobacco and method of curing (Akehurst 1981) • These 
considerations do not appear to affect CO yield. 
vi) Health Effects of CO (See Table 5) 
CO is a gas of molecular weight 28. It is stable in air and relatively 
unreactive but at high temperatures undergoes oxidation to CO by oxygen. 
2 
(One potentially extremely important reaction is combination with the 
free hydroxyl radical which is quantitatively the major fate of CO in the 
atmosphere (Khalil and Rasussen 1984). It is possible that CO in 
c igarettes undergoes similar reactions to "abort" free radical chain 
reactions). Of grea t biological importance is its capacity to form 
complexes via weak bonds to trans i tion metals. In this way it combines 
with the iron in haemoglobin and myoglobin and the copper in the 
cytochromes. The forward reaction of the combination is in fact 
relatively s low, (Gibson 1959) rather slower than that for oxygen, but 
the back reaction is very much slower than for oxygen so the net effect 
is the f ormation of a stable compound carboxyhaemoglobin (COHb) which is 
only slowly broken down. This compound will not transport oxygen and 
therefore reduces the oxygen carrying capacity of the blood. It also 
c auses a shift of the oxygen dissocation curve to the left (West 1979). 
41 
There is a large literature on the alleged toxic effects ·of carbon 
monoxide undoubtedly because it is easy to measure in the atmosphere and 
easy to quantify exposure by measuring the blood carboxyhaemoglobin 
concentration. Knowledge of its health effects have come from 
theoretical predictions based on its known reaction with haemoglobin, 
experiments where animals have been exposed to CO for prolonged periods 
and experiments where humans have been exposed to CO for short periods. 
Information has ·also come from the case histories of patients who have 
been poisoned by CO. There is very limited epidemiological information 
on atmospheric CO due to its coexistence with other pollutants and until 
this study there were limited epidemiological data relating to its 
toxicity in cigarette smoke. 
The effect of CO in combining with haemoglobin and reducing oxygen 
saturation coupled with its effect on shifting the haemoglobin 
dissociation curve to the left will reduce the capacity of the blood to 
carry oxygen and its ability to deliver oxygen to tissues, thus a heavy 
smoker with a carboxyhaemoglobin saturation of 15% (Wald et al 1981) 
would have an oxygen saturation of 97.5% - 15% = 82.5%. This saturation 
could also be achieved by dropping the alveolar PO to about 50 mm of 
2 
mercury e.g. by rapidly ascending to 15,000 feet (West 1979). The effect 
of carbon monoxide however, would be greater than just hypoxia due to the 
left shift interfering with oxygen transport. It has been proposed 
therefore that CO induced interference with oxygen transport would be 
particularly harmful where transport was critical e.g. in patients with 
pathologically narrowed coronary arteries with respiratory failure and in 
the placental transfer of oxygen to the fetus (Surgeon General 1979). 
prolonged exposure to CO in . animals affects the heart, blood vessels, 
haemopoetic system and fetus. Astrup induced "atheromatous" lesions of 
the aorta by exposing cholesterol fed rabbits to 170 ppm CO for 10 weeks 
achi eving COHb saturations of 15% (Astrup 1972). A similar lesion was 
induced by reducing the oxygen concentration in the chamber to 16 or 10% 
and could be reversed by hyperoxia suggesting that hypoxia was the 
mechanism (Astrup 1972). In primates exposure of macaca monkeys to 250 
ppm of CO induced similar lesions in the coronary arteries to those of 
CHD in man (Thomsen and Klem 1974). Exposure to CO for prolonged periods 
also results in an increase in heart size. Penny found that exposure of 
r ats to 200 ppm for 30 days giving an HbCO of 15.8% caused a significant 
increase i n heart weight (Penney, Benjamin and Dunham 1974). In contrast 
to the effect of hypoxia which only causes right ventricular enlargement 
he observed enlargement of both right and left ventricles indicating that 
the effect of CO is not just that of hypoxia causing pulmonary 
hypertension and right heart strain (Penny et al 1974). Exposure also 
causes other effects on the blood and circulation. 0.24% (2,400 ppm) 
giving a COHb level of 74% in mice doubled the haematocrit and quadrupled 
the blood volume . The adaptation of the circulation to withstand high 
COHb c oncentrations is well illustrated by this work. Using a 10 day 
"run in " period Zebro's mice could withstand CO concentrations that would 
otherwise be rapidly lethal. Interestingly splenectomy which reduces 
erythropoesis was associated with increased survival (Zebro et al 1976). 
Similar concentrations and exposure periods also induce changes in bone 
tissue which were related to increased blood flow (Zebro et al 1983). 
Prolonge d exposure of pregnant rabbits giving levels of COHb of 9-10% 
produced a reduction in birthweight and an increase in neonatal mortality 
(Astrup 1972). 
13 
Short exposure in animals appears to affect the heart's electrical 
stability: De Bias et al demonstrated a reduced threshold for induced 
ventricular fibrillation in monkeys in whom experimental myocardial 
infarction had been induced following exposure to 100 ppm CO giving a 
COHb concentration of 9% (De Bias et al 1974). 
Acute exposure studies in men have shown effects in both normal 
individuals and those with impaired circulation, however, there is also 
evidence of compensation. In healthy individuals exposure to 225 ppm 
achi eving COHb saturation of 18-21% showed a rise in lactic acid 
product ion and reduction in oxygen consumption indicating a shift to 
anaerobic metabolism due to loss in blood oxygen carrying capacity (Vogel 
and Gl aser 1972). In contrast to hypoxia there is a lesser 
card i ovascular response at rest and ventricular response on exercise with 
CO. As well as increasing anaerobic metabolism, compensation occurs by 
greater ' tissue extraction of what oxygen is available (Turino 1981). 
Following exposure of 10 men with stable angina to 100 ppm CO for 4 hours 
on 5 successive days Anderson noted a reduction in treadmill exercise 
tol e rance with angina and accompanying ST segment changes appearing 
s ooner than in controls (Anderson et al 1973). Aranow claimed similar 
resul t s by r aising COHb concentrations to 5% by driving individuals on a 
Los Angeles freeway and exercising them after (Aranow et al 1972). Apart 
from the obvious reduced tolerance of such patients to reduced oxygen 
delivery their coronary arteries are unable to increase blood flow in 
respons e to CO exposure unlike healthy controls (Ayres, Gianelli and 
Mueller 1973). From cardiac catheter measurements Aranow demonstrated a 
negative inotropic effect of CO in patients with angina and documented 
CHD (Aranow, Stemmer and Isbell 1974). Similar types of experiments have 
4+ 
been perfo r me d on pati ents with arteriographically demonstrated vascular 
disease of the legs. Breathing 50 ppm CO for 2 hours and increasing the 
COHb concentration to 2.77% significantly reduced the time to onset of 
ca l f and t high pain on bicycle ergometer exercise (Aranow et al 1974). 
I n addi t ion , in patients already hypoxic from established chronic air 
flow obs t r ucti on 100 ppm for one hour giving a COHb of 4% significantly 
r educed exe r c ise to l erance (Aranow et a l 1977) and these results were 
repeated by a British gr oup (Calverley, Leggett and Flenely 1981). 
Since t he brain and heart are the organs most sensitive to interference 
in t he i r oxygen s upply the effects of a cute CO toxic ity are pr edictable. 
Acute exposure to CO to rai se the COHb concentration to 30% causes 
headache and naus ea and about 50% causes coma, convulsions and death. 
Exposure to CO i n c oncent r ations in excess of 5% can result in fatal 
dysrythm ias and dea th before the COHb is significantly elevated (Stewart 
1976) . I nte r estingly pulmonary damage may also occur during CO 
poisoning. Radiologica l e vi dence of i nterstitia l chan ge s are well 
describ ed (Sone et al 1974) and isotopic clearance studies suggested that 
"shock l ung " a dul t respiratory distress like lesions with increased 
alveolar ep i thelial membrane permeability may be responsible (Fein et al 
1980) . Ther e are few ep i demiological studi es spec i f i cal ly relating 
atmospher ic CO t o dis ease. However, one group demonstrated an increased 
fatality rate from myocardial i nfarction in 35 Los Angeles hospitals in 
1958 in areas of "high" ai r pollution that occurred dur ing per iods of 
increased CO pollution (Cohen, Deane and Goldsmith 1969). Interestingly 
a study of motor vehic l e exam i ner s in New Jersey showed an increased 
exposure to carbon monoxi de and increased susceptibil i ty to 
cardiovascu l a r deaths and also to cancer (Stern, Leman and Curtis 1981). 
The exces s of cancer deaths could possibly indicate that CO was 
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carcinogenic but the authors thought it more likely that CO was a 
"marker·· for carcinogens in exhaust. Until recently CO measurements were 
not made on cigarettes so it was not possible to relate CO exposure to 
disease risk as was possible for tar e.g. in the American Cancer 
Association studies. However, Wald et al documented an association 
between CO exposure as measured by carboxyhaemoglobin levels and symptoms 
of CHD and peripheral vascular disease in smokers (Wald et al 1973). 
Until this study was started there were no publications attempting to 
link smokers· cigarette related CO exposure to disease. 
vii) Health Effects of NO 
Two oxides of nitrogen, nitric oxide (NO) and nitrogen dioxide (NO) have 
2 
been isolated from tobacco smoke (Norman and Keith 1961). Both NO and 
NO possessed unpaired electrons and are therefore by definition II free 
2 
radicals·· but NO is far more reactive than NO. There are, however, two 
2 
reactions of NO that have been well characterised and are of great 
i mportance in understanding its potential toxicity. The first is 
oxidation to NO . Oxidation by oxygen is instantaneous at concentrations 
2 
of 1% NO in air and above but since the rate is proportional to the 
square of the NO concentration it slows markedly as the NO concentration 
falls (see Table 6). Oxidation by ozone and oxygen centred free radicals 
proceeds faster and the latter species have been demonstrated in the gas 
phase of cigarette smoke (Pryor, Prier and Church 1983). The other 
biologically important reaction relates to the ability of NO like CO to 
form complexes with transition elements such as iron in haemoglobin to 
form nitrosylhaemoglobin (NOHb) , methaemoglobin (metHb) and nitrosyl 
methaemoglobin (NOmetHb) (Toothill 1967; Doyle and Hoekstra 1981). NO 
also forms similar complexes with myoglobin (Hoekstra 1981) and 
Cytochromes (Boelens et a1 1982). 
NO , unlike NO, is thermally unstable decomposing completely into NO and 
2 
o above 600°C (Cotton and Wilkinson 1980). It reacts with water to form 
2 
nitrous and nitric acid and is a reactive oxidising agent (i.e. it 
accepts electrons). Thus it attacks double bonds, e.g. in the 
unsaturated f'atty acids in surfactant (Rowlands and Gause 1971), or 
"abstracts" hydrogen atoms from carbon or sulphur. A potentially 
important reaction is the abstraction of hydrogen from an amine to . 
produce a nitrosamine. Nitrosamines are potential carcinogens (Surgeon 
Genera l 1982) . This reaction does not occur with NO in isolation but if 
a small amount of NO is added to the reaction vessel then NO is 
2 
i ncorporated to form nitrosamines (Challis and Kyrtopoulos 1976). The 
initial products of the reaction of NO with organic molecules are 
2 
usually highly reactive ·intermediates and chain mechanisms often set up 
producing further reactive and potentially toxic compounds. 
Toxicity of NO 
2 
Much of the literature on the toxicity of oxides of nitrogen is devoted 
to NO since it is believed to be the more toxic and it is difficult to 
2 
maintain an NO free atmosphere in exposure chambers when attempting to 
2 
study NO in isolation. Knowledge of the biological effects of NO comes 
2 
from experiments when animals have been exposed to low concentrations for 
long periods or high concentrations for short periods, where humans have 
been exposed to NO and from epidemiological surveys. Unfortunately 
2 
unlike CO there is no "exposure index" comparable to COHb and hence the 
interpretation of different experiments is difficult because of differing 
exposure cond i tions and species differences . Nevertheless, broadly 
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similar eff ects a r e observe d in a nimals a nd men over a range of . exposure 
levels. Tabl e 7 s hows the chief b i ological effects of NO . 
2 
The fo l lowing s hows the chief biological effects of NO • 
2 
Unlike more 
soluble gases s uch as SO, NO has been shown to pass directly to the 
2 2 
alveolus an d t hence to be absorbed using lung model experiments (Ichioka 
1972), by radiolabelling studies (Goldstein et a l 1977) and by low dose 
up take exp e rime nts in man (Wagner 1970). It is therefore understandable 
that t h e lung is the chief target of NO damage. Acute exposure of man 
2 
or a n i ma ls to ove r 100 ppm for more than a few minutes causes death from 
pulmonary oe de ma. Follow i ng brief exposure t o these levels full recovery 
is poss ib l e, but pulmonary fibrosis and obliterative bronchiolitis may 
result. Sh or t exposure to 10- 100 ppm i s not generally fatal but human 
subjects note c hest and ey e discomfort a nd diffi c ulty breathing 
Chronic exposure of an i ma l s to concentrations in t his range cause 
bronchiolit i s a nd emphysema (Freeman e t al 1968). Ther e is much debate 
a s to whether occupationa l e xposure a s has occurred in the past to miners 
(Kennedy 197 2 ) , we l der s (Morley and Silk 1970), and farm workers (Ramirez 
and Dowe l l 1971 ) c auses a similar l ung lesion . It is difficult to 
differenti a t e the effects of other occupational risk factors for chronic 
lung disease s uc h as coa l dus t, s ilage (farmer's lung) and above all the 
effect of cigarette s mok ing (Ramire z and Dowell 1971). Below 10 ppm i t 
is believ ed t hat no effect on a nimal longevity is observed nor do gross 
anatomi cal c hang e s occur though ultrastructural effects are well 
descri b ed ( Mus t a f a a nd Ti erney 1978) . In man these concentrations 
produce an i ncreas e i n ai rways resistance and reducti on i n gas transfer 
but below 1 ppm phy siologi c a l c hanges appear confined to asthmatics 
(Orehek et al 1976). The changes in ultrastructure below 10 ppm exposure 
in an ima ls are loss of cilia, hypertrophy of terminal bronchioles, 
increases in the number of type II pneumocytes and loss of collagen 
(Mustafa and Tierney 1978). Similarly changes in biochemistry such as 
increased protein alveolar exudation, increased collagen turnover, 
reduced GSH levels and reduced enzyme activity, perhaps related to active 
site damage, occur (Mustafa and Tierney 1978). An important observation 
following NO e xposure is the production of nitrosamines (potential 
2 
carcinogens) both in the intact animal (Iqbal, Dahl and Epstein 1980) and 
in the iso lated perfused lung (Postlethwaite and Mustafa 1977) . 
Th ree i mportan t epidemio log ical studies have looked at the effect of low 
l evel NO (less than 1 ppm) exposure in circumstances where interference 
2 
from other pollutants was les s likely. Shy et al noted an increase in 
respiratory illness in families with high (0.15 ppm NO ) exposure due to 
2 
prox i mi t y t o a TNT factory (Shy et al 1970). Melia and colleagues noted 
inc r eased NO concen trations in homes with gas cooking (Melia et al 
x 
1982a) in t he U.K. and an increased frequency of respiratory infections 
in the occup ants of such homes (Melia et al 1982b). Speizer (1980) 
confirmed the re lationship of increased frequency of respiratory illness 
and also noted a reduced FEVI in the occupants of such homes (Speizer et 
al 1980) . 
Toxicity of NO 
There is substantially less information about exposure to NO. Our 
knowledge about high level exposure to NO comes from a series of 
accidents in which nitrous oxide (N 0) for use in general anaesthesia 
2 
be came contami nated by higher oxides of nitrogen (Clutton Brock 1967) and 
from the investigations that were set up in the wake of these accidents. 
T ABLE 8 
BIOLOGICAL EFFECTS OF 
_Concentrati 0rl. Duration S~ecies 
20 ,000 ppm (2%) Dog 
I 5-136 mins 
5 , 000 ppm ( . 5%) 
43 ppm 6 days Rabbit 
40 ppm 
I 
15 mins ~lan 
5 ppm 
2-10 ppm 1 hour ~11ce and 
Rats 
1 ppm 2 hours I~an 
NO 
Effect Reference 
Death Greenbaum 1967 
met. Hb.1' 
Hypoxia 
Acidosis 
Pulmonary oedema 
No effect Hugod 1979 
met. Hb.l' Von N1ed1ng 1973 
DL CO J, 
RA l' 
w 
NOHbl' Oda 1975 
RA t KagaIVa 1982 w 
Exposure of dogs to 0.5-2% of NO led to death in 7-50 minutes. Cyanosis 
became visible within a few minutes of exposure and this was believed to 
be due to metHb formed and to hypoxia thought to result from acidosis 
causing a shift of the Hb dissocation curve and reduced alveolar 
capi llary PO from pulmonary oedema (Greenbaum et al 1967). 
2 
At these 
concentrations the rate of oxidation of NO to NO becomes competitive 
2 
with its reactions with Hb so inevitably there would have been NO in the 
2 
mixture also. Exposure to concentrations such as 3-20 ppm NO which are 
stable in air appear to elevate metHb levels in man (Case, Scholey and 
. Dixon 1975; Von Nieding 1973) and perhaps NOHb levels in animals (Oda, 
Kusumoto and Nakajima 1975) but do not seem to cause ultrastructural 
damage i n animals (Hugod 1979a; Hugod 1979b). Kagawa's group noted a 
r e duc tion in some of the airways specific conductance at levels at low 
as 1 ppm (K.agawa 1982). An effect on coronary blood vessel calibre has 
been suggested (Gruetter et al 1980). 
Because of the continuous conversion of NO to NO in the atmosphere there 
2 
are no epidemiological studies of exposure to NO in isolation. Though NO 
i n i solation will not form nitrosamines (Challis and Kyrtopoulos 1976) in 
a c omplex mixture such as cigarette smoke nitrosation by NO is believed 
to oc cur (Neurath, Dunger and Pein 1976) giving NO carcinogenic 
potent ial. 
Until this s tudy was started there were very limited data on cigarette 
oxide of nitrogen yields. Accordingly no attempt had been made to use 
cigarette NO data for epidemiological purposes. The next chapter 
describes the analysis of cigarettes for oxides of nitrogen. 
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CHAPTER 3 
GENERAL METHODS 
i) Use of' Chemiluminescence to Measure Nitrogen Oxides in Cigarette Smoke 
and Alveolar Air 
Introduction 
Analysis of cigarette smoke poses two formidable problems: firstly the 
large number of chemical compounds (approximately 3,600) (Green et al 
1980) which may interfere with the species of interest, and secondly the 
possibilities for interactions between the ingredients, so that, unless 
analysis is carried out immediately the yield obtained may not reflect 
that in the fresh smoke. 
The original descriptions of nitric oxide in cigarette smoke use 
colorimetric methods such as the Saltzmann technique (Norman and Keith 
1965) which was widely used to detect oxides of nitrogen in polluted 
atmospheres (Saltzman 1954). This method relies on oxidation of NO to NO 
2 
which is then reacted with sulphanilic acid to form a diazonium salt 
which couples with N-C1-ethylamine diamine hydrochloride to give a red 
dye which can be estimated colorimetrically. Colorimetric methods, 
however, are inconvenient, they are slow (oxidation to NO may take an 
2 
hour) and only one cigarette can be analysed at a time. 
A number of physical methods have been described, again "borrowed" from 
methods used for estimation in polluted atmospheres. The 
chemi l uminescent method is the most widely used and is that recommended 
by the Tobacco Research Council (Rothwell and Grant 1974) and adopted by 
the laboratory of the Government Chemist. The principle on which it is 
based is that if NO is reacted with ozone it is converted to activated 
NO , which emits light in the range 600-3000 nm (visible light is 420-750 
2 
nm) on returning to the ground state (Clyne, Thrush and Wayne 1964). 
NO + 0 = NO + 0 
3 2 2 
NO NO + h y(light energy) 
2 2 
The chemiluminescent reaction is not exclusive to NO. Light is emitted 
by the r eaction of CO and NO with ozone (Fontijn, Sabadell and Ronco 
2 
1970) and interference by hydrocarbons such as isoprene (Copeland RG, 
Laboratory of the Government Chemist, personal communication) has been 
described. Choosing an optical filter with a sharp "cut-off" will 
eliminate such interference (Fontijn, Sabadell and Ronco 1970). 
Similarly high concentrations of CO will quench i.e. reduce the signal 
2 
(Klimisch and Kircheim 1977). This may be reduced by diluting the sample 
containing NO in a stream of nitrogen immediately prior to the reaction. 
Becaus e of the rapid oxidation of NO to NO each puff has to be analysed 
2 
as soon as it is drawn ("puff by puff analysis") (Williams 1980). 
Generation of the smoke Sample 
Generation of smoke for analysis requires a machine to smoke the 
cigarette and the sample so produced to be presented to the analyser. In 
the 1920s as interest first turned to the analysis of cigarette smoke 
highly variable results were reported (Bradford Harlen and Hamer 1936). 
Bradford et al attributed the variability to lack of standardisation of 
techni que and laid down guidelines for a successful smoking experiment 
that are still highly relevant today. 
It shou ld be reproducible. 
2. Th e smoking procedure, the cigarettes smoked and the 
envi r onment while smoking should be definite~y characterised. 
3, It should sufficiently approximate the conditions of human smoking to 
admit of interpretation in vivo . 
He then desc ribed a device that smoked a "cigaret" at the rate of a 35 ml 
puff of 2 seconds duration taken once per minute. These criteria were 
"arbitrarily selected" after observing some individuals smoking. They 
are now us e d as the standard for smoking machines in many countries 
inc l uding the U.K. (Rothwell and Grant 1974), It is of great interest 
that an early German worker (Pfyl 1933) also observed a group of smokers 
and arbitrarily chose a regime of a 40 ml puff of 2 seconds duration 
t aken twice a minute . It can be seen (see Table 2) that Pfyl's 
observations more closely approximate to recent laboratory smoking 
studies than do the universally adopted criteria of Bradford. 
Mo dern smoking machines may e ither s moke a single cigarette at a time 
(single port device ) or a large number (manifold or multiple port 
devices). I n principle a machine has some sort of suction to draw a 
constant vo lume with a constant profile and duration from a cigarette. 
As a c igarette burns it gets shorter so the resistance to flow may change 
tending to alter the profile and volume/time relationships. Various 
r egu stors have b een developed to overcome this difficulty. In the U.K. 
guidelines hav e been laid down for analysis to ensure uniformity between 
laboratories ( Rothwell and Grant 1974). 
c lose l y. 
I adhered to these guidelines 
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BAT Smoke Nitric Oxide Analyser 
This device was developed at British American Tobacco Research and 
Development Headquarters in Southampton and I used one of the early 
models. An identical machine is built by Chemlab Ltd. and the laboratory 
of the Government Chemist uses one of the Chemlab machines. 
Fig. 2 
illustrates the layout of the device. 
The sample of smoke is drawn into the machine by a vacuum pump and the 
aspiration rate is set by a needle valve to be 120 ml per minute. The 
-gas sample valve is then manually opened and the sample enters the sample 
loop where is it mixed in a stream of nitrogen travelling at 120 mIl 
minute. The sample then reaches the reaction cell where it reacts with 
ozone. The ozone is generated by passing a stream of oxygen at 30 ml per 
minute through an EHT (7,000 volts) discharge. The light generated by 
the reaction then passes through a red filter to a photomultiplier cell. 
The electric current so generated is amplified, passed through an 
attenuator and measured on a graph recorder. The attenuator has a push 
button range of 1- 50 times allowing a wide range of NO concentrations to 
be estimated. (The manufacturers quote a range of 1-5,000 ppm with 
linearity, accuracy and reproducibility of +1- 1%). Because the signal 
is flow dependent (Steffenson and Stedman 1974) there are pressure 
regulators with manual controls for nitrogen, oxygen and vacuum. These 
are adjusted using a bubble displacement column containing detergent in 
low concentration. In practice adjustment is only rarely required since 
the device is very stable once set up. 
Calibration and interfering species 
It is recommended (Rothwell and Grant 1974) that calibration is performed 
using a series of standard gas concentrations, covering the range of 
1.00-1000 ppm NO in nitrogen with certificates for analysis accompanying 
each cylinder. The cylinders need to be aluminium lined to prevent 
deterioration of gas mixture and even then the manufacturers guarantee 
concentration for only 6 months. Since each cylinder costs over £80 this 
becomes an expensive addition to a research budget I I calibrated at the 
beginning and end of each day using a 52 ppm mixture and a 1000 ppm 
mixture when high NO yielding cigarettes were smoked. 
Lineari ty, interfering specieB and "quenching" 
Exp e riments to address these subjects are described in Chapter 4. 
Use of the Nitric Oxide Analyser for detection of NO in exhaled breath 
Investigation of the rate of uptake of NO in the concentration in a 
smoker's alveoli requires that the instrument can detect over the range 
?O ppm down to 1 or 2 ppm since it is known that 90% of NO is retained in 
the lung during rebreathing (Wagner 1970). Because of this the 
instrument needs to be linear over that range and there needs to be no 
i nterference from CO nor from respiratory gases such as oxygen nor with 
2 
helium that may be added to the NO to allow for dilution. 
Experiments to confirm these operating characteristics are described in 
Chapter 5. 
57 
ii) Measurement of' gas uptake !'rom the ltmg 
Measuring the rate at which a gas is taken up from the lung gives 
information about the lung, its blood flow and ventilation as well as 
helping to understand the gases' toxicology. Measurement of the 
concentration of the gas within the lung is particularly important in 
determining the toxicology of a gas such as NO or NO 
2 
effects entirely dependents on the 
since the spectrum 
concentration (see of biological 
Chapter 1). Uptake of gas from the lung in man can be measured either by 
observing the disappearance of gas from the lung or its appearance in the 
blood stream . Both approaches have been used in this study. The next 
chapter di s cusses measuring pigments in the blood derived from inhaled CO 
and NO. 
The simplest way to quantify gas uptake is to breathe a mixture 
containing the gas under study and to separate inspired and expired 
bre ath and monitor the concentrations of gas in inspirate and expirate 
dur i ng a period of "steady state breathing". The difference in the two 
concentrations divided by the inspired concentration gives the fraction 
r etained (commonly given as a percentage). If the minute volume breathed 
i s a lso measured the rate of gas uptake (volume or moles) per minute can 
be calculated after allowance for modification of the expired air due to 
breathing (in terms of oxygen CO and water vapour). Finally if the 
2 
a lveolar partial pressures of the gas is known, the diffusing capacity 
(rate of uptake divided by alveolar-pulmonary capillary partial pressure 
difference) could be calculated. Measuring the concentration of the gas 
in the blood is in general of limited value in assessing the gas exchange 
f unction of the lung since there is a large reserve capacity. Much lung 
t issue needs to be destroyed before arterial blood concentrations of the 
respirator y gases (for example 0 
2 
and CO ) are altered. 
2 
Measuring gas uptake by "diffUsing capacity" 
The diffusing capacity is a constant derived from applying Fick's law of 
diffusion to the membrane barrier between alveolus and pulmonary 
capillary. The concept was first developed by Marie Krogh (Krogh 1914) 
who made measurements using carbon monoxide and extrapolated to oxygen to 
demonstrate that oxygen uptake by the lung occurs by diffusion. Fick's 
law (Brown 1982) states that the rate of uptake of gas across a membrane 
is proportional to the partial pressure across the membrane and its 
surface area but inversely proportional to the membrane thickness. 
Applying this law to the whole lung it follows that the rate of uptake 
divided by the alveolar capillary partial pressure difference is a 
constant (D) incorporating terms for surface area, thickness and 
L * 
"diffusivity". Diffusivity is in turn proportional to water solubility 
divided by the square root of the molecular weight according to Graham's 
law (Brown 1982 ). Krogh assumed the alveolar capillary membrane to be 
a queous. She used carbon monoxide to measure D rather than oxygen 
L 
because for CO the pulmonary capillary partial pressure (pCO) is close to 
zero due to the high affinity of Hb for CO. She estimated D 0 from a 
L 2 
knowledge of the diffusivity of 0 compared to CO. Though it is now 
2 
clear that the rate of uptake of gases does not depend solely on 
diffusion across the alveolar capillary membrane (Roughton and Forster 
1957) t he diffusing capacity is a useful concept for theoretical 
predictions of gas behaviour and an obvious yardstick for comparing the 
uptake of different gases. It is also an important physiological and 
c linical quantity (Piiper and Scheid 1980) (Ogilvie 1983) (Forster 1983). 
>'f(for an aqueous membrane) 
Theoretical treatment 
I t is instructive to apply Fick's law to an idealised alveolar unit and 
t o e xplore how different physical properties of gases affect their 
b ehaviour. 
Considering a pulmonary capillary of length x and total diffusing 
o 
c apacity D. As blood travels along the capillary at flow rate Q the 
part i al pr essure of gas (l~) 
pressure ) . Rate of removal 
inc reases towards P ,(end capillary partial 
• c. 
of gas QSP (P - P ) dD (Piiper et al 
c A c 
197 1 ) . The capacitance coefficient (SOl~bili t Y )(3 includes blood 
dissolve d in plasma and c ombine d with haemoglobin. Rearranging and 
i ntegrat ing over the whole capillary 
- D 
e 
Q B 
Th e i mportance of this equation is that the ratio D/QB enables us to 
. 
predict the magnitude of P - P The expression D/QB is known as the 
A c' 
Bohr integral from its original use for determining the diffusing 
capac ity of oxygen (Comroe et al 1955). If the ratio is greater than 1 
then t h e c apillary blood tension of the gas equals alveolar tension and 
e qui librium has been reached before the blood has traversed the 
cap i llary. Uptake of gas therefore ceases. If the blood flow is 
i ncreas e d however, further "fresh blood" arrives and uptake will 
i nc rease. Such gases are described as perfusion limited since further 
uptake of gas depends on the arrival of unsaturated blood. If on the 
other hand D/sQ is much less than 1, P - P becomes larger, in other 
A c' 
words, a significant gradient exists between alveolar and end capillary 
partial pressure. Diffusion is therefore the rate limiting step in 
uptake and such gases are described as diffusion limited. Now the 
diffusing capac ity across the membrane D, according to Graham's law, is 
water solubility divided by the square root of molecular weight if it is 
assumed that the surface lining of the lung to be aqueous. It can 
therefore be seen that for gases of similar molecular weight (C H, CO, 
2 2 
o , NO) diffus i on or perfusion limitation is determined by the ratio of 
2 
water to blood solubility (a H 0 divided by Ct blood) (Piiper and Scheid 
2 
1980) . For a gas such as C H 
2 2 
water and blood solubility are 
approximately equal D/sQ '" 1 and uptake is perfusion limited. Measuring 
C H can t herefore be used to obtain pulmonary capillary blood flow 
2 2 
(Johnson e t al 1960 ) since D is approximately equal to sQ. For a gas 
such as CO, combination with haemoglobin greatly increases the solubility 
of the gas in blood c ompared to water. Accordingly D/SQ is much less 
than 1 and uptake is diffusion limited. For oxygen the position is 
rather more complicated: due to the shape of the oxygen dissociation 
curve the Affinity of haemoglobin f or oxygen falls as saturation is 
approached while the red cell traverses the capillary. In fact in the 
resting healthy s ub ject the back tension within the red cell equals the 
alveolar pO about one t hird of the way along the capillary (West 1979) 
2 
and uptake is normal ly perfusion limited. On the other hand, if the 
alveolar PO is reduced (eg in disease or at altitude) uptake occurs on 
2 
t he steep part of the dissociation curve (ie back tension is relatively 
sma ller) and a gradient between alveolar and end capillary partial 
pressure will exist. Similarly if the time for equilibration is reduced, 
61 
ie on exercise at higher cardiac output, n/BQ becomes smaller. In all of 
these situations uptake of oxygen becomes diffusion limited. 
Drawback to the approach based on Fick' slaw 
It i s now apparent that the model system in the figure above in which 
iffus i on c onstitutes the rate limiting step to the uptake of gases such 
as CO is an over-simplification for a number of reasons. Roughton and 
For ste r (1957) measured the rate at which carbon monoxide combined with 
haemoglobin and showed that it was at least of the same order as the rate 
o f d iffusion across the alveolar capillary membrane. They regarded 
diffu s ion from alveolus red cell as occurring in two steps, from alveolus 
to capillary plasma and from plasma to combine with haemoglobin, ie 
par t ia l pressure difference difference ac~oss + diiierence within 
alveo lus -red c e ll interior alveolar membrane plasma + difference 
. . 
veo veo + veo 
DL DM j3iR~ 6\fc into red cells 
dividing each side by VCO the rate of CO uptake gives 
-
-= + 
The left handside expression is the reciprocal of the diffusing capacity, 
t he middle one the reciprocal of the diffusing capacity across the 
alveolar capillary membrane and the righthand expression can be shown 
(Roughton and Forster 1957) to equal the reciprocal of 
BQ + 0 V . I n t h e c as e of CO, 8 plasma is very small so 
Roughton and Forster used this equation to obtain values for D and V • 
They made measurements of D at 
L 
2 alveolar 
m 
oxygen tensions and 
c 
from 
knowledge of e at these two tensions, obtained from in vitro experiments, 
constructed two simultaneous equations and obtained values for D and V • 
m c 
Thi s e legant approach can be criticised on three grounds. Firstly D 
m 
must include t he conductance of all the structures, membrane plasma and 
plasma to red cell interior and it is misleading to think of it just as a 
conductance afforded by the alveolar capillary membrane. Secondly a 
fundamental assumption of the liD o V II equation is that after a period 
m c 
of breathing 100% oxygen the only variable that is likely to vary is 0 • 
This assumption is almost certainly wrong, particularly in disease 
because of the e ffect of alveolar oxygen tension on small airway and 
blood vessel calibre (West 1978). This leads on to the final point that 
the whole lung should not just be thought of as a conglomeration of 
uniform model s ubunits. 1here is good evidence that in health, and 
particularly in disease, non-uniformity of ventilation and perfusion 
occurs and may well be the major rate limiting step to gas uptake in 
disease states (West 1978). It is obvious that changing oxygen tension 
may alter s uch ventilation perfusion mismatch in an unpredictable way . 
In view of these reservations about the interpretation and in view of the 
laborious nature of the measurements D and V have not found wide 
m c 
acceptance (Saunders 1977). 
Recently there has been debate as to whether D reflects membrane 
L 
t r ans port at a ll. Recent investigators have shown that conductance 
through the thin alveolar capillary membrane is so great that it cannot 
be the rate limiting step to gas exchange. Weibel has estimated D for 
L 
o by directly estimating the the size and thickness of the membrane 
2 
using EM studies and synthesising D from its component of diffusivity 
L 
(solubility divided by route molecular weight) area and thickness (Gehr, 
Bachhofen and Weibel 1978). Burns, using isolated lung preparations, 
perfused the pulmonary vessels with dithionite, a substance of very high 
affinity for oxygen and extremely rapid reaction rate. Both these 
authors give values for the conductance of the alveolar capillary 
membrane for oxygen and, by implication, CO in excess of D as measured 
m 
by Roughton and Fors ter's methods (Burns and Sheppard 1979). More 
recent ly Weibel's morphometric approach has been applied to CO (Crapo and 
Crapo 1983). 
Despite the uncertainty as to what is actually measured D CO is a useful 
L 
clinical technique (Ogilvie 1983). It is rapid and non-invasive and is 
perhaps rather akin to the "ESR" in clinical medicine. If it is reduced 
in a breathless patient it often indicates parenchymal lung disease. 
Similarly it is a useful yardstick for measuring the progress of 
inter stitial lung disease or response to therapy. On the other hand, 
si nce it is re duced in a wide variety of parenchymal diseases it is of 
little use in the differential diagnosis of lung disease. 
Application of D to other gases 
L 
The aforegoing discussion shows that the diffusing capacity for carbon 
monoxide measures something different to that for oxygen or acetylene. 
Thus Krogh's extrapolation of D 0 from values for CO by correcting for 
L 2 
differring water so lubilities and molecular weight we now know to be 
e r roneous. It is essential therefore to specify the gas for which D is 
L 
measure d. Can the diffusion characteristics for NO be predicted from 
what i s known of its physical and chemical properties compared to CO? 
O2 
CO 
NO 
TABLE 9 
PHY S I CAL PROPERTIES OF 02 ' CO and NO 
a so lu b ili ty i n B capa c i t an ce * Diffusivity 
Mwt H 
° 
3 7 °C ml.m l- 1 c o e f f icient for water relative to 
°2 2 
37°C mmol.L - 1 kpa - 1 
32 0 . 024 
* 
0 . 0105 1.0 
28 0. 0184 
* 
0 .00 8 1 0 .82 
30 0.35 ~ 0' . 0 15 1. 51 
Solub il i i e s for ° a nd CO obta in ed fro m Cotes 197 9 , fo r NO f rom 2 
Ge rrar d 1980 
Solub i l i ty for NO a t 3 7 °C was o b ta in ed f r om pl o tting a a t 0, 20 , 40, 
60 a nd 80 deg rees C and rea d i n g t h e v a lu e f o r 37 ° C from c urv e 
a H O ~ 222 
2 1 1 = 0 . 09 mmol. L- 1kpa- 1 The sol ub i lit y of 02 i n b l oo d i s O. m p e r m 
Because 02 ' CO a nd NO combine with haemoglobin i n t he same molar 
equival e nce , s imil ar blood so lubilities and c apacitance coefficients 
ar e expected (G i bso n 19 59) 
Predicted behaviour of nitric o~ide 
The water solubility of NO (.036 ml/ml) (Stephen and Stephen 1963; 
Gerrard 1980) i s twice that of CO at 37 0 (see Table 9). The solubility 
in blood wi ll be virtually identical to that of CO since each haem will 
ligan d four NO molecules (or 
Sol ubil i ty will be 1.39 ml/g 
four CO or four 0) 
2 
Hb, ie approx. 20 ml/100 
ablood 1979 ) (Gregory 1974) . Accordingly 
awater 
(Gibson 1959). 
ml blood (West 
is of the same order of but slightly smaller than for CO. D/BQ will be 
much l es s than 1 and uptake should be diffusion limited. Roughton made 
measurements o f the rate of combinati on of NO with haemoglobin and found 
them to be two orde r s o f magnitude greater than for CO (Gibson 1959). He 
attach ed cau t i on t o the figures obtained because the reaction was so 
rapi d (it was at the l i mit of resolution of his technique). On the other 
hand t he back reaction was slower than for the dissociation for CO from 
Hb (Gibson 1959) . If the very rapid reaction of NO with Hb pertains in 
vivo t hen the diffusing capacity should be independent of the combination 
step with h a emog lobin and therefore should reflect liD II i n Roughton and 
m 
Forster ' s equation 
( 1 1 
D 
m 
+ 1) 
e V 
c 
Two prov isos must be attached to this reason i ng. Firstly Roughton' s 
reaction rates were obtained f or isolated haemoglobin in the presence of 
dithion ite and r eac t ions with oxyhaemoglobin in the oxygenated red cells 
may very we ll occur by different kinetics. Secondly D will, as for any 
m 
other gas, b e affected by processes such as ventilation perfusion 
mi smatch, diffusion from alveolus to red cell interior and will not 
s olely r eflec t diffusion across the red cell membrane. It is highly 
l i kely t hat a very rapid combination of Hb with NO would Bet up a 
g r adien t between the exterior and interior of the red cell for example. 
Previous work on nitric oxide uptake 
Very l ittl e work has been done on measuring nitr'ic oxide uptake in man. 
Wagner (1970) measured the uptake of low concentrations of NO (.33 to 5 
ppm) by exami ning the difference in concentration during periods of 
"steady state breathi ng" in volunteers and described 85 to 93% retention. 
He be lieved t ha t t he rate of a bsorpt i on was independ ent of gas, 
c oncentration (s uggesting zero order kinetics) but was greater at maximal 
t han norma l inspira ti on. Bokhoven and Niessen (1961) measured nitric 
oxide c oncentrat i ons in tobacco smoke and noted a high percentage 
retention after i nhalat ion. Some useful Japanese work has recently been 
publ ished confirming the view that at low concentrations nitric oxide is 
not c onverte d to nitrogen dioxide in the airway but is rapidly absorbed 
i nto t he blood stream to react with haemoglobin in the red cell. When 
rats were exposed to labelled NO for 1Yz hours taking precautions to 
prevent NO conversion to NO in the exposure chamber, the label was 
2 
predominantly found in blood (serum and red cells) and in the urine, 
l ittle be ing found in the lung, trachea, liver, kidney or muscle (Yoshida 
et al 1980 ). Th i s g roup then investigated the rate of conversion of NO 
to NO i n a mo de l airway and i n i solated perfused rat's lung and f ound it 
2 
to be s low , c ertainly n o faster than oxidation in air (Yoshida et al 
1981 ). Unti l my present study no attempt had been made to measure the 
diffusing c apacity in man using nitric oxide . 
The single breath method of measuring diffusing capacity 
The measurement of diffusing capacity requires knowledge of the rate of 
disappearance (ie quantity/time) and mean partial pressure of gas in 
alveolus and capillary. In the case of CO (and it is assumed also NO) 
pulmonary capillary gas tension is zero. To obtain the rate of gas 
uptake a steady state method using the volume and inspired and expired CO 
concentrations over a known period of time could be used. Krogh's 
initial method for measuring D CO was by this technique. They 
1 
experienced difficulties however in estimating pCO from expired CO and 
assumed a value for VD/VT in the Bohr equation (Davies 1982). They then 
devised a single breath technique: after a rapid inspiration from RV to 
TLC of a gas mixture containing about .3% CO an initial expirate of 1 
litre was made. The subject exhaled again after a known period of breath 
holding and the alveolar portions of both expirates were analysed for CO. 
They measured alveolar volume by hydrogen dilution (Davies 1982) and then 
calculated D CO as follows. 
1 
Assuming Fick's law of diffusion, rate of disappearance is 
proportional to P - P. Since P = 0, 
A c c 
rate d(FA CO) = k (CO) where k is a "first order" rate constant. 
dt 
Rearranging and integrating over a period of time between t1 and t2 
ln = kt or k = 1 ln COt2 
t 
DL ~ rate of uptake k (FA CO) = 1 x 1 In COt2 
t 
If rate of uptake in 81 units is expressed in mmol/min/kpA final 
calculation becomes 
DL ~ VA x 1 x 1000 x 60 x 1 In COt2 
RT t COt1 
Converts fractional conc to litre VA -
RT Converts L to moles at body 
body temperature in degrees 
temperature (R is gas constant, T is 
Kelvin) 
1000 - Converts mol~~ to mmol~~ 
60 - Converts sec to mins 
The modern single breath technique side-steps the measurement of V and 
A 
the need for two alveo l ar CO measurements. 14% helium is incorporated in 
the mixture and a single breath helium diultion gives V 
A 
and also F 
A 
CO 
at time 0, assuming CO and He have the same volume and rate of 
distribution 
ie FA CO = F insp CO x He ex 
He in ie including constants 
DL = VA x 23.33 In x CO in 
--- ---
BHT He in 
Methods in use 
D CO i s generally measured by the single breath technique for clinical 
L 
and r esearch purposes. Because of the difficulties inherent in measuring 
P O , D 
c 2 L 
diffus i on . 
o is not used as a measure of the lungs' 
2 
In s i tuations where it is impossible to hold 
capacity for 
a full vital 
capcacity breath, ie on exercise or very ill patients, other methods have 
be en tr ied . For maximal exercise a steady state method is employed and 
for i l l patients a bedside technique of rebreathing a CO/He/air mix has 
been described (Clark et al 1978). By using a mass spectrometer, gases 
such as SF and acetylene can also be measured, the former giving indices 
6 
of gas mixing and D ace tylene leading to the calculation of cardiac 
L 
outpu t (Sackner et al 1975). Recently making measurements of alveolar CO 
during a slow exhalation have been employed using a rapidly reacting CO 
analyser (Cotton et al 1979) . Whilst this method is currently still a 
r e search t echnique it may be less subject to regional variations of D 
L 
within t he lung . 
Because o f the slow response time of our NO analyser the rebreathing and 
the s low e xpiration methods were precluded. The single breath method was 
chosen because the equivalent apparatus for CO is widely available and 
was eas ily adapted and the method is considered less prone to ventilation 
perfus i on i nequality compared to the steady state method (Davies 1982). 
I t also yields a measured value for alveolar NO which could be used to 
ex t rapolate a l veolar NO concentrations in smokers. 
iii) Measurement of Carboxyhaemoglobin Metbaemoglobin by 
Spectrophotometry 
Introduction 
Methaemoglobin (metHb) and carboxyhaemoglobin (COHb) are derivatives of 
haemoglobin that are incapable of carrying oxygen. They are both present 
in small amounts in normal blood. Methaemoglobin is formed when the haem 
moiety in haemoglobin i s oxidised to the ferric state. 
Carboxyhaemoglobin is formed when carbon monoxide rather than oxygen 
forms a ligand to the iron atom. Once formed both compounds are stable " 
and are only slowly converted to haemoglobin. Methaemoglobin is 
reconverted to haemoglobin by metHb reductase (an enzyme system within 
the red cell) , carboxyhaemoglobin by displacement by oxygen (Kiese 1973) 
(Gibson 1 959) . 
Measurement 
Both compounds are pigments, that is they are coloured compounds. They 
t h erefore absorb visible light energy and measuring the degree of 
absorption is the most widely used method of estimating their 
concentration. Application of Beer and Lambert's laws shows that the 
absorbance of radiation for a given wavelength depends on the thickness 
of the absorbing layer and the concentration of substance within the 
layer 
intensity of incident light 
log 10 = Ecl (Brown 1982) (1) 
intensity of transmitted light 
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c is concentration (mol M ), L is thickness of layer (m) and e: a 
cons tant for a given substance at a given wavelength (molar extinction 
coefficient) • A spectrophotometer is an instrument for measuring 
radiation absorption over a range of wavelengths. Spectrophotometers for 
t he investigation of haemoglobins operate over the range of visible light 
(417 to 750 nm). Oxyhaemoglobin, reduced haemoglobin, sulphaemoglobin, 
carboxyhaemoglobin, methaemoglobin and its derivative cyanmethaemoglobin 
all have characteristic absorbtion maxima (see Fig. 3). By scanning over 
the appropriate wavelengths the various pigments may be identified. If 
the wavelength, dimensions of the cuvette and e: the extinction 
c oefficient are known then the molar concentration can be calculated from 
the absorbance (Sykes, Vickers and Hull 1981). A colorimeter is 
dedicated to measuring absorbance at a single wavelength, often that 
corresponding to the maxima of the compound of interest. The instrument 
is calibrated by measuring the absorbance of a serial dilution of the 
stock solution and constructing a calibration graph. The concentration 
of the unknown solution can then be read off the graph without requiring 
accurate knowledge of wavelength and cuvette dimensions. A stable 
compound for calibration purposes is however a prerequisite. The widely 
used cyanmethaemoglobin for estimating Hb is an example of this 
technique. 
Estima tion of pigments in a mixture 
A g lance at Fig. 3 shows that metHb, HbO and HbCO have overlapping 
2 
s pectra and estimation of one in a mixture may present problems. These 
are most commonly circumvented by noting the change in absorbance after 
a ddi ng a chemical which reacts with the pigment under study hence 
removing its maxima. 
71 
Estimation of MetHb 
For es timation of metHb the absorption in the region 620 to 650 greatly 
exceeds HbO and HbCO. The presence of SHb should first ideally be 
2 
excluded by adding ammonium sulphide . A band due to metHb but not HbS in 
the 620 to 650 region will disappear . The Evelyn and Molloy method 
(Rodkey and O'Neal 1974) is to add cyanide to a lysed solution containing 
unknown metHb. The cyanide reacts with the MetHb to produce cyanmetHb 
and t he absorbance difference before and after addition of cyanide is a 
measure of metHb . It is expressed as a percentage of the total Hb which 
is the n calculated by converting all Hb to metHb with ferricyanide. 
Estimation of COHb 
This may b e estimated by adding dithionite to the sample under test when 
HbO will be reduced and its spectrum abolished. Alternatively COHb may 
2 
be measured by a non-photometric technique by splitting the CO from Hb 
and measuring the CO by gas chromatography (Baretta et al 1978). 
Estimation of pigments by IL282 co-oximeter 
It can be seen that over the range 550 to 650 the spectra are due to the 
above mentioned pigments . If, as is usual, SHb is not present in the 
sample under study then the absorption at 4 wavelengths can be used to 
calculate the concentrations or per cent total Hb in the sample. 
Rearranging (1) C 
RHb 
=K ( € A + 
535RHb 535 
A ) where C = concentration, A 
626RHb 626 
A + A + 
585RHb 585 E 594RHb 594 
absorbance, Eis the reciprocal 
E 
of extinction coeffic ient as defined in (1) and 535, 585, 594 and 626 are 
and K a cO ll stantfor that avparat us . 
the wave lengths in nm I The above equation applies to reduced haemoglobin 
(RHb ) and similar equations apply to oxyhaemoglobin, carboxyhaemoglobin 
and methaemoglobin. THb = C + CO Hb + C + CmetHb = total 
RHb 2 COHb 
Estimation of MetHb 
For es timation of metHb the absorption in the region 620 to 650 greatly 
excee ds HbO and HbCO. The presence of SHb should first ideally be 
2 
exc luded by adding ammonium sulphide . A band due to metHb but not HbS in 
the 620 to 650 region will disappear . The Evelyn and Molloy method 
( Rodkey and O'Neal 1974) is to add cyanide to a lysed solution containing 
unknown metHb . The cyanide reacts with the MetHb to produce cyanmetHb 
an d t he absorban ce difference before and after addition of cyanide is a 
measure of metHb . It is expressed as a percentage of the total Hb which 
is then calculated by converting all Hb to metHb with ferricyanide. 
Estimation of COHb 
This may b e estimated by adding dithionite to the sample under test when 
HbO will be reduced and its spectrum abolished. Alternatively COHb may 
2 
be measured by a non-photometric technique by splitting the CO from Hb 
and measuring the CO by gas chromatography (Baretta et al 1978). 
Estimation of~ents by IL282 co-oximeter 
It can be seen that over the r ange 550 to 650 the spectra are due to the 
a bove mentioned pigments . If, as is usual, SHb is not present in the 
sample under study then the absorption at 4 wavelengths can be used to 
calculate t he concentrations or per cent total Hb in the sample. 
Rearrangi ng (1) C 
RHb 
= K ( € 
535RHb 
A + 
535 
A ) where C = concentration, A 
626RHb 626 
A + A + E 
585RHb 585 E 594RHb 594 
absorbance, Eis the reciprocal 
of extinction coefficient as defined in (1) and 535, 585, 594 and 626 are 
a nd K a c ons t a ntfo r that apparat us . 
the wavelengths in nm I The above equation applies to reduced haemoglobin 
(RHb ) and similar equations apply to oxyhaemoglobin, carboxyhaemoglobin 
and methaemoglobin. THb = C + CO Hb + C + CmetHb = total 
RHb 2 COHb 
haemoglobin. Percentage methaemoglobin C (metHb) x 100 and so on for 
the other pigments. THb 
By us ing filters the 1L282 estimates absorption at 4 separate 
wavelengths . It can be seen that a series of 4 simultaneous equations is 
created that provided SHb tends to zero can be solved for HbCO, HbO, 
2 
reduced Hb and hence total Hb and metHb since Land E: are known 
constants . I t i s also clear that calibration is only necessary on the 
basis of a s ing l e pigment since the products k are constants which can 
be c alcul a ted for the various wavelengths. The most useful wavelengths 
include the "isosbestic point" where the absorbtion coefficient for " all 
pigments is similar. This yields concentration of total haemoglobin 
independent of whether it is reduced, oxy COHb or metHb. On the other 
hand a wavelength where the difference in absorbtion is at a maximum or 
" infle xion point" where rapid changes in absorption occur helps 
di scriminate between similar pigments in a mixture (Sykes, Vickers and 
Hul l 1981). The IL282 afforded a rapid means of assessing HbCO and metHb 
concentra t ions simultaneously in a series of blood samples. It 
automa tically aspirates a sample which is then diluted, passed through a 
vibra t ing haemolyser and preheated as it enters a cuvette. Sample 
absorption i s measured and compared to filtered light. The absorption is 
t hen c alculated via e quation (1) by amplifying the currents from 
detectors monitoring the sample and reference signals using a log 
amplifier. The cuvette and tubing are then automatically flushed by 
detergen t solution . The absorption is entered into the memory and 
c omputation s of concentrations are performed and the answers displayed on 
a d i g ital readout . 
iv) Epidemiological Methods in Cigarette Smoke Toxicology 
Epidemio logy is the study of the distribution and determinants of disease 
in a human population. It was this discipline that originally identified 
the link between c igarette smoking and disease and it has provided the 
most i nformation a bout how to make cigarettes less hazardous. 
Epidemiologic al s tudies may observe the change in frequency of disease 
over a period of time or differences in frequency between populations and 
attempt to r e late these observations to proposed causes. An analytical 
epide miological study examines the frequency of disease within a single 
population c omparing groups that differ in exposure to the cause under 
study. There are two fundamental designs of analytical epidemiological 
study (Barker and Rose 1979) (Alderson 1976). The prospective study 
exami nes a cohort of individuals for a period of time allowing the 
disease to develop . Th e case control study identifies subjects who 
already have t h e disease and compares their exposure to the putative 
c ause t o "controls " from the same population who are otherwise identical 
in a l l respec ts . At t he completion of a prospective study the number of 
new c ases of disease t hat have developed (the incidence) since the study 
started are calculated. The rates (number divided by total divided by 
time) are t h en c ompared for exposed and non-exposed subjects. A third 
type of study, the cross sectional study, is less often performed: it is 
identical t o the prospective study except the study population is 
examined at a single point in time and the prevalence (ie number of 
peopl e who s uffer from the disease) assessed. 
The one fundamental difficulty with analysis of all epidemiological 
studies i s the occurrence of "bias" . The frequency of a disease is often 
mul tifactorial and in a biological experiment studying laboratory animals 
randomisation would be performed to ensure that other determinants of 
disease were equally distributed between control and exposed groups. 
This clearly does not occur in an epidemiological study. Whether 
somebody smokes and whRt he smokes is clearly not randomly decided and 
might be determined by nationality, age, sex, professional class and, 
mos t worrying ly, presence of chronic illness. All of these may be 
independent determinants of the disease and may bias the conclusions. 
There a re obviously overwhelming ethical and practical obstacles to 
r andomly allocating a populations 's exposure to different cigarettes and 
so epi demiology remains the fundamental tool for the study of cigarette 
related disease. 
Relative merits of case control and prospective epidemiological studies 
(Alderson 1976) 
The case control study has the advantage of cheapness and applicability 
t o uncommon diseases. In a prospective study many healthy subjects may 
be examined who may contribute nothing to the analysis. Many years may 
elapse before a prospective study yields sufficient data for 
statistically significant conclusions. The main disadvantage of the case 
con trol study is its vulnerability to bias. The controls need to be 
careful ly sel ected and it i s in practice difficult to match cases and 
controls for a ll the relevant variables. It is particularly difficult to 
obtain Rccurate i nformation a bout a causative agent, (particularly 
somethi ng like a brand of c igarette), wh e n many years have elapsed 
between exposure and disease onset. Indeed recall may vary markedly 
between people who have a serious illness and controls, especially if the 
interviewees suspect the cause under study. Questionnaires need to be 
very carefully designed and ideally the interview should be carried out 
"blind". A final disadvantage of case control studies is that they 
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Sample, f ollow-up etc _ 
mi llion subjects f ollowed for 
12 years (13,027 deaths ) 
18,786 1968- 197 7 
-( 925 deaths) 
17,696 1964-1977 
(3 , 170 deaths) 
18,043 1967 for 10 years 
(1,127 deaths) 
Statistically SiGnificant findings 
Higher tar assoc i ated with higher al l causes mortality 
Hicher tar associated with hiChe r mortality fo r cancer 
of l ung, coronary heart disease bu t not i n a l l 
subc;roups 
f ilter c icare ttes not associated "ith l owe r' all cause t!lortality 
lung cancer or coronar y heart disease mortality 
filter cir;arettes not associated with 10~/er all cause mortali t y 
lune cancer or coronary heart disease mortality 
(Lee and Garfinkel 1981 ) 
Increased tar yield associated with increased lune cancer 
deaths (non-inhalers only) and coronary heart disease 
(inhalers only ) (Higenbottam, Shipley & Rose 1982) 
Possible association between increased tar yield and chronic 
airflow obstruction (Higenbottam -et al 1981, Lee 1981) 
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inher ently have reduced statistical power of detecting small differences 
(Alder son 1976). The prospective study on the other hand collects 
i nformation in a largely unbiased fashion. At the time of entry neither 
t hose collecting the data nor the subjects know the identity of "cases" 
and "controls". Prospective studies are particularly suitable for 
studying coronary heart disease and carcinoma of the bronchus since these 
caus e death in smokers sufficiently frequently to draw conclusions based 
on mortality data . Chronic air flow obstruction is a less common cause 
of death in smokers but its frequency can be assessed by cross-sectional 
preva lence study examining symptoms or simple respiratory function tests 
eg Fletcher et al (1976). Similarly the prevalence of coronary heart 
diseas e may be estimated by recording symptoms of angina or performing an 
ECG . The chief disadvantages of the prospective study are its expense 
and the time lag before conclusions may be drawn. "Losses to follow up 
due t o migration" are a further potential problem but may be circumvented 
by recording deaths at a central agency. 
H1stor ical sU1~eys of epidemiolog~cal studies of tobacco toxicology 
The accompanying tables (10 and 11) outline the major epidemiological 
stUdies r el ating mortality to cigarette type and delivery. Cigarette 
studies presen t several particular problems which need to be born in mind 
before drawing conclusions (Lee and Garfinkel 1981). A major difficulty 
ari s es from the change in the last 30 years from plain to filter 
cigarettes and the resulting fall in the tar content of the "average 
personfs cigarette". As a result of this the "filter cigarette group" in 
an analytical study will be heterogeneous. It will consist of a very few 
older life long filter smokers. There will be rather more younger 
life-long filter cigarette smokers and many who have changed to filters 
during the years up to the study. In the plain group however there will 
7" 
be some smokers who will change to filter cigarettes after recruitment 
but before the end po i nt of the study. These may be identified by 
carrying out a further questionnaire during the years of the study. The 
problems of c hanging tar yields are even greater: not only have average 
( s ales weighted) tar yields fallen with the change to filter cigarettes 
but many higher tar cigarettes have been withdrawn from the market and 
those that have been retained have had their tar yields reduced (Capell 
1978). It i s likely that the reducti ons in delivery that have occurred 
in recen t years, particularly since the adoption of low tar ventilated 
filter cigarettes also apply to the study of other agents in cigarette 
smoke (Young, Robinson and Rickert 1981) again leading to difficulties in 
interpretat i on . 
A second d i ff i culty concerns how much smoking behaviour alters risk of 
disease. Only a minority of workers have approached this problem and 
t hey have merely asked whether subjects inhale or not. This very 
rudi mentary a ssessment has given apparently contradictory findings, 
sugges t ing t hat behaviour modifies the association of cigarette 
type/del i ver y and d i sease (Wald et al 1983). Certainly other aspects of 
behaviour s uch as puff vol ume and frequency can profoundly modify 
delivery (Crei gh t on and Lewis 1978) so that "low tar" smokers may in 
real ity r e ceive similar exposure to "middle tar" smokers. No 
epidemiological study has so far attempted to comprehensively record such 
b eh avi our at entry . 
The most serious difficulty arises from the problem of separating risk of 
disease du e to c i garette type from risks due to the type of person who 
chooses that cigarette. Plain/high tar cigarettes are chosen by people 
who i n dep endently of smoking have higher risk of bronchitis and ischaemic 
17 
heart disease (Lee and Garfinkel 1981). Sophisticated statistical 
analyses will never circumvent this problem simply because they are 
designed to demonstrate associations rather than reasons underlying these 
associations . Fortunately the conclusions in the published studies (Lee 
and Garfinkel 1981) (Tables 10 and 11) are in general consistent. 
Furthermore, it is now emerging that changes in cigarette design and 
delivery are in g eneral being followed by changes in disease frequency 
that are consistent with the results of the case control and prospective 
studies (Royal College of Physicians 1983). 
Results from previous epidemiological studies (Tables 10 and 11) 
The studies published have in general been performed in the US or UK and 
have concentrated on differences in mortality between filter and plain 
cigarettes . Fewer studies have looked at tar and nicotine yield. Some 
studies have studied morbidity rather than mortality. Only one study has 
looked at any other ingredient in cigarette smoke. Kaufman et al (1983) 
looked at CO and heart disease incidence but their work was published 
after my work had been commenced. In general the studies show that total 
mortality in smokers of plain cigarettes is higher than among filter 
smokers and for smokers of higher tar cigarettes than lower tar 
cigarettes. 
Lung cancer 
Data from 11 studies (Lee and Garfinkel 1981; Alderson, Lee and Wang 
1986 ) show reduced risks of lung cancer for smokers of filter compared to 
plain cigarettes. 
ChrOnic air flow obstruction 
Three s tudies (Hammond 1966; Dean 1977; Alderson, Lee and Wang 1986) show 
reduced rates of chronic bronchitis among filter smokers. Higenbottam 
(1980) showed a reduction in symptoms of cough and phlegm with reduced 
tar yields and possibly a similar association for air flow obstruction 
(Lee 1980). 
Coronary heart disease 
Only the large Hammond study in the USA (of the six studies which have 
addressed the relationship between filter/tar and CHD) has demonstrated a 
significant positive association (Lee and Garfinkel 1981). No positive 
associati on between CO or tar/nicotine and myocardial infarction was 
foun d by Kaufman et al (1983). 
Extension of the epidemiological approach to other agents 
The availab i l i ty of CO data from old cigarettes (Wald, Doll and Copeland 
1981 ) has allowed me to examine associations between CO yield and disease 
f or t his s tudy. Similarly I have carried out analyses for NO on 
contemporary UK, US and French cigarettes (Chapter 4) which I have used 
in epi demiol ogical analysis. 
v) Statistical Methods 
The purpose of statistical inference in this study is threefold: firstly 
to describe experimentally measured data collectively in terms of single 
numbers: to extend conclusions from small samples to larger populations 
and hence determine whether differences between samples or groups in the 
data are due to chance or to real differences between the groups as a 
result of representing different populations. Finally statistical 
techniques have been used to detect associations between attributes of 
i ndividuals within the same sample. 
Description of Data 
Though ideally all data should be represented graphically, as the number 
of data points >increase it becomes harder to "see the wood from the 
trees " . Statistical terms may be used to describe data collectively but 
are frequently used incorrectly (Altman et aI, 1983). Many biological 
variables are normally distributed so that the frequency of a value 
occurring (or more precisely the probability that it will occur) is 
symmetrically distributed about a central "average value" (the mean). 
Because of the symmetry only a single number is needed to represent 
"scatter" (generally the standard deviation). A number of variables in 
this study (e.g. cigarette NO yield) are not normally distributed in the 
populations under study, with many low values and only a few higher ones. 
Furthermore if repeated measurements are made, greater precision is 
found for lower values, i.e. the standard deviation increases in 
proport ion to the mean. This is a common occurrence in biology - it is 
possible to measure a bacterium to within a few microns but such 
precision could not be applied to a whale I Transformation of such data 
to the logarithm both "normalises" the distribution and equalises the 
~o 
standard deviations for repeated observations on different individuals 
(Armitage, 1977). Variables such as cigarette NO yield should really be 
described by the geometric mean (the antilog of the log mean) to give a 
number in the units of the original data. For the standard deviation the 
transformation is more complex and I have used 95% confidence intervals 
on the mean obtained from the antilog of the standard deviation. An 
alternative approach would be to use non-parametric terms such as median 
or percentile which make no assumptions about distribution. However,-
transformation to the normal distribution allows the use of powerful or 
more detailed analyses (see below). 
Mean, Standard Deviation and "Standard Error" (Campbell, 1974) 
For a normal distribution the mean is the arithmetical average of the 
observations. (That is the total of the observations divided by the 
number of observations). 
The deviati on of each observation from the mean = x - x, - etc. x - x 
1 2 
Since the sum of these deviations is zero each deviation is squared and 
summed to give a measure of scatter (x X)2 (the sum of squares). An 
idea of the average scatter is obtained by dividing this expression not 
by n but for mathematical reasons by n - 1 (the "degrees of freedom") to 
yield the variance (S2) 
The sum of squares and variance are extensively used in the calculations 
of regression and analysis of variance but the square root of the 
variance, the standard deviation (s) is used for description of the raw 
data because it is expressed in the original units. If a series of 
samples is taken from a single population the means of the samples can be 
proven to also follow a normal distribution. The mean of this 
81 
distribu tion is lr, the population mean and its standard deviation, the 
stan dard error of the mean can be estimated mathematically from the 
single sample as s 
;; 
n 
Comparing two samples 
The s p e c i al properties of the normal distribution allow the calculation 
of t h e p r obability that an observation will fall outside a certain range. 
To determine the probability that an observation from a normal 
di s tribution with standard deviation a will deviate by greater than x 
units greater or less than the mean, x is expressed in "standard 
X 
deviation un i ts", i.e. x = a and the corresponding probability P is 
obtained from a table devised from the probability function of the normal 
distribution e.g. for x = 1.96 P = 0.05. This approach may be applied to 
determine the likelihood of the sample mean differing significantly from 
t he population mean. 
Ca lculate x = sample mean - population mean 
standard deviation of population mean (ie standard error) 
and obtain the corresponding p from a suitable table . The main use of 
this techn i que is to determine how likely it is that 2 samples of 
differi ng means but equal variance are drawn from the same population. 
Since in general the population mean and its variance are unknown they 
are es timated from sample data. 
Calculate z = difference between 2 sample means 
standard error of the difference between 2 means 
Since t h e variance of a difference of 2 independent quantities can be 
mathema t i cally shown to equal .the sum of their two independent variances, 
(Armi tage, 1977) the population standard error can be estimated as the 
sum o f t he 2 sample standard errors, hence z can be calculated and the 
probab i l i ty of the observed difference between the 2 means if they were 
both drawn from a single population determined. If z is greater than 
1.96 t h e n t he chance is 1 in 20 or less that the samples are from the 
same population and they are therefore statistically significant at the 
5% leve l . (This method is used in Chapter 6 to compare methaemoglobin 
levels in smokers and non-smokers). For smaller samples (n < 30) where 
the populat i on variance is unknown, z as estimated above is no longer 
norma l ly distributed but follows the "t" distribution. 
s 
Since the standard error is calculated as In it can be seen that as 
samples get larger so the standard error gets smaller and t or z gets 
larger. Put another way smaller differences are less likely to have 
occurre d by chance . One drawback at expressing a result as a 
sign ificance level (e.g. p < 0 . 05) is that in a very large sample small 
differences which are unimportant may become "statistically significant"; 
conve rsely i f the sample is too small, differences which are important 
may be overlooked and declared "statistically non-significant". This 
difficulty may be circumvented by expressing the results as "confidence 
intervals" (Gore and Altman 1982). These are obtained by rearrangement 
of t h e above equations inserting tabulated values for t or z at the 
desired s ignificance . 
Thus c onfidence intervals for x - x = [x 
121 
error x - x • 
1 2 
- x J+ tabulated t x standard 
2 
.. 
For P = 0.05, the intervals calculated are the 95% confidence intervals. 
We can be 95% certain that the true difference between x and x is 
1 2 
larger than the lower and smaller than the upper i nterval. If the 
inter vals include 0 then p is > 0.05 by conventional significance 
test i ng . If the intervals include 0 but also include a clinically or 
exper imentally important difference then the result deserves a larger 
study. In general wide confidence intervals suggest the sample is too 
small (Gore and Altman, 1982) and indicate the need for a larger study. 
However, it is perhaps rather better at the outset to plan with a 
statistician that numbers of individuals are adequate and conversely to 
interpret with great caution a very small difference that is 
statistically signi ficant in a very large sample. 
Analys is of variance 
Thi s techn i qu e i s an extension of the procedures used for comparing 2 
sampl e s and allows the comparison of a number of group means to establish 
whet her they are drawn from the same population or whether "statistically 
signi ficant differences" exist between them. In the simplest case each 
group is a sample and the technique can be used to compare the mean 
val ues of a single variable in a number of samples. Groups can also be 
created from the way the data is subdivided. For example if the 
experimental subjects included males and females we could compare the 
e f fect of sex or more generally look at a "between individuals" effect. 
It is possible, by way of intelligent experimental design, to investigate 
the effec t of a number of different factors on a single variabl e and use 
analysis of variance to assess the contribution of each factor (Armitage 
1977) • 
84 
The essence of the technique is to calculate a stati stic "F" which is a 
ratio of two variances of normally distributed data. The numerator is a 
variance representing the variability between the group means and the 
denominator a variance representing "scatter" within each group. We are 
only i nterested in the situation where the variance between the means is 
~reater than that within groups. In fact, if the groups were identical 
we shoul d expect the within groups variance to be greater than the 
between groups variance. Accordingly, a "one tailed" probability for F 
is chosen when comparing calculated with tabulated values. The number of 
degrees of freedom associated with the numerator and denominator are 
neede d to obain the tabulated value for F and depend on how the analysis 
is struc tured (see below) . There are three reasons why a value for F 
grea ter than the tabulated may be obtained (Meddis, 1975): 
(i) the "within groups" variance differs between groups 
(i i ) t he variable does not follow a normal distribution 
(i i i) the difference between groups is greater than expected by chance 
Obvious l y (iii) is the possibility that interests us most so it is vital 
to r estrict the technique to normally distributed data of equal within 
group variance, if necessary transforming 
trans formation to achieve these criteria. 
the data e.g. by log 
The procedure is best considered by reference to a hypothetical example. 
Cons ider a group of n individuals who are subjected to t treatments . 
"Individuals" and "treatments" both constitute "groups" and are important 
s our ces of variation in our experimental data. 
anal ys i s of variance depend on the equation 
The calculations of 
total variation sum of between groups variation + within groups 
variation 
(Where variation is expressed as the sum of squares). 
The mean squares (variances) are obtained by dividing the sums of squares 
by the appropriate degrees of freedom, (n - 1) and (t - 1) respectively. 
The residual sum of squares here is the "unexplained variation" and is 
what is left after the main effects (between rows and between columns) 
has been subtracted from the total sum of squares. The degrees of 
freedom associated with the residual SS similarly are those remaining 
after the others have been subtracted. 
In t he simple 2 factor (eg individuals and treatments) design there is a 
fur ther source of variation that may be of interest. This is the 
"interaction effect" or whether there is a tendency for a treatment to 
affect different individuals to a greater or lesser extent. It can only 
be estimated if there is more than one replicate per individual per 
treatment (per "cell") since it cannot~~e extricated from the residual 
variation. 
A significant interaction term suggests that the individuals do not form 
a uniform group and therefore the experiment was poorly designed. 
Not infrequently one of the factors in the design may occur at increasing 
"leve ls". For example the treatment in the example could be two doses of 
a dru g (or in chapter 5, 4 "doses" of treadmill induced exercise!) It is 
possible to test whether increasing the dose of treatment has a linear 
effect on the variable , of interest by subtracting a "regression SS" (see 
next section) from the treatment SS with one degree of freedom and 
Bb 
performing an F test using this regression mean square divided by a 
deviation mean square (equalling treatment SS regression SS) on 
treatment - 1 degrees of freedom. 
If a significant difference between individuals or between several 
treatments is detected by an F test then further" examination is required 
to determine which differences between means are responsible. Two 
pitfal ls may occur at this stage: firstly if all possible group mean 
comparisons are made it is highly likely that spuriously significant 
differences will be found. Secondly it is common to find differences 
between groups that were not expected before the experiment was started 
and it is human nature to invent reasons for their occurrence I There are 
a number of approaches to this problem but in this study I have 
restricted my analyses to those which need to answer the questions for 
which the experiment was designed which involve 2 comparisons at most. 
Most techniques of comparison of group means are based on the t statistic 
as above deriving the standard error term from the residual variance in 
the analysis of variance. 
Association between two variables 
In any discussion of smoking and lung disease the vexed question of 
association will arise. Merely to demonstrate an association does not 
necessarily imply cause and effect as the tobacco companies frequently 
restate. It is the qualities of an association (its strength, 
specificity, consistency between different studies etc) that implies its 
causality (Surgeon General, 1982). The contribution of statistical 
analysis is to measure the strength of the association and perhaps more 
usefully describe it mathematically in the form of a model. 
The familiar Pearson-product moment correlation co-efficient (r) is the 
simplest and most frequently abused measure of association (Altman et aI, 
1983). It is a number from 0-1 (or to -1 for a negative association) 
demonstrating the strength of linear association between 2 normally 
distributed variables. It is in fact, the square root of the ratio of 
the regression sum of the squares to the total sum of squares so thatr2 
x 100 gives a measure of the percentage variation of one variable due to 
change in the other. A high value for r does not necessarily demonstrate 
a close relationship: it occurs more frequently by chance in a small 
sample than in a larger sample. Similarly a low value does not 
necessarily indicate no relationship: it may indicate a close but · 
non-linear relationship. Finally, it must be stressed that it is a 
measure of association, not agreement and is inappropriate for the 
comparison of two methods for measuring the same variable. In this 
situation (e.g. comparing Government Chemist and tobacco companies' tar 
estimates in Chapter 4) the mean difference between methods and standard 
deviation of the mean difference provide more information (Gore and 
Al tman 1982). A large mean difference indicates bias and a large 
standard deviation indicates lack of precision of one or both methods. 
As far as possible in this study r is restricted to the measurement of 
association and is accompanied by a p value and a "scatter diagram" so 
that the reader may decide the closeness of the association for himself. 
Regression 
Linear regression indicates the mathematical form of the linear 
association between 2 variables y = bx + a (note x does not equal by + 
al). y is known as , the dependent variable (the measurement under study) 
and x is the independent variable (usually a "gold standard" or reference 
measurement which is known to a high degree of accuracy). It is implicit 
in the method that values for yare normally distributed about a mean for 
each value of x and that the variances of each of these distributions are 
equal (Campbell, 1974). It is not essential for the x variable to be 
normally distributed and indeed it is desireable for precision that some 
extreme values for x are included. A standard use for linear regression 
is shown in Chapter 4 to determine the order of reaction for the rate of 
oxidation of NO in cigarette smoke. At the start of the experiment 2 
1 
hypotheses are possible. Either NO = kt + c or ln (NO) = -kt + c where k 
and c are constants and t is time. It is simple to use linear regression 
to obtain a straight line fit to the experimental data and see which 
"model" fits the data best. We are generally most interested in the 
slope (b) and a significance test for this can be performed for this by 
calculating 
observed t slope 
standard deviation of slope 
or alternatively obtaining confidence intervals for the slope as b + 
tabulated t x standard deviation of b. 
Analysis of' covariance 
The residual sum of squares in an analysis of variance represents the 
within group variation, the unexplained variation or "noise". By careful 
experimental design the contribution of various factors (eg different 
observers, different days etc) to this can be investigated and by careful 
tec hnique its magnitude minimised. Sometimes the "unexplained" variation 
in t he data can be "explained" be an entirely separate measurement. For 
example, much of the variation in a respiratory function test in a 
population can be "explained" from a knowledge·of individuals' age or 
height. Separate measurement or "covariate"is entered as the x variable 
in a linear regression and the contribution of the sum of squares due to 
thi s regression to the residual sum of squares assessed in a conventional 
ANOVA. If statistically significant the regression equation can be used 
to adjust the group mean of the dependent variable to "weight" it for the 
covariant. This technique is used in Chapter 4 to reduce the "random" 
varia tion in NO yield of handrolled cigarettes and adjust the measured 
mean NO yield for "weight of cigarette" (covariate) and hence obtain a 
true "average NO yield". 
Multiple Regression 
An i mportant extension of linear regression is to include more than one 
independent variable y = a + b x + b x + •••• b x. A variety of 
1 1 2 2 n n 
different variables can be included as x variables and there is no 
cons t raint on the numbers that they take. Indeed, it is common to 
i nc l ude "dummy variables" taking the value of 0 or 1 to include presence 
or absence of a state (e.g. smoker/non-smoker). As in linear regression 
the dependent variable needs to be normally distributed about each mean 
value of x. By including a large number of variables a "model" of the 
form y = a + b x etc can be constructed and one can examine how closely 
1 1 
the model fits the observed data for example by calcuating r2 • 
The e ffect of adding or substracting an x variable from the model can 
the n be assessed to determine which x variables exert the greatest 
i nfluenc e on the y variable. In this way the effect of a single x 
variable can be examined while "correcting" for the influence of the 
others. One pitfall may arise however. Ideally all the x variables 
s hou l d be independent but in epidemiological work they may not be. For 
example, "age" and "years a smoker" will be closely related. To separate 
the effect of these variables it is necessary to look at the changing 
goodness of fit when either and both are included in the model. The 
significance of each x variable can be tested by calculating its slope b 
and the s tandard error and hence its t value. Confidence intervals can 
also be c alculated using tabulated t values. 
Extension of multiple regression to a transformed dependent variable 
Multi ple regression is ideal for examining the effect of various 
indep endent variables on a dependent variable such as FEVl that is 
approximately normally distributed in a large population. The other 
dep endent variables in the reanalysis of the Whitehall Study in Chapter 
7, however , are plainly not normally distributed. For example mortality 
can only take 2 values dead or alive! (you cannot have varying degrees of 
death !) Where such a variable exists in 2 states and the probability of 
one state in an individual is independent of the probability in another 
individual the probabilities follow the binomial distribution. If the 
chances o f the event were 50/50 this distribution approximates to the 
normal. However, in our Whitehall Study data the chances are 
considerably lower than t hi s and the mean probability will be highly 
"skewed " towards O. Clearly a transformation of the probability of death 
so it is no longer constrained to take values of be twee n 0 an d 1 in needed so 
it approximates t o the norma l distribution. 
There are a numbe r of transformations that may be used. We used the 
logit transformation of disease risk p so that the dependent variable 
be comes y log p 
1 - p 
alternatively p = exp (y) 
1 + exp (y) 
One of the attractions of this transformation is that the coefficients 
may easily be "translated" into risk: 
p = probability of event = "odds" 
1 - P probability of event not happening 
hence log p = log odds 
1 - p 
Consi der a sing~e risk factor occurring in two states (e.g. smoker and 
non-smoker) and probability of disease associated with these two states 
as p (0 for non-smokers) 
o 
defined as: 
1jJ = odds for smoker = 
and p (for smoker). 
1 
odds for non-smoker PO + (1 - PO) 
The "odds ratio" is 
The relative risk of factor 1 is obtained as follows: 
p 
Since log , _ P is approximately normally distributed a linear 
regression model: 
log p = a + bx can be constructed. 
1 - P 
Inserting the two states 0 and 1 for x it is easy to see that when x = 0 
logit P = a and that when x = 1 a + b 
o 
Henc e b logit p - p 
1 0 
logc1jJ • 
= logit p • 
1 
An'tilogging b will give the IV, the odds ratio. For small risks 1 - p is 
approximately 1 so that antilog b becomes a relative risk = probability 
of smokers dying divided by probability for non-smokers. 
Accordingly, a multiple logistic regression model can be set up: 
. log P 
1 - P 
The antilog of the regression coefficient b gives the change in risk of 
i 
inc luding factor x in the model. 
i 
The 95% confidence intervals on this 
change can be calculated as b + t x standard deviation of b. How well 
i 
t he model fits the observed data can be checked and how this "fit" is 
aff ected by the presence or absence of a variable of interest. Such 
questi ons are answered by estimating the maximum likelihood "G". 
The maximum likelihood G = - z L(Y log p + (1 y) log (1 = 
"-
observed logit and p is logit obtained from fitted variables . As each 
"-
vari able is added p approaches y and G tends to a maximum. The change in 
G associated with adding a variable is approximately distributed as 
chai-square . In this way a significance test of the contr ibut ion of each 
variable to the model can be performed (Breslow and Daly 1980). Computer 
packages are available to rapidly carry out this type of analysis (eg 
GLI M (Baker and NeIder 1978). 
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TABLE 13 
EQUIPMENT AND MATERIALS 
CIGARETTE SMOKE ANALYSIS 
Single port smoking machine (Heinrich Borgwaldt RM 1/G R58 Hamburg) 
50ml glass syringe (Rocket, London) 
55mm Cambridge filter pad (T39z Evans Adlard, Winchcombe, Glos ) 
Metaphene bags (various sizes)(Metal Box Co., Southampton) 
Matches (Bryant&May) 
Cigarettes (Brands and sources as in text) 
Nitric Oxide Analyser (Chemlab, Hornchurch, Essex) 
Calibration Gases: 
1000 ppm NO in nitrogen (Hilger Analytical Margate, Kent ) 
02 14% Ar 8% CO2 8% + Nitrogen ( " " " 
52 ppm NO in nitrogen (Air Products, Bracknell, Berks) 
Oxygen ( " " " " 
Oxygen-Free Nitrogen ( " " " II 
Carbon Dioxide (BOC Medishield, Harlow) 
Nitrous Oxide ( " " " 
Isoprene (BDH Chemicals, Poole Dorset) 
Two Channel Pen Recorder (Vitatron, Fison's Scientific, Loughborough) 
Second Order Low Pass Filter (Addenbrooke's Hospital Instrument Lab.) 
Mass Spectrometer (Centronic MGA 200,Centronic, New Abington, Surrey) 
Vacuum Pump (From PK Morgan "Transfertest"-see over) 
Paramagnetic Oxygen analyser ( 
" " 
Chemical Balance (Sartorius 2001 MPZ, Sartorius GMBH, GBttingen) 
Barograph (3123/T1 Casella London) 
Mercury Thermometer 
Rizla Handrolling Device (London) 
= 
EQUIPMENT AND MATERIALS (CONTINUED) 
NITRIC OXIDE AND CARBON MONOXIDE UPTAKE 
Gas Transfer Apparatus ("Transfertest", PK Morgan, Chatham) 
(Comprises Dry Spirometer, "bag in a box",He CO and 02 analysers etc.) 
Gas Mixtures- CO .3% and He 12% in air and Oxygen (Hilger ,Margate) 
Body Plethysmograph (Constructed at London Chest Hospital Workshops) 
Vitalograph Spirometer (Medical Instrumentation, Beckenham) 
1.5 volt Dry Cell Battery (Ever Ready Gold Seal) 
Fleisch Pneumotachograph & Transducer (PK Morgan, Chatham) 
Electronic Integrater 
1L Syringe 
" 
" 
Three way valve " 
" 
" 
" 
Four Channel Pen Recorder (W & W Electronics, Basel) 
Anaesthetic Bags (various sizes,Medishield, BOC, Harlow) 
Bicycle Ergometer ({unturi, Turku, Finland) 
Mixing Box, Low resistance 2 way valve (Papworth Hospital Workshop) 
Medical Examination Couch 
For Hb measurement: (Co~lter S plus Four, Harpenden) 
EQUIPMENT AND MATERIALS (CONTINUED) 
Methaemoglobin and Carboxthaemoglobin analtsis 
IL 282 Co-Oximeter (Instrument Laboratories, Andover, Mass. ) 
IL 282 Control ( 
" " " " 
) 
Zero solution ( 
" " " " 
) 
Cleaning solution 
" " " " 
Cal dye standard ( 
" " " " 
) 
EDTA blood bottles (Sequestrene, Labco, Marlow) 
Potassium Ferricyanide (Fison's Scientific Instruments, Loughboro') 
500 ml Conical Flask 
" " " " 
) 
. 1 M Phosphate Buffer (BDH Chemicals, Poole, Dorset) 
"Nonidet" Detergent ( " " " " 
Haemoglobin measurement (Coulter S Plus Four, Harpenden , Herts) 
Statistical analtsis and Computing 
Apple Two Microcompute~ Europlus (Apple Computer Inc.,Cupertino,Calif.) 
Green Monitor DM8112CX (Sanyo Electrical, Japan) 
5" Minidisk (Verbatim , Sunnyvale, California) 
Printer Silentscribe DP9000A ( Amadex, Chatsworth, California) 
Calculator FX82 (Casio Computer Co., Japan) 
This chapter has reviewed the general methods used in this work. The 
next five chapters describe the more detailed experimental methods and 
results. 
CHAPTER 4 
EXPERIMENTAL: CIGARETTE SMOKE ANALYSIS 
i) Factors affecting the nitric oxide yield of cigarettes 
Introduction 
Method - measurement of NO in cigarettes 
Purchase of cigarettes 
Cigarette preparation 
Smoking procedure 
Analysis of handrolled cigarettes 
Yields of CO, tar and nicotine 
NO analysis 
Method - measurement of N02 in cigarettes 
Smoking procedure 
Results 
Discussion 
ii) Kinetics of Disappearance of Nitric Oxide in Whole Smoke and Gas 
Phase 
Introduction 
Method 
Cigarettes 
Smoking machine 
Nitric oxide analysis 
Number of replicates 
Oxygen analysis 
Continuous smoking method 
Determination of reaction order 
Results 
Disappearance from whole smoke 
Disappearance from isolated gas phase 
Disappearance of NO in air 
Experimentally determined rate constants 
Discussion 
CHAPTER 4 
EXPERIMENTAL: CIGARETTE SMOKE ANALYSIS 
i) Factors af:fecting the nitric oxide yields o:f cigarettes 
Introduction 
It i s clear from Chapter 1 that the toxicity of oxides of nitrogen 
depends on the exposure concentration. Accordingly, if the cigarette 
·yield is known, alveolar concentration can be estimated and the 
likelihood of toxicity predicted. Because NO is so much more toxic than 
2 
NO at low concentrations it is particularly vital to know whether NO is 
2 
present in cigarette smoke or whether it is rapidly generated as the 
smoke ages . The yields of cigarettes may also be used for 
ep i demiological analysis. If a population's cigarette NO is known (:from 
br and yields and number 'smoked) it may be linked to rate of disease. 
Un f ortunately disease developing in smokers now is the result of smoking 
t hat may have commenced 10, 25 or 50 years before so that NO exposure 
cannot be calculated directly unless old cigarettes are available. 
However, knowing how the type of tobacco, type of cigarette and presence 
of a f i lter al ter NO might enable prediction of lifetime NO exposure. 
Published yields of oxide of nitrogen in cigarettes are very limited. 
Two studies (Norman and Keith 1965) (Barkemeyer and Seehofer 1968) 
demonstrated that fresh cigarette smoke contains NO only and that NO is 
2 
onl y generated as smoke ages. It must be pointed out, however, that both 
t hese studies were carried out by employees of the tobacco industry. 
Earl y estimations of NO in smoke gave concentrations of up to 1,000 ppm 
(Bokhoven and Niessen 1961) (Norman and Keith 1965) but their analyses 
p 
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were restricted to US cigarettes • Ondrus gave values for thre e popul a r 
contemporary US filter cigarettes (Ondrus 1979). Neurath showed that as 
predicted from nitrate yields (Akehurst 1981) the order of NO yield was 
Black tobacco> German > Maryland > Turkish > Flue cured (Neurath , Dilliger 
and Pein 1976). Ross (1976) published the yields of 21 contemporary US 
cigarettes in the Reader's Digest(l) but quoted his results as NO rather 
2 
than NO so complicating interpretation. Griest , Quincy and Guerin et al 
(1977) published the yields of 33 low tar US cigarettes but since all but 
eight of these had tar yields of below 10 mg they cannot represent th.e 
"average American cigarette" • No data are available on yields of UK 
cigarettes though it is understood that the tobacco industry and 
Laboratory of the Government Chemist are currently performing analyses. 
The initial part of the chapter gives the yields of 14 UK, 14 US, 8 
French, 2 Turkish and also 2 UK handrolled cigarettes. The effect of 
cigarette design, CO, tar and nicotine yield is explored. In the second 
part of the chapter experiments to look for NO in the smoke and to 
2 
determine its rate of production from NO are described. 
During the analysis of the first 10 brands an e rror occurred. Instead of 
calibrating the NO analyser using a 35 ml syringe containing 50 ppm NO, I 
calibrated using NO from a metaphene bag. Since the signal is slightly 
smaller at a lower volume (see Fig. 4 ) this \'Jill lead to under 
estimation of concentrations and yields. The data were not irretrievably 
lost since I included a Benson and Hedges King Size filter cigarette in 
each "run" of 10 cigarettes as a control. Accordingly, I scaled up the 
NO concentrations and yields by multiplying each brand/concentration by 
the average Band H yield calculated correctly divided by the incorrect 
value. 
,.......---
TABLE 14 
LATIN SQUARE DESIGN FOR FIRST '0 CIGARETTE BRANDS 
Day 
Order 2 3 4 5 6 7 8 9 '0 
EKSF 2 6SF 1 \1 1 6KSF 1 SC2 G2 JPS1 ESF 1 B&H 1 C1 
2 G1 EI(SF 2 ESF1 JPS, C, 6KSF, 6SF2 8&H, SC, 1-12 
3 1'2 C, 6KSF2 8&H, EKSF2 ESF2 SC2 JPS2 6SF , G2 
4 6SF2 JPS 1 C 2 G1 B&H2 EKSF 1 6KSF2 H, ESF2 SC2 
5 SC1 B& 1l 2 EK SF 1 H2 JPS, C2 ESF2 G, 6KSF2 6S1~ 
6 6KSF 1 G2 B&H 2 6SF2 \-1 2 JPS2 EKSF2 SC , C2 ES, 
'( B&H1 ESF2 6SF1 C1 6KSF2 SC1 1-12 EKSF , G1 JPS 1 
8 C2 SC , G2 ESF2 6SF 1 H, B&1I 2 6KSF, JPS2 EKSF , 
9 ESF 1 \-12 JPS2 SC2 G1 8&H1 C2 6SF , EKSF2 6KSF 1 
10 JPS 1 6KSF2 KSF 1 ·EKSF 2 ESF 1 6SF2 _ G2 C, 1-1, B&H 2 
~: 
B&H Benson and HedGes KinG Size Filter 
SC = Silk Cut Kine Size Filter 
EKSF Embassy King Size Filter 
JPS = John Pl ayer Special KinG Size Filter 
6KSF No . 6 King Size Filter 
6SF No . 6 Filter 
ESF = Embassy Filter 
G = Gauloise plain 
C Capstan plain 
1-1 
" 
Iloodbine plain 
, and 2 refer to di fferent r etai l ers . 
~""""""""""""--------------------T-A-B-L-E -1-5------------------
Run no. 
ANA LYSI S OF LATIN SQUARE OF FIRST TEN BRANDS 
(Using log transformation) 
( yields i n mcg ) 
Order in Run 
2 3 4 5 6 8 9 10 
121 84 48 . 106 74 348 
7 
98 68 113 54 
2 
3 
5 
6 
'7 
8 
417 75 70 85 63 
71 72 134 93 
90 
56 
65 48 389 147 
78 134 73 55 77 
96 363 107 86 52 
157 77 82 62 89 
71 74 337 70 81 
81 84 121 75 68 
76 69 67 82 389 
68 88 50 85 52 
45 88 324 73 76 
72 84 65 45 
80 63 80 288 
76 
78 
47 137 81 78 67 . 
9 86 47 69 80 376 137 60 69 83 131 
10 86 81 
BetHeen runs 
Orde r in r un 
BetHeen brands 
IVithin brands 
betHeen r e tailers 
Residua l 
Total 
66 81 53 
Sum of Squares 
.762 
. 378 
26 . 839 
.014 
.51 
28 .503 
DF 
9 
9 
9 
71 
99 
68 356 
I·jean 
Square 
0.085 
.042 
'3.35 
38 53 67 
Variance 
Ratio 
12.1 
6 
472.5 
2 
Method - measurement of NO in cigarettes 
Choice of brand 
A total of 14 UK, 14 US, 8 French and 2 Turkish brands were purchased. 
UK and French cigarettes were purchased retail in the UK, but US 
cigarettes were obtained in the US because yields of cigarettes for 
export differ from those for home consumption (Copeland G, Laboratory of 
the Government Chemist, personal communication). One Turkish brand was 
purchased in the UK and one in Turkey. The two varieties of handrolled 
tobaccos were purchased retail in the UK. The UK cigarettes were chosen 
to i nclude the most popular varieties but also included some high tar 
p plain and low tar ventilated filter brands. The US and French brands 
< .001 were chosen to i nclude popular brands. For the first 10 brands of UK 
< .001 cigarettes 2 packets of each brand were purchased, each packet from a 
< .001 different retailer to estimate between retailer variation. 
NS 
Purchase of cigarettes 
The composition of a certain brand of cigarette may vary between areas of 
the country, between wholesalers, between retailers, between packets and 
within a packet. To be comprehensive ideally analyses should be 
performed on large numbers from a variety of wholesalers, retailers and 
packets. Such analyses become expensive and time consuming. An 
alternative method of addressing this variation is to estimate it 
statistically by including between packets and between retailers as 
factors in a factorial design, for example a Latin square (see Tables 14 
and 15). The randomisation necessary for this square was carried out 
using a simple computer programme on an Apple microcomputer. 
Cigarette preparation 
In order that my results could be compared to other laboratories I 
followed closely the guidelines for sampling published by the Tobacco 
Research Council (Rothwell and Grant 1974). After purchasing a packet of 
20 cigarettes it was opened and then stored at room temperature in an air 
tight plastic container with a solution of saturated sodium bromide in a 
wel l to achieve constant humidity. Cigarettes were stored for at least 
48 hours prior to smoking. They were then selected at random from the 
packet by marking each cigarette with a number from 1-20 with a soft 
pencil. The order of smoking within the packets was then randomised by 
generatin g numbers from 1-20 by a random numbers algorithm on a 
microcomputer giving a convenient paper printout . For the first 10 
brands a Latin square experimental design was used, for subsequent ones a 
randomised block was employed . Analysis of the Latin square revealed 
that s ufficient prec ision could be obtained with 5 cigarettes. In all 
smoking runs a Benson and Hedges King Size filter cigarette was included 
as a "control". This cigarette was chosen because it had a reproducible 
NO yie ld and has the largest UK brand share. After removing all the 
cigare ttes required for a "run" of 10 from the airtight container, each 
was "butt marked" to the length recommended (Rothwell and Grant 1974) and 
placed to one side ready for smoking. 
Smoking Procedure 
The NO analyser was kept permanently switched on. The valves on the 
n itrogen and oxygen cylinders were opened and adjusted to give the 
correct flow rates. I found that this could be achieved by adjusting the 
regulators on the cylinders to give a pressure of 60 psi for nitrogen and 
10 psi for oxygen on the pressure guages on the front panel of the 
machine . The ozone generator and the vacuum pump linked to the exhaust 
were then switched on and a sample of 35 ml of approximately 50 ppm NO in 
nitrogen was introduced into this syringe at A (see Fig 5). (The exact 
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concentration was taken from the certificate of composition but varied 
between cylinders). The sample was then drawn into the analyser at a 
constant flow rate. At least 3 35 ml aliquots of known NO concentration 
were analysed at the start and end of each "run" of 10 cigarettes. After 
a run with US or French cigarettes of high yield calibration was also 
performed with a gas of 1,000 ppm NO in nitrogen. The temperature was 
recorded by mercury thermometer and the barometric pressure by barograph 
calibrated against a local RAF weather station report. 
The cigarette was placed in the holder of the machine and lit with a 
match. The smoking machine was then started and a perspex draught shield 
placed over the burning cigarette. The machine was set for one 35 ml 
puff of 2 seconds duration taken every 58 seconds. The smoke was drawn 
through a Cambridge filter situated on the "front end" of the machine. 
The exhaust was then directed into the free running glass syringe by 
turning the taps appropriately (see Fig. 5). By turning the tap again 
the sample could then be directed into the analyser. Each cigarette was 
then smoked until the paper burn line crossed the pencil butt mark. The 
cigarette was then extinguished by cutting it with sharp scissors and any 
burning coal rapidly removed and extinguished. One "clearing puff" 
followed and the machine was then stopped, the filter changed and the 
next cigarette in the run inserted and lit. The typical NO profile from 
a cigarette is shown in Fig. 6. The yield is simply calculated according 
to the formula 
yield/35 ml puff 0.0168 x P/T x C ppm (Rothwell and Grant 1974) 
where P = barometric pressure in mm of mercury and T temperature in 
degrees kelvin. 
I 
I 
I 
I 
I 
I 
I 
The total yield for the cigarette is the sum of all puffs including the 
clearing puff. The factor 0.0168 converts ppm to ug and is derived from 
Avogadro's law (Brown 1983). 
Analysis of handrolled cigarettes 
Because of the large variation in the way smokers roll their own 
cigarettes there are no data on the yields of handrolled cigarettes. I 
developed a method to reduce this variation and allow analysis. 
Cigarettes were handrolled in a "Rizla" cigarette rolling machine from 
cut tobacco to produce a relatively uniform cigarette size. They were 
then weighed since I suspected that the weight of tobacco rod may 
influence the yield of NO. The cigarette holder on the smoking machine 
was adapted to take the thinner handrolled cigarette while maintaining an 
airtight seal. The cigarette was butt marked as for a plain cigarette 
and smoked in the usual way. Delivery was calculated in the usual way 
but to calculate mean yield the technique of analysis of covariance (with 
log transformation) was used to correct mean delivery to mean weight of 
the cigarettes analysed. 
Yields of CO, tar and nicotine 
These were obtained from Government bodies: UK Government Chemist (UK and 
French cigarettes) and Federal Trade Authority (US cigarettes) for a 
month as close to the purchase date of the cigarettes. These yields were 
obtained by directly writing to the responsible bodies. 
NO analysis 
A fuller description of the instrument and layout is given in Chapter 3 
and Chapter 5. Linearity was checked over the range 1-25 ppm by dilution 
as described in Chapter 6. At higher ranges it becomes difficult to 
TABLE 16 
"QUENCHING" DUE TO CO2 
Mixtur e of NO and either pure CO2 or Oxyge n free Nitrogen 
NO Concentration ( ppm ) 
\Hth CO2 Hith 02 free N2 
39.5 41 
40.0 40.5 
38.5 40 
39.3 mean 40.5 
Thus CO2 concentration of approximately 20% produces about 3% 
reduction in NO s i g nal. 
perform dilutions because of oxygen inevitably entering the system during 
the dilution process. Accordingly the linearity of the machine was 
tested by following. the decline in concentration of a gas mixture of 
known NO concentration and air over the working range. If the instrument 
response is linear the decline plotted as .1/NO against lit should be 
linear (Sloane and Kiefer 1969). 
Because cigarette smoke is a complex mixture it is important to check for 
interfering species in analysis. C02 has been reported to IIquenchll the 
chemiluminescence signal due to activated N02 (Klimisch and Kircheim 
1977) Table 16 shows the signals produced by making up a mixture of NO 
with the remainder either pure CO or nitrogen. The volumes were made up 
2 
in the dry spirometer of the PK Morgan transfer test. It can be seen 
that there is a small but consistent loss at high concentrations of CO 
2 
but that it only forms a fraction of the signal . 
It has been reported that isoprene may produce a significant deflection 
(Laboratory of the Government Chemist, personal communication). A US 
cigarette contains about 1 mg of isoprene (no figures available for UK 
cigarettes, Surg eon General 1981). A 1% mixture was made up in a 
metaphene bag (by adding 0.04 ml of isoprene to 3 1 of air) . This high 
concentration, which greatly exceeds that in the cigarette, produced a 
deflection equivalent to 5 ppm of NO. N 0 will react with ozone at high 
2 
temperatures but 100% N 0, as used in general anaesthesia, produced no 
2 
deflection on the most sensitive scale. Forty ppm NO produces a small 
2 
deflection equivalent of less than 5 ppm of NO but according to the gas 
cylinder manufacturers . (Air Products Ltd.) this is probably due to 
contaminating NO. Certainly on the operating principle a signal from NO 
2 
would be unlikely. 
TABLE 17 
AvernGe Puff Concentration (five replicates) 
IlenslIrinG 110 t1easurinc Total Oxides 
309 302 
293 297 
339 299 
~9/, 2DD 
293 JJ6 
J06 mean 30 /, 
20 s 18 
Efficiency of Converter (weasurinG total oxides) 
"i 1 f r:J r: I10i · S1(Tn~1 from 1·0 ppm ll02t ,) Gn<l rOln J • J ppm u U ... , 
+ 5.3 ppm 110;/ 
(five replicates) 
53 
52 
51.5 
52 
52.5 
52.1 
Efficiency 
averaGe 
Actual si0nnl 
Predicted sienal 
28.6 E = (52.1 - 5.3El x 1,0 
5J.':) 
Positive root for E = 0.8 = 00% 
= 
29 
29.5 
29 
29 
26.5 
20.6 
S1 nal from NO:!. 
SiGnal due to NO - E[N02 in NO mix))t x N02conc ~)~ 
NO conc · 
_4E2 + 39E + 20.6 
t Concentrations froln man\lfacturers certificate of annlysis. 
Method - Measurement of NO in cigarettes 
2 
Measurement of NO and efficiency of the converter. 
2 
The c he miluminescent method can be used to estimate NO in a sample by 
2 
passing it through a column which will reduce NO to NO. This allows the 
2 
"total oxides of nitrogen" NO to be measured and theoretically the NO 
x 2 
is NO - NO. I used a ferrous sulphate converter in which the reducing 
x 
agent ferrous sulphate reduces NO to NO. In practice the converter 
2 
efficiency should not be assumed to be 1.0. The efficiency can be 
r eadily calculated by comparing the signals produced by samples of NO and 
NO of certified composition. I found that s ome loss of NO occurred 
2 
after passing through the converter, therefore the signal obtained for NO 
after passing t~rough the converter is used. 
Signal due to x ppm N02 
Efficiency 
Si gnal due to y ppm NO x (x(/(y) 
However NO s81nples a l ways contai n s ome N0 2( Z) whic h will be c onv ert ed to NO 
in passing through the ferrous sulphate column. 
Effi c i e ncy E 
Si gnal due to x ppm N0
2 
(Signal due to y ppm NO - ( E x Z») x (x)/(y) 
This equa tion can be simply solved by substitution of experimentally 
determined values ( s ee Ta ble 17). 
NITRIC OXIDE YIELDS (HCG) OF CIGARETTE BRAI'IDS 
_Re~licCl tes 
Length ~ 2 3 4 5 - Lab. 
of Govt . 
Brand " s Chemist Result 
U.:<. : 
Genson & Ji edces 8 /\ F 156 134 106 13 /-4 11,7 135 19 117 
Silk Cut S/, Iff 78 'II, 66 80 'II, 75 5 C)5 
No.6 KinG Size 83 [0' 96 8 1 72 10 5 89 88 :20 'I" 
Peter .Stuyvesant [~L 91, F '92 75 118 98 91 95 16 [35 
Rothmans Kine Size Gil F 95 100 103 9 1 89 96 6 97 
Embassy 84 f 121 'IS 72 80 93 88 20 74 
Embassy Extra t·[ild 8/j VF 12 (; 5 10 16 10 I, 
Silk Cut Extra :·[ild 84 ifF 37 51 33 55 38 1,3 10 3e 
John Pl ayer Specia l 83 r 85 65 69 85 77 76 9 76 
Du I·\au·rier 74 F 58 52 63 54 55 56 I, 59 
110. 6 70 f 90 :]/. 82 8() 8 1 US I, 7'. 
Ef:lbass y 110. 1 70 F 12 1 75 72 80 93 71 12 7', 
Capstan 69 P 71 57 48 ()2 63 60 9 6 1 
\'Ioodbine 65 P 71 47 48 55 52 55 10 1,9 
Came l t 83 F 245 227 215 204 200 2 18 18 192 
.L Chesterfield ' 84 F 2 10 190 177 201 201 1')6 13 
~'Ia r 1 borouGh t 84 F 211 263 182 234 222 222 30 251 
French: 
Gau loi se ' 69 P 416 362 337 388 376 376 29 397 
Gauloise ~Iild 70 f 319 338 360 390 356 353 26 
Gauloise 70 F 302 367 346 417 38 1 363 43 
Gau loise LonGue 83 F' 368 363 434 353 376 379 32 
GHa nes 70 P 1,06 391 472 353 425 409 44 
GHanes 70 F 370 333 313 315 267 320 37 391 
Gitanes In ternational 90 VF*" 412 441, 368 426 367 403 35 434 
Disque Bleu 70 p 36 1 315 429 353 334 358 43 415 
U.S. : 
ned t 85 F 232 236 237 223 223 230 7 
Sa lem 85 F' 39 1 377 441 475 237 38/, 91 
Sa l em (liGh ts) 85 VF 258 273 309 257 362 292 45 
~Ial'lboro 80 F 295 29 1 288 276 267 283 12 
l'\arlboro (Soft Pack) 85 F 286 30G 252 285 241 274 27 
Camel 80 P 273 298 374 300 333 316 39 
Kools (Soft Pack) 85 f 289 308 297 362 303 3 12 29 
Koo l s (Super' Lo nGs ) 100 F 333 337 383 263 3G8 32 1 1.7 
\-Ji ns ton ( Soft Po ck) 85 f 370 350 327 372 384 36 1 22 
\Iinston (LiGhts) 100 VI' 352 355 383 393 395 376 2 1 
',.Iinston 100s 100 f 345 372 395 371 371 371 113 
Pall [-ln11 85 P 400 390 29 1 381 435 379 54 
Va ntage Q5 'IF 336 34 1 341 290 275 3 1? 32 
Benson and Hedr,es 100 100 F 305 278 290 290 3 11 295 13 
t U.S. type on IJ . :-: . l~al'J.: et 
* Activated charcoo l filter 
Tur:(ish: 
Sullivan KS 85 F 113 102 97 105 130 109 13 
Samsun 100 100 F 181 17 5 204 215 178 198 18 
Ilandrolled: ( Srnol:inc 10 ciGarettes ) x s 
Old Holborn P 150 135 175 175 175 185 14 5 160 170 2 10 168 22 
Three Castles P 53 57 50 73 83 75 8 1 87 87 102 75 17 
5 (me:;i 
100 
10 
• 
STANDARD DEVIATION PLOTTED AGAINST MEAN YIELD OF NO 
(ALL 40 CIGARETTE BRANDS) 
• 
• • 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
10 
• 
• • 
• 
• 
• 
• 
.-.. 
I~ 
• 
• • 
• • 
.. 
• 
n= 40 
mean (meg) 100 
Smoking procedure 
A Benson an d Hedges King Size filter cigarette was smoked in the usual 
fashion and the .average concentration of NO per puff determined 
(exc luding the c l earing puff). For five c igarettes the analyser was used 
in th e usual way but for fiv e other cigarettes the exhaust from the 
s moking machine was passed through a ferrous s Ulphate column to reduce 
a ny NO to NO. The order of s moking was randomised. 
2 
It can be seen from Ta ble 17 that there is very close similarity between . 
t he NO y i e l d and the total ox ide of nitrogen yield s uggesting that, even 
a llowing for the l ess than 100% efficiency of the converter, at the most 
less than 5 ppm of NO are produc ed . 
2 
Results 
Ta ble 18 s 11ol,ls the yields of UK, US and French cigarettes. The range of 
UK brands analysed comprised 57% (Tobacco 1983) and US brands 43% 
(Maxwell 1983) of the 1982 market. The French market is classified by 
manufacturer rather than by brand. It i s therefore difficult to estimate 
t he share ana lysed but all popular Gitanes and Gaulo ise range that are 
avai labl e in the UK were analysed and together these accounted for 70% of 
the French market in 1982 (Maxwe ll 1982) . 
Fig. 7 s hows t hat t he stand ard deviation within a single brand increases 
with mean yie ld. This is a characteri s tic of a l og normal distribution 
(Armitage 1977) and acco r dingly data was transformed to the logarithm 
prior to statist i cal ana l ysis . Analysis of th e Latin square for the 
first 10 brands (Tab l e 15) shows that by f ar the largest source of 
variation is differences between brands. There was no significant 
difference between packets or r e tailers. Between runs and order in runs 
105 
TABLE 19 
COMPARISON WITH OTHER LABORATORIES 
Laboratory No . of Brands Mean diff. (mcg) (Geometric mean) 
SD of Mean diff. 
(66% conf. ints.) 
Br. Am. Tobacco 
" " " 
Laboratory of the 
Government Chemist 
" " 
Laboratory 
My results 
Snell in Ross (1976) 
Griest, Quincy and 
Guerin (1977) 
Ondrus (1979) 
Neurath, Dunger and 
Pein (197 6 ) 
. -t- All low tar. 
5 
6 
13 
19 
+ 9.8 (7.5) 
+ 1. 2 (1, 1.3) 
+ 6.2 (7.2) 
+ 1.0 ( .9, 1. 2) 
COMPARISON FOR U.S. CIGARETTES 
Number of U.S. Brands 
14 
21 
32 t 
3* 
2* 
U.K. type 
cigarettes only 
All cigarettes 
(After log. trans-
formation) 
U.K. type 
cigarettes only 
All cigarettes 
(After log. trans-
formation) 
Range (mcg) 
230-384 
167-378 
5-238 
202-247 
194-267 
t Calcula~ed from mean puff concentration using formula (Rothwell and Grant 1974) 
• 
NO YIELD PLOTTED AGAINST CO YIELD FOR UK, US AND FRENCII CIGARETTES 
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VARIATION IN NO YIELD WITH CIGARETTE WEIGHT 
FOR TWO HANDROLLED CIGARETTE BRANDS 
NO YIELD (MCG ) 
200 OLD HOL30RN 
"" 
"" 100 
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.9 1.1 WEIGHT (q) 
GEOMETRIC MEAN ADJUSTED GEo.MEAN 
166 
72 
160 
74 
contributed small but statistically significant variation. After 
consultation with statisticians it was calculated that five cigarettes 
were required to giv~ a precision to the nearest 5 ug for UK cigarettes. 
Since standard deviation increases with mean yield, precision for high 
yielding cigarettes will be less. Table 18 and Figs. 8 and 9 show that 
by far the major f ac tor determining NO yield is country of origin. US 
and French cigarettes e xceed UK NO yields by 3 fold. Turkish type 
cigarettes appear to have similar yields to the upper end of the UK 
range . It can be seen (Figs. 8 and 9) that there is very little 
correspondence between NO yield and CO or tar yield except that the very 
low tar yield ventilated filter cigarettes tend to have low yields of NO 
as well as the other ingredients. Ordinary filter cigarettes by contrast 
tend tO , have no lower and, indeed, often higher NO yields than plain 
cigarettes. Using the Rizla handrolling machine appears to reduce the 
standard deviation of handrolled cigarettes so that it approximates to 
those of manufactured cigarettes. Though cigarette weight appears 
positively related to NO yield, analysis of covariance adds little to the 
analysis (Fig. 10). Table 18 and 19 shows that there is reasonable 
agreement between my estimates and those of the tobacco industry (British 
American Tobacco Ltd) and the Laboratory of the Government Chemist. My 
figures, however, are an average 10% higher. For reasons of 
confidentiality I could not reproduce the actual values for the British 
American Tobacco or the Laboratory of the Government Chemist estimations. 
Discussion 
The average cigarette NO concentration per 35 ml puff varies over two 
orders of magnitude from a UK "ultra mild ventilated filter low tar 
variety at 10 ppm to about 100 ppmm for a lower yielding UK plain 
cigarette to 1,000 ppm for a US or French cigarette (see Figs. 8 and 9). 
lOb 
Such extremes of variation have not been observed for tar or CO. The 
major source of variation is the country of origin and it appears to be 
intimately linked tp the type of tobacco used in manufacture. For 
example US type and French type cigarettes manufactured for the UK market 
retain their high yields. Filters and the CO or tar yield exert little 
influence over NO yield within a country/tobacco type except for a few UK 
ventilated filter cigarettes which have generally low deliveries all 
round. 
The individual yields of UK cigarettes appear to be similar to those of 
the other two laboratories. The range of values for US cigarettes appear 
to be similar to those of other workers (Table 19) In both cases my 
values appear to be consistently higher by about 10%. This may well be 
due to a calibration problem since it is apparently notoriously difficult 
to produce exact concentrations of NO in gas mixtures for calibration 
purposes. This source of error may have accounted for the "between run 
variation". A likely cause of the order in run variation being 
significant is a low yielding cigarette being smoked after a high 
yielding cigarette. It probably takes far more than 1 "clearing puff" to 
purge the smoking machine of NO. In fact, if two or three clearing puffs 
were taken following a high yielding cigarette there was still detectable 
NO in these puffs. 
Between packet and between retailer variation appears to be negligible. 
It is possible that if the analysis covered a larger area of the country 
or took place over a longer time significant variation would have been 
identified. 
10'7 
It can be seen that the standard deviation on five handrolled cigarettes 
is similar to manufactured cigarettes of similar NO yield. If similar 
precision can be achieved for tar and CO there is no reason that 
handrolled cigarettes should not be included in the league tables. Their 
exclusion may conceivably lead smokers to believe they are as "safe" as a 
pipe or cigar. 
Analysis for total oxides of nitrogen as well as NO confirms that fresh 
cigarette smoke does not contain NO . 
2 
ii) Kinetics of disappearance of nitric oxide in whole smoke and gas 
Introduction 
It is known than when cigarette smoke ages the NO is oxidised to NO . 
2 
Indeed the Saltzmann method of analysis (Norman and Keith 1965) relies on 
all the NO being oxidised to NO which is then measured. 
2 
Further 
reac tions to form more complex molecules such as methyl nitrite may then 
take place (Vilcins an d Lep ha rdt 1975). The reaction of NO with oxygen to 
yield NO is known to be 3rd order 
2 
- d (NO) 
dt 
The recommended value for k is derived from an extensive review of 
9 -2 -1 
experimental values 1.2 x 10 exp (530/T) cm6 mol sec (Baulch et al 
1972) where T is temperature in degrees kelvin. There is disagreement 
among previous investigators regarding the value for k for the oxidation 
of NO in cigarette smoke. Sloane and Kiefer (1969) found a similar value 
to that recommended (Baulch et al 1972) whereas Williams (1980) obtained 
a rather higher fi gure. The rate of oxidation of NO in whole smoke and 
gas phase were therefore investigated. 
Method 
Cigarettes 
A Benson and Hedges King Size middle tar (18 mg) filter cigarette was 
used. Packets were purchased retail, opened and stored in an airtight 
container at constant humidity over saturated sodium bromide solution for 
48 hours prior to smoking (Rothwell and Grant 1974). 
Smoking machine 
The standard single port smoking machine was used (Heinrich Borgwaldt, 
Hamburg: RM l/G - R58). A single cigarette was inserted in the filter 
holder, lit and smoked in the standard fashion, ie 35 ml bell shaped puff 
of 2 seconds duration taken once per minute. The third puff, empirically 
found to have the most reproducible NO concentration, was then directed 
w 
into a 50 ml glass syringe where ageing occurred for 0-10 minutes. The 
~ 
0 
~ 
~ cigarette was then extinguished. Following ageing the concentration of 
~ 
w 
~ 
2 
ru 
= C 
~ 
NO in the syringe was measured. The determination of the rate of 
i ~ ~ 
z 
~ ~ 
~ 
~ 
~ ~ 
ro ~ reaction in the gas phase, a 35 mm Cambridge filter (T39Z, Evans Adlard 
~ 
Z 
H 
en 
E and Co Ltd, Winchcombe, Cheltenham, Glos, England) was inserted into the 
W 0 
~ ~ 
< filter holder on the smoking machine. For determination on the whole 
smoke the filter was removed but the machine was regularly cleaned to 
remove deposited tar. In addition the exhaust was directed into a second 
50 ml syringe since in practice it was found that the tar deposited on 
the inside of the barrel of the syringe prevented aspiration of the 
sample into the analyser. This syringe was then manually emptied into 
the first immediately prior to analysis. For both gas phase and whole 
smoke the 3-way tap was turned to permit aspiration of the sample once 
the ageing period had elapsed (see Fig. 11). 
Nitric oxide analysis 
The instrument was used as described previously except that all samples 
were passed through a low dead space filter prior to sampling to prevent 
deposition of particulate matter within the analyser. 
Number of replicates 
Two replicates were made for both gas phase and whole smoke for ageing 
periods of 0-10 minutes in 1 minute intervals. 
interval was randomised. 
The order of ageing 
oxygen analysis 
In a separate experiment the oxygen concentration for the third puff of 
the same brand of cigarettes was smoked in an identical fashion was 
determined. Oxygen analysis was performed by a mass spectrometer (MGA 
200, Centronic Ltd, Croydon, Surrey, England) calibrated for oxygen in 
air and in a mixture of oxygen 14%, argon 8%, carbon dioxide 8% and the 
remainder nitrogen. A sample was aspirated directly into the syringe via 
a filter and five replicates were performed for whole smoke and separated 
gas phase immediately after taki~g a puff and after a 10 minute ageing 
interval. 
Continuous smoking method 
Values for the rate constant using the method described above are subject 
to variation due to different NO concentrations for the third puff from 
different cigarettes. It would obviously be preferable to continuously 
observe the decline in NO concentration from the smoke from a single 
cigarette. Using the standard 35 ml puff this is impossible because the 
analyser require s the entire 35 ml for analysis. By smoking the 
cigarette with continuous suction a considerably larger volume can be 
generated which can then be continuously analysed increasing the 
precision of kinetic determinat ions. The continuous smoking method 
obviously smokes the cigarette in a different way to either a human .or a 
conventional smoking machine. The brand chosen and method of preparation 
were as described above. A cigarette was placed in an adapated holder 
which was attached to a Cambridge filter and then to a vacuum pump 
(salvaged from a PK Morgan gas transfer apparatus). The cigarette was 
LAYOUT Fon CONTINUOUS SMOKING 
Cigarette in Cambridge 
Filter Holder 
Vacuum 
Pump 
Metaphene Bag Nitric Oxide Analyser 
Fig 12 
-
] 
Metaphene nag 
Recorder 
lit, air drawn through at 1 1 per minute and the exhaust collected in a 
metaphene bag (Metal Box Co, Portsmouth, Hants). After the cigarette had 
been smoked it was extinguished and the exhaust continuously analysed for 
NO over approximately a 10 minute period (see Fig. 12). For one 
cigarette oxygen was also continuously analysed by paramagnetic analyser 
(PK Morgan, Chatham, England). 
Determination of reaction order 
The rate of oxidation of nitric oxide in air is 3rd order and when oxygen 
is grently in excess it becomes (pseudo) 2nd order: 
dt 
integrating and rearranging 
1 2k (02) t + 1 
(NO)t (NO)O 
Accordingly if pseudo 2nd order kinetics are observed a plot of 11NO 
against t will be linear with slope 2k (0). If (0) is known k may be 
2 2 
calculated (Sloane and Kiefer 1969) (Brown 1982). To investigate other 
orders of reaction the following graphs were plotted: 
1) Zero order ie - d (NO) k 
dt 
A plot of (NO) against time will be linear of slope k. 
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First order - ci (NO) k (NO) 
dt 
inte grating In (NO)t In (NO)O - kt 
A plot of In (NO) against time will be linear of slope - k. 
Results 
-
Disappearance from whole smoke 
Figs. 13 and 14 show that for both methods of cigarette smoking the 
disappearance of NO closely conforms 
recommended rate constant of 7.3 x 10 
to the predicted 
9 6 -2 
cm mol sec 
slope using 
-1 
the 
for the mean 
temperature of 20°C and barometric pressure of 767 recorded during these 
experiments a nd the oxygen concentrat ion of 14.4% measured. 1I0\vever the 
correlaLion coefficient s for (NO) versus time (Inean = .Y5 (SU .04» and 
log (NO) versus time (mean = .Y5 ( SD .04» lvould indicate as good if not 
better fit for the zero an d first or d(~r mechanisms as for the second order 
(liND versus time r= .95 (SD = .05» . 
Disappearance from isolated gas phasE" 
It can be C-lcen from Fies .13 - 18 that disappearance from the gas phase 
proceeds considerably faster than either the predicted slopes or that 
observed for the whole smoke. 
The correlution coefficients were calculateci for (NO) versus time ( zero 
order) lo g (NO) versus ti:1l2 (first order) a nd liND versus time (second order) . 
The 2verage value for r ( SD) 1V8S .9tH (.02)for log (NO) vers us ti.me, for ( ~ O) 
ver s us t Line . YL1 (.06) Cille: r or liNO . Y7 t5 (. Ol) . 
Disappearance of NO in air 
Fig 19 show that NO disappears at a rate close to predicted. 
1 I ~ 
TJ\I3LE 20 
Concentration (~/. ) of oxygen in puff Imean (standard devialionl 
at 5 estimations on each phase and lime interval! . 
Whole smoke 
Gas phase 
Time (minutes) 
142 (0.9) 
146 (0 .3) 
10 
14 .5 (06) 
141 (0.3) 
Value5 for rate constants. 
1. R ale constam k for thud order rcaclio" ~ dl~IOI_ 2 k IN0 1110:1 
Ikl- em' mol " s '" Ikl "" 11mo, +l min- ' 
Source 
05 x 10" 5 2 X 10' OUf dOli" (whole Smoke) 
80 x 10' 4 8 X 10' unspccifif'!d phase (Sloan 
7.3 x 10" 4.4 X 10\ recorllmcnde j al 22 ·C (lJau 
43 
" 
10'" 2.6 X 10' our dnta rgas phase) 
0.83 0 .50 
and Kiefer 1969) 
leh et al 1972) 
10 x 10'" 10 x 10' gas phase (IYill ia 28 1.65 ms 1980), 
2. Rate conslant k for first order reaction _ dlNOI _ k (NO) 
dl 
Ikl - s " 
2.7 X 10 - 1 
our d:1 la (9(1.5 phase) 
70X lO -) 
eslint:1lcd from gas phase 
(Vilcins and Le hardt p 1975) 
Experimentally determined rate constants 
Table 20 shows the experimentally determined oxygen concentrations for 
the third puff. Table 20 also shows the rate constants derived for 
smoke and for gas pnase assuming pseudo second order kinetics together 
with values obtained by earlier observers. The close agreement between 
our value for whole smoke to that of Sloane and Kiefer (1969) is 
apparent. On the other hand, our value for gas phase agrees with that of 
Williams (1980). In addition, if we assume first order kinetics the rate 
constant WP. have derived for gas phase agrees reasonably well with that 
we have estimated from Vilcins and Lephardt (1975) if the absorbance 
deCRY for NO in their fi gure is plotted against time on a semilog graph. 
Discussion 
The results described above and those of others who have studied the 
disappearance of NO in the isolated gas phase (see Table 20) suggest that 
oxjdation proceeds faster than predicted. It seems impossible that that 
the increased loss Vias due to leakage or apparatus dead space because the 
same results were observed using two different techniques and the 
apparatus used was identical in each case for whole smoke and gas phase. 
Similarly the filter on the entry port of the analyser should prevent 
particulates causing a falsely elevated signal when the whole smoke was 
analysed. 
Th e whole smoke reac tion a ppears to conform reasonably closely to the 
pr e dicted disappearance of NO in oxidation in air though the da ta i s also 
con s i ~;L'nt with zero or f i rst order kinetics . 
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Interpretation of ti~ gas phase data rests on what can oxidise NO faster 
than oxygen. 1 am deeply grateful to Professor Brlan fhrush of the 
Universlty of Cambridge Chemical Laboratory for his assistance in the 
interpretation of these data. The gas ph~se oxidation of NO fast than 
by oxygen impLies the participation or oxygen centred free radlcais since 
these species are known to reacc especially rapidly wit" NO (Cox and 
Tindall 1980). ~urther support for free radicai participation is the 
first order kinetics anO also the presence of tree radicals in tne 
cigaretce smoke gas phase (Pryor, Prier and Church 1983). The con-
tinuation of the rapid oxidation over a period of severaL minutes implies 
continuous regeneration and it is highly likely that the products of NO 
oxidation ar~ themselves reactive oxidants. In the presence of parti-
culate matter, however, recombination or free radicals may occur resulting 
in slower dlsappearance. If indeed "quenching" 01 free radicals by 
particulates takes pLace, and tnere is evidence from electron spin resonance 
that it does (Pryor, Prier and Church 1983), then ic is highly likely that 
the COIlcentrations of free radlcais in the smoke a smoker innales will be 
inadequate to contribute to emphysema in the model proposed (Janoff et al 
1983). 
If oxidation or NO takes place at the same rate ill cigarette smoke as in 
air reierence table 6 shows that significant N02 is only likely to be 
generdted in the second or two tilat the smoke is wi~hin the mouth. How-
ever, by the very aCL of smoking this will be diluted severai fold so that 
alveolar concentrations of N02 are unlikely to be more than one or two ppm. 
In the alveoli the NO is so diiute that littie N02 wlll be generated. 
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The above discussion relates to the reactions of NO in cigarette smoke 
within a reaction vessel such as a glass syringe or methaphene bag. In 
the real life situation the smoke is inhaled into the lung which is 
itself a complex biophysical and biochemical surface. The reaction of NO 
with the lung is the subject of the next chapter. 
r 1(, 
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CHAPTER 5 
EXPERIMENTAL: COMPARISON BETWEEN NITRIC OXIDE AND CARBON MONOXIDE UPTAKE 
FROM THE RKSPRIATORY TRACT 
i) Factors a:ffecting NO and CO uptake in heal thy voltmteers 
Introduction 
There is growing evidence that when NO is inhaled it "reacts" not with 
the lung but with the blood. Yoshida (Yoshida et al, 1980) administered 
. labelled NO to rats and found that the label was present in the blood (in 
both red cells and serum) but not in the lung tissue. This contrasts 
with the finding with inhaled NO (labelled) in primates where lung 
2 
retention of label was observed (Goldstein et al, 1977). When NO is 
administered to dogs at concentrations of 0.5 to 2% death due to hypoxia 
from methaemoglobin rapidly results (Greenbaum et al, 1967). When lower 
concentrations (10 to 20 ppm) (Case and Scholey, 1975; von Nieding, 1973) 
are administered to man, metHb has also been isolated. In vitro 
experiments show that NO reacts very rapidly with reduced haemoglobin in 
the strict absence of oxygen (Gibson, 1959) and with oxyhaemoglobin by a 
different mechanism (Doyle and Hoekstra, 1981). 
Nobody has previously tried to determine the in vivo rate of uptake of NO 
from the lung or establish its kinetics. Such determinations are 
important for this study for several reasons. 
1) The toxicity of NO depend::: very much on the concentration (see 
Chapter 1). Measurements of alveolar concentration in smokers in 
between cigarettes and in vlJlunteers following an inhalation of NO 
11<3 
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allow prediction of toxicity. 
? ) At low ~oncentrations (ie below 20 ppm) the major toxicity of NO 
3) 
4) 
resul t- I; not from the gas itself but from its ability to form toxic 
compounds from reaction ~lith oxygen, oxygen centred free radicals 
(NO and peroxy nitrites) and amines (nitrosamines). If the rate of 
2 
removal in the blood is faster than the rate of formation of these 
compounds then they a re less likely to be produced in toxic 
quantities. 
Measuring uptake of NO and comparing it to CO uptake in a variety of 
circumstances allows comparison in behaviour. It is well known that 
CO reacts with haemoglobin. If the behaviour of NO is similar it is 
likely to have a similar fate and may confirm the labelling and other 
studies described above. 
The most intriguing reason for quantifying NO uptake is not to learn 
about the gas but to learn ahout the lung. Measurements of the 
"diffusing capacity" of gases used to date (0 CO and inert gases) 
2 
are affected by events in the pulmonary capillary at least as much as 
by membrane diffusion. The idea of a gas that might combine 
instantaneous ly with haemoglobin and had no back tension such that 
its transfer reflected only alveolar capillary membrane diffusion is 
conceptu a lly exciting and potentially useful clinically. 
Method 
The Gas Analysers 
Linearity of the instrument to dilution over the operational range was 
tested by serially diluting a helium/carbon monoxide/nitric oxide mixture 
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with air by a closed circuit method. (This was achieved using the dry 
spirometer of the gas transfer apparatus - see below). Linearity of the 
helium analyser in oxygen was also tested by diluting a helium CO mixture 
in oxygen since the h~lium katharometer will also respond to oxygen. The 
and signal to noi s e r a tio 
/ f h I tt d by continuously sam!llin'o' mixture s of pr e ci s ion ate an a yser was e s -e 
approximately 50 ppm and 1 ppm in nitrogen and recording the deflection 
produced. The reponse time was measured by making a stepwise change from 
an NO mixture to NO free air using a valve with a microswitch attached 
and recording the signal on the same (2 channel) recorder as the NO 
analyser output. Interference from other gases was tested by adding 50 
ppm NO , 1% N 0 or 
2 2 
50% CO to 
2 
a mixture containing NO. The latter 
precaution was taken since CO (but not CO) has been reported to "quench" 
2 
(ie reduce) the chemiluminescen~ reaction (Klimisch and Kircheim 1977). 
Measurement of diffusing capacity 
The s -in g l e breat h method (Ogilvie et al 1959) was adopted since 
manufactured equipment is available that can easily be adapted for use 
with NO (see Fig. 20). The slow response time of the NO analyser 
precluded a re-breathing or slow expiration technique. Similar 
difficulties were anticipated with D NO to those experienced for D CO by 
L L 
the steady-state method. The instrument used (Transfertest, P.K. Morgan, 
Chatham, England) is a more recent version of a device described 
elsewhere (Cotes 1979). It consists of 2 bags in a box connected to a 
dry s !)irome ter with a series of valves to control the onset and duration 
of breatholding, size of the inspiration and time of alveolar sampling. 
An electronic timer and potentiometer record breathold time and inspired 
volume on a digital display. (The duration of breathold was taken to 
inlcude two thirds of the duratj ·)n of inspiration to half way through the 
sampling period) (Cotes 1979). Attached to the Transfertest apparatus 
1'2. J 
were analysers for helium (He) (thermal conductivity) ("Katharometer"), 
carbon monoxide (CO) (infra r8d) and oxygen (0) (paramagnetic) (P.K. 
2 
Morgan Ltd, Chatham, England). 
Each analyser was calibrated daily using a test gas mixture supplied by 
the manufacturer (CO .3%, He 14%, 0 
2 
18% and the remainder N). 
2 
Linearity of the CO and He analysers over the working range was tested in 
conjunction with the NO analyser by diluting an NO, CO, He mixture in air 
as described in the previous section. Since the helium katharometer 
responds to oxygen it was calibrated in oxygen also. A manual 
potentiometer on the helium analyser adjusted the He signal for varying 
oxygen concentrations. All samples for CO and He analysis were passed 
through soda lime and calcium chloride prior to analysis to remove CO 
2 
and water vapour. Since passage through soda lime was found to cause a 
slight reduction in NO signal, samples for NO analysis were drawn off 
prior to passage through soda lime and calcium chloride. 
Measurements of D CO and D NO were made simultaneously on the same 
L L 
manoeuvre. A mixture containing He 13%, CO .3%, NO 30-50 ppm, 0 16% and 
2 
the remainder N was made up in the inspirate bag immediately before each 
2 
test by carefully adding 0.3L of 1000 ppm NO in N (Hilger Analytical, 
2 
Margate, Kent) to 7L of He/CO/air (P.K. MOrgan Ltd) checking the volumes 
on the dry spirometer of the "transfertest". As a precaution the 
approximate NO concentration of the inspirate bag was checked on the NO 
analyser prior to the manoeuvre . The subject was then asked to breath 
tidally with the valve connected to air. He then exhaled to residual 
volume (RV) and the valve was switched to the inspirate bag for a full 
inhal a tion. After a precise time of breatholding an audible signal 
instructed him to exhale to RV ~gain. During exhalation after about 0.7L 
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Fig 21 
had been exha led (to wash out dead space) an alveolar sample was drawn 
into the exhal e d bag . The inspirate bags were then analysed for He, CO, 
NO and (where thi s was of interest) oxygen. 
A small adjustment was made to allow for oxidation of NO occurring in the 
inspirate bag betwe en the manoeuvre and analysis which would reduce the 
concentration obtained: a battery connected to a potentiometer on the dry 
s pirometer gave an "event marker" which was plotted with the NO 
conc entration on the 2 channel pen recorder (see Fig. 21). Knowing the 
time e l apsed, ux yge n concentration a nd kin~tics of NO i n air (whic h we 
c onfi rmed fo r our a ppara tu s ) it was thus poss ible to adjus t the inspired 
NO co nce ntra tion . I n a dd it io 1 the r a pid a lveolar upta ke of NO required a 
s horter brea thold t i me fo r sufficient alveola r NO to be present for analysis 
( 2- 3 ptJ lIl ) a nd a durat.io n of 7. 5 second s . was used. If 10 s econd s \va s employed 
less t ha n Ippm was fo und in the a lveol ar sampl e . 
Calculation of D NO and D CO 
L L 
DL for CO was c alculated as 
o = V x 23.33 log Fe He Fi CO 
L A. x 
BHT Fi He Fe CO 
. - 1 - 1 
mmol mln kpa 
Where BHT (breathbld time) is in seconds, F (concentration) in % and VA 
(alveolar volume) in litres and the subscripts i and e denote inspired 
an d exp i r ed r espectively. 23.33 is derived from (60 x 826)/(22.4 x 94.8) 
where 60 converts seconds to minutes, 826 L BTPS to ml STPD, 22 . 4 ml to 
mmol and 94.8 is P 
B 
H 0 in kpA. For the one subject who smoked with 
2 
detectable P and for estimat ion of D CO in oxygen a term for CO back 
vco L 
tension was included (Cotes 1979). V was calculated from the single 
A 
breath helium dilution (Cotes 1979). Assuming a neglible NO back tension 
and semi log alveolar NO uptake (see later section for justification of 
this) DL for NO was calculated eXllctly as for CO except that F
eNO was 
multiplied by 1.1 to allow for the reduction in volume which occurs when 
CO 2 and H20 vapour are removed from the sample for helium analysis. 
The inspired FNO at the time of the manoeuvre FNOO was obtained from 
(FNO t ) (FNOat the time of analysis) knowing Fi02 and the time between 
manoeuvre and analysis as follows (assuming the order of reaction to be 
pseudo second order). 
1 1 1 
+ 
F NO (t) F NO (0) 
(Brown 1983) Where NO-N02 is the third order rate constant for 
oxidation of NO by oxygen. o The value of KNO-N02 at 273 K was taken 
from a survey of values in the literature (Baulch et al 1972) and was 
confirmed by following the rate of oxidation of NO at known 02 
concentration in the ins pirate bag. 
Calculation of D CO 
m 
The derivation of the calculations are described elsewhere (Cotes 1979). 
DL for CO was calculated at 2 alveolar oxygen tensions, the lower 
breathing air and the higher breathing oxygen. From this knowledge CO 
and hence DMCO can be calculated. This requires knowledge of PC02, COHb 
and Roughton and Forsters value for e (Cotes 1979). 
Haemoglobin and carboxyhaemoglobin were measured in triplicate on a 
single venous blood sample drawn [rom each individual and analysed using 
an automated spectrophotometer (IL 282, Instrument Laboratores, Andover, 
124 
Mass., USA) (Baretta et al 1978). The instrument was calibrated daily on 
the Hb channel usin g a solution of known concentration (Caldye, 
Instruments Laboratories, Andover, Mass., USA). Pc (the mean capillary 
oxygen tension) was measured as follows: 
D CO 
m 
PA02 is alveolar 02 tension, .83 adjusts for the greater diffusivity of 
oxygen relative to CO. M0 2 is the resting alveolar oxygen uptake and was 
-1 1 taken as 12 mmol min and DmCO was taken as 1~ times DLCO (AIR). The 
exact value used for these two latter terms makes a negligible difference 
to the final value for D . 
m 
Combined measurement of DLCO and DLNO on volunteers 
i) Selection of volunteers 
Thirteen volunteers from the staff of our physiological lab were 
recruited. All provided informed verbal consent and the study had the 
approval of the hospital Ethical Committee. None gave a history of 
respiratory illness. Each performed a series of respiratory function 
tests: forced expiratory volume j_n one second (by "vitalography"), total 
lung capacity (body plethysmography) and DLCO by the single breath method 
(see Subjects and Methods Table 12). 
ii) Measurement of DLNO and DLCO at rest 
A combined measurement of DLNO and DLCO was made on each subject seated 
at rest. Three replica tes were performed for all 13 subjects. 
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iii) Measurement of alveolar NO at varyi~g breatholdtimes 
Two subjects performed combined DLCO/DLNO measurements but the breathold 
time was varied using the electronic timer and audible signal on the 
apparatus to signal to the subject to exhale. The duration of breathold 
(including two thirds of inspiration to half way through sampling) was 
varied from 4 to 10 seconds. The alveolar NO at each time was calculated 
as a fraction of initial concentrations. 
Fractional alveolar NO FE NO x Fi He 
Fi NO Fe He 
iv) Measurement of DL at 2 different oxygen tensions 
Prior to measuring DL in oxygen five subjects breathed oxygen from a mask 
for 5 minutes. They then re-breathed 100% oxygen for 4 minutes from a 6 
litre anaesthetic bag (Medishield, British Oxygen, Harlow, England) 
containing a soda lime canister in series. The gas mixture in the bag 
was analysed for CO, O2 (and NO in 2 subjects). Following this procedure 
they immediately made 3 single breath manoeuvres with the CO/NO/He 
mixture made up in oxygen. At least 5 minutes elapsed between manoeuvres 
and during this time they breathed oxygen from a cylinder. On a separate 
occasion they performed 3DL manoeuvres breathing air but the alveolar 
sample was also analysed for oxygen. 
v) Measurement of DL at varying lung volumes 
Six subjects were studied seated at rest. The solenoid operated valve on 
the "transfer test" was adjusted either to allow a full vital capacity 
breath or to terminate inspiration at approximately TLC + 2. Two 
replicates were made by each individual at each lung volume. 
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vi) Measurement of D at varying level of exercise 
L 
Three subjects were studied at rest and on exercise seated on a bicycle 
erogmeter (Tunturi, Turku, Finland). The brake tension was ajusted to 
give work loads of 50, 75, 125 and 175 watts at 60 revolutions per 
minute. Each subject cycled or rested at the required level of exercise 
for 4 minutes, oxygen uptake was then measured for 2 minutes and then, 
while still maintaining the required workload, a single breath manoeuvre 
was performed. 
The rate of 0 uptake was measured with the subject breathing via a low 
2 
resistance three way valve which separated inspired and expired air. The 
expired air was passed through to a mixing box and was sampled for oxygen 
using the paramagnetic analyser on the "transfertest". Exhaled minute 
volume was measured using a heated Fleisch pneumotachograph and 
transducer (P.K. Morgan Ltd, Chatham, Kent, England). The signal from 
the transducer was passed to an electronic integrater (P.K. Morgan Ltd, 
Chatham, Kent, England) and pen recorder (W. and W. Electronics 404, 
Basel, Switzerland). The pneumotachograph was calibrated for air at room 
temperature using a lL syringe . 
. 
The oxygen uptake (MO was calculated from the exhaled oxygen and 
2 
exha led volUiae (fv1us grove and Dare 1974). 
It was assumed that the air emitted from the end of the mixing box was 
approximately ATPS. (This assumption was checked on one subject by 
mea.suring the temperature using a termocouple and the temperature of the 
exhaled air was never greater than 4°C above ambient). 
vii) Measurement of D at different postures 
L 
Single breath manoeuvres were made on 5 subjects with one replicate in 
sitting, standing and lying postures. Each posture was maintained . for at 
least 5 minutes (sitting and lying on a medical examination couch) prior 
to the singl.e breath manoeuvre. '[he bag-in-box could easily be adjusted 
to an appropriate height by adjusting a clamp on its supporting tripod. 
Measurement of back tension for CO and NO in smokers 
The alveolar CO and NO following a standard 20 second breathold was 
measured in smokers as follows (Jarvis, Saloojee and Russell 1980). Each 
was Rsked how many cigarettes or how much tobacco he consumed daily and 
when he had last smoked. He then exhaled to RV, inhaled to TLC and h~ld 
his brea th for 30 seconds. After exhaling 500 ml to wash out dead space, 
an a lveol ar sample was taken and analysed for NO and CO using the 
:Jnnly s c r s d,-, ;:: rr i. l>C:'d C1nd cn ltLJr ,lteJ as previ.o ll sly . Jll iJddi.tlun a.lveolar ;~ U 
c~.nd C() concel i t.ra t ions \-Jer e r:leasllred in one smoker a nd one non-sr.1oker af ter 
breathing oxyge n Eor [our minutes. 
Experimental protocol and treatment of reBu~tB 
No more than 4 single breath manoeuvres were performed per person per 
day. For eac h person the experiments were carried out at least 2 hours 
a fter a meal and at the same time of day on each occasion. Within each 
eX\-ler"i.JIle nt the order of st udy Has randomi.sed. One s ubject Has a s moker \,,110 
maintai ned hi.s LlsLlal s lilok1.n g pattern and each estimate of DtCO \"as adjusted 
f- or CU i)d Li( t:ension. '>:11culations of Dl..' randomisatj.on and sta t1.stical a na l-
ysis were periornlccl using simple computer I-lro~ral[1mes. The Pea rson product 
IllomenL correiat:l.Ol l coefficient Vi8 ~ calc ulnt. ed to qll a lltif y association between 
, , 1) r 'll \ j) N(l ' j ' \·". 1 \·' .~l'i ;':1 r l ~ll . v,',· l· so l· V e'r)· c'111C e \hlS lls e d Lo st ud y 'Ji1 LU<:; ~ , 'J I 1, -' ':1 1;( L · · . v J '} - u - -
cll.t.f:er e nc es in U
L 
be t\-Iee n different lililnoeuvres . To com par e the \-lercentage 
t all in D]l.\) and u,lW \'/1. th re ducing 1un 3 volurne a t\.;o sClIil\-ll e t test \.;as used . 
'" 
I n eacll ci:lse the null hypothesis \Vas set for the whole eXiJer1.:nent (e 6 
·' f-xe. r r i s e has no statistical ly significant effecL on DLIt) rather than on s ub 
uJteljorie s (e ~~ "there is no statistically significant differ e nce betHeen DL 
a t 7 ':J \·!3tL s c om par ed to SO H?ttS lt ). 
TABLE 21 
ALVEOLAR CO AND NO IN SMOKERS 
Subject Alveolar CO Alveolar NO Time Since Last No. of Cigarettes 
(ppm) (ppm) Smoked per Day 
FM 16 0 ! hour 10-15 
MC 10 0 2 hours 2 oz per week (Pipe) 
WW 22 0 i hour 25 
NWL 21 0 ! hour 40 
RA 22 0 i hour 20 
GJ 18 0 10 min 30 
LB 34 0 10 min 25 
DILUTION OF NO AND CO IN HELIUM OVER WORKING RANGE 
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Fig 22 
CONTINUOUS SAMPLING OF NO AT 50 PPM AND 1 PPM (APPROX) 
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TIME RESPONSE OF NO ANALYSER 
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Fig 24 
OXIDATION OF NO IN AIR (LINE IS PREDICTED SLOPE) 
- 2 - 1 
l l NO x 10 ppm 
• 
• 
~ . 
, 
10 
~. 
~. 
, 
30 ~o 
Fig 25 
",if'S 
R 
0 
U 0 
Z VI 
U 
<V 
0 .... ~ 
e VI 
0 
u ~ 
0 
z Cf.l ~ ~ • 
~ ~ 
;5i! 
0 H 
• • 
~ ~ 
Z E-< 
• • t:.. 0 
0 ....:l ~ ~ . 
0 
Z ::r: 
0 ::r: 
H E-< 
~ ~ • 
E-< ~ 
~ ~ 
~ 0:: • 
~ . 
E-< CQ 
z 
~ c.:::J 
U Z 
Z H 
Q1 ::c 
U ~ 
0 >< 
U 0:: 
<: 
-4 • 
0:: :> 
<t: 
....J E-< 
0 ~ ~----------------------~----·------------------~~o 
~ 
:> 
....:l 31VJS ~Ol 
~ 
(11?!l!U! )0 lIO!PI?J) 51?) 
'JNOJ ~Vl03"lV 
to 
C'l 
0.0 
.,..; 
~ 
Results 
Fig. 22 shows that the instruments give a linear response to dilution to 
o )[ygell i.IIHJ Clt r ove r the I~orking range s (1-40ppm), There 1~i:l S an a pparent 
departure from linearity at the hi gher j 'O co ncentratiu ns (S-30pplil) but. in-
sertl ng <.1 " corrected" NO val ue into the calc ul(1tions fi1ade a negligible dif-
f'2renc(' L() the IJLNO figure ( u bout 0.0:)) mmols/lilin/kpA. The precision of the 
NO in str ument IV8S (reading standard deviation) .5 ppm at 53.5 ppm and .1 ppm 
3 1. 1 ppm (see Fig 23), The noise level was .5 ppm. Se nsitivity (twice noise) 
was t herefore 1 pPIlI, signal to noise ratio \Vas 2 at 1 pprl1 and 100 at 50 PiJlll. 
[nterference f roln N02' N20 and CO2 \Vas not observed \Vhen samples containing 
these gases \Vere a nalysed. Fig 24 shows that the response time to InaxirnUiil 
signnL is a IJIJro xima tely 1 min. Fig 25 shows that the rate of di sa ppearance in 
NO in air over a 50 minute period agrees reasonably with the predicted 
rate of oxidation. In fact calculation of the rate constant from my data 
-10 -2 -1 
gives a figure of 7.14 x 10 
the published value of 7.6 x 10 
mm HB (Raulch et nl 1972). 
Voltmteers 
ppm 
-10 
min 
-2 
ppm 
which agrees to within 10% of 
-1 
min corrected to 293°k and 760 
Table 12 shows the age, sex, rnorphometric and lung function data of the 
voluntee r s. Smoking status is also given and where relevant exhaled CO 
concentrations. 
Rate of decline of alveolar NO 
Fig 26 shows that the declj.ne in alveolar NO, like that of CO is 
logarithmic when plotted as a function of time. Table 21 shows that the 
alveolar back tension (here given as a concentration) of NO is negligible 
in smokers eve n when they have recently consuilled their last cigarette with 
a1 veol (1 r CO ranging I ()-34 pPfil, 
(] 11 2 !lull-sr.lOkers I~e a l so a nalysed for NO \oIhen ('0 b I . measuring, ac ( tenslon 
TflULE 22 
COIIP/lIlISOI1 OF DLNO /lIID DLCO 1·IE/lSUIlED TOGETIIEIl IIIID SLP/ln/lTELY 
(llcans (SD) thrce replicat es ) (mmol/min/kp/l) 
1- DLCO(wlth NO)f t t-SUbject DLCO( fllorlc) DLNO (/llone) DLNO (wHhCO) 
CD 13.3 (0.0) 14.3 (0.4) 57.6 ( 1.0) 59.6 ( 1.2) 
IIG 11.9 (0.3) 11.9 (0.3) 57.9 ( 5.6) 55.2 ( 1.6) 
NC 13.7 (0.3) 13.5 (0.3) 53.5 (3.6) 61.0 (0.7) 
/Ill 12.0 ( 1.1) 12.0 ( 1. 1) 49.4 (4.7) 50.2 (4.1) 
t1P 0.9 (0.3) . 8.7 (0.3) 117.5 ( 1.6) 42.6 (2.8) 
Dreathhold time of 10 seconds 
t 8reathhold time of 7.5 seconds 
.-
TABU: <.:3 DATA fRo.~ IIIltCH RESTING DLCO AND DLHO WERE CALCULATED 
Initials Hellurl ~ (;if. .. HO{pP"') In3plred In3plred Dreathold VA KCO KIlO DI.cO DLiIO 
Inhaled Ex""led Inhaled Exhaled Inhaled Exhaled Oy-ycen Vol (L) Time (s) IL) (orwol/llllnl:pAIl ) 1,..·.,I/ ... III/I:pA) 
(';:) ATPS 
CB 13.~5 9.89 .270 .112 35 2.2 17.2. '> ~.95 7.4 7.8 1.80 7.46 1' • . (J(. ~0.23 
13.46 9.29 .270 .101 40 2.1 17 .0 4.55 7.~ 7 •. 6 1.93 7.0.4 14. '{I, 1j').:J~ 
13.2~ 9·70 .266 .111 ~~ 2.6 17 .2 4.95 7.3 7.0 1.00 7.72 II, .In 60.61, 
SI 13.~6 9. 41 .270 .082 32 0.8 16.8 2.95 7.3 4.9 2.67 10.34 13.0. 50.Ij/, 
13.~8 10.18 .270 .079 32 0.6 17.0 2.B5 7.7 4.4 2.01 10.91 12.~'j 41.00 
13.35 10.22 .26B .097 39 1.1 16.8 3.10 7.1 ~.7 2.21 9.72 lU.OO 45.56 
Het 13.31 10.35 .262 .120 49 3.2 16.7 5.25 7.2 1.0 1.14 7.72 13.~0 (,0.36 
13.6~ 10.71 .261 .124 51 3.3 16.9 5.45 7.3 8.0 1.10 7.68 13.66 61.6'1 
1~.28 10.43 .219 .125 15 1.0 17.1 5.30 7.4 8.4 1.56 1.25 13.11 60.91 
RD 12.62 10.12 .253. .115 51 2.6 16.6 5.40 7.2 7.4 2.03 8.Bl 14. ') 1 64.05 
12.12 10.41 .255 .10B 59 2.7 17.0 5.30 B.3 1.2 1.99 1.98 14.20 56.99 
11.51 9.01 .214 .121 33 1.8 20.9 4.90 7.0 6.7 2.03 B.BS n.Jl JB.90 
til' 12.38 10.!>3 .251 .121 35 2.3 16.0 3.20 ·6.9 4.3 2.03 B.37 D.n 36.12 
12.45 10.31 .256 .114 30 1.8 16.9 3.35 7.6 4.5 2.07 7.91 9.32 35.35 
12.60 10.94 .262. .126 31 1.8 17.0 3.40 6.9 4.5 2.00 8.03 9.06 40.02 
~ 11. ~ 1 9.61 .273 .142 32 2.4 20.9 5.20 6.B 7.1 1.6B B.OO 11.n 56.74 
".H 9.25 .275 .126 34 I.B 21.1 5.00 6.2 1.2 1.62 7.49 l'.n 53.61 
11.04 9.31 .266 . .131 59 3.9 20.3 5.00 1.1 6.9 1.78 8.06 12.13 55.31 
1" 12.81 'J.02 .268 .112 22 1.2 11.2 5.00 7.0 7.6 2.02 8.49 15.27 64.15 
12.36 9.92 .259 .117 51 3.4 16.6 4.95 6.9 7.1 1.9~ 8.09 13.no 51.00 
12.66 10.?B .266 .120 37 3.3 11.0 5,00 6.8 7.1 2.02 7.25 1',.30 51.72 
lUI 13.36 9.43 .269 . '101 46 2.3 16.8 3.1,0 7.8 5.6 1.89 1.64 10.53 42.59 
13.85 10.22 .278 .111 21 1.2 11.3 3.65 7.4 5.1 1.9~ 8.56 11.0<) 49.03 
13.60 9.76 .275 .109 12 .7 17 .3 3.60 7.5 5.8 I.B5 1.74 10.73 44.9() 
RL 13.54 11.45 .270 .113 34 1.3 17 .4 2.60 7.1 3.6 2.13 9.10 7.59 32.30 
13.21 10.76 .263 .110 38 1.7 11.3 2.30 7.3 3.3 2.13 0.97 6.96 29.34 
13.n 11.11 .275 .111 18 0.8 17.7 2.40 8.1 3.4 2.02 8.10 6.89 21.69 
BP 13.26 9.07 .264 .083 45 1.4 16.6 2.~5 7.1 4.2 2.55 9.84 10.59 40.87 
13.22 10.10 .265 .110 43 1.7 16:6 2.50 6.8 3.8 2.52 9.06 9.46 J7 .OB 
13.66 10.)) .273 .111 24 1.0 16.9 2.30 6.6 3.5 2.~5 9.62 6·.63 33.92 
HP 11.00 e.96 .260 .136 45 3.7 21.0 4.20 7.4 6.0 1.40 6.94 e.3(' 1,1.3 /, 
10.92 6.68 .257 .126 51 4.3 20.9 4.00 1.4 5.8 1.52 6.96 6.83 40.50 
10.06 7.'J5 .253 .128 55 4.(; 21.0 4.20 7.2 6.2 1.43 7.41 0.04 45.61 
All. 13.40 11.06 .265 .11~ 46 2.5 16.7 4.55 7.3 6.4 2.06 0.53 13.14 54.44 14.07 11. 74 .279 .136 16 1.4 11.0 4.30 6.4 6.0 1.95 7.76 11.69 46.31 g.OO 11.76 .277 .139 20 1.5 17 .2 4.75 7.1 6.6 1.69 7.63 11.06 49.95 
I'll 12.72 0.47 .251 .092 61 3.2 16.5 4.05 7.5 7.0 1.66 1.61 n.oe 53.60 12.74 0.04 .251 .OB6 61 3.1 16.5 3.70 1.6 6.6 1.06 7.44 12.73 50.53 12.78 7.62 .252 .081 6J 2.4 16.5 J.15 6.1 7.3 '.76 7.65 12.9(, 55.72 
~ 
'I Inhaled HO .dJu~tcd for olld.tlon as de.crlbed In text. 
:f tCO and OLCO ro" IIC (3moker) " .. adjusted for alveolar CO .OQ~ (mca~ured durlnr- rCbreathln~). 

TADLE 25 DlffUSIIIG CIIPACITY AT V AIl"ilIiG OXYGEn TEIiSIOn AnD CALCULATED DI 'I 
Subject Alvcolar 
°2 !lUIO DI.CO 01-1 ( /,.) 
................ - ~ ... -- ........ -_ ........ --- "--,, ........................ _ ................ - --
( 1I IIJlol /lllill/kpA) 
DR ,., . ') 'i').H 1].2 19.1 
19. 2 Sf,. 'I 13.1 ,20.5 
10.2 'i'1.5 12 .(, 16.9 
6JJJ 'in.9 1l.5 
6',.0 Sf). S U.l 
63.5 'i').O U.7 
li t..: 19.7 ', <J .II 10.2 1(,.6 
19.3 ~;J . 0 11.n 19.5 
19.3 ~)(). ;' 11. 5 23.3 
(",.3 5'j .n 6.;, 
70.3 50 . :1 (,.n 
71.1 55.n 5.7 
1IF 17 .0 ,, ;> .7 9.0 113.7 
10.3 ',o.n 9.1 1' •• 9 
10.7 3,) ./l 9.2 16.5 
71.3 ,,0.', ',.9 
69.0 3'). ;' 5.1 
73.0 ',oJ, ',.7 
KII 10 ." 50.7 11.0 22.7 
lfl.O 5 1.0 12.3 25.8 
lfl.2 5',.n P.2 21.9 
(,3.1 ', (, . 1 6 .', 
(J(, ." 11 5. ? 6.2 
7',.2 50.) 6.2 
An lB." 5:'. ) II." 17 .8 
I f) .1 ',(1.n lO.n 15.3 
19.1 51." lOJ, 1',.6 
(,fl.') 'i'I.') (,.7 
'11.(, 5tl.7 (,.13 
71.0 5(' .'1 (,.9 
U[1ill[,; tlW I-my nllnly!>i!> of vnrlallcc I " CoI'pot'aline; nil interac tion ter'm elvcsi 
!lUIO: Val'lancc rntio (Bel.l-/cc n 02 tcn"Jona).(r'esldual) on 1,20 df = .1,8.4.63 = .1 (HS ) 
DI.CO: Vnl'inllce l'otio (l1ctllCC Il 02 t.CI1fI I 011[1) ~ (rcsldual) on 1,20 df = 17 I .1,\ •• II', (P< , .001 ) 
TADLE 26 DLOOD PIGIIEIiT 
DATil 11111) IILVEOLIIR CO TEllS ION liFTER DREIITIiING OXYGEN 
lib. COllo metH13 
1I1veol'lr CO (at) 1I1veolar O2 
( c/dll ( ~\ ) (%) 
(%) 
cn 15.6 0.6 0.13 
.001 73.2 
IIC t 1/1.1 2.~ 0.5 
.007 75.0 
I-If 13.3 0. /1 0.3 
.001 79.13 
KII 14. 1 0.7 0.3 
.001 7 /1.2 
RLt 13.0 0.6 ' 0.5 
.001 134.6 
IIR 1/1.1 0.7 0.5 
.002 79.3 
t Smolccrs 
TABLE 27 
EFFECT OF CHANGING LUNG VOLUME ON OLCO ANO OLNO 
Subject VA OLCO OLNO 
(L) (mmol/min/kpA) (mmol/min/kpA) 
CB 1,.7 13.5 1,5.0 
1,.5 13.5 33.9 
7.0 13.0 60.1 
8.0 13.6 56.7 
NL 3.6 11.9 40.5 
4.0 11.0 39.1 
7.9 11, . I, 59.1 
0.0 12. I, 53.8 
HF 2.0 9.8 30.6 
2.7 0.6 29.2 
5.0 11.5 lIS. 2 
4.7 9.4 1,0.9 
III 3. 1, 11.2 36.6 
3.6 10. I, 36.6 
7.3 1/,.4 ' 63.4 
7.3 14. 1 59.9 
PH 4.7 11,.3 1~6. II 
4.9 13.8 1~7 .6 
6.9 12.6 50.6 
7. 1 13.0 55.3 
Using two-way analysis of variance, incorporatinG an interaction 
For DLeO. Vnrinnce ratio ( bet\~ccn TLC nnd TLC/2)~ (residual) on 
For D:1"~O: Variance ratio (betHeen TLC and TLC/2).;.. (residual) on 
term givesl 
1,10 df = 10.8 (P(.Oll 
1, 10 df = 104.9 
'P <.. 00 1) 
I 
,4, 
TABLE 28 
EFFECT OF CHANGING POSTURE ON DLCO AND DLNO 
DLCO 
(rnmol/min/kpA) 
Subject 
Lying Sit-ting Stand inc LyinC 
CB 17 .5 14. 1 14.3 63 .1 
NC 13.3 12.6 13.6 54.2 
KH 13.1 11.8 10.6 52.6 
IH 14.4 13.4 14.1 53.0 
PW 13.6 12.1 12.6 41.& 
x 14.4 12.8 13.1 54.1 
s 1.8 .95 1.1 5.6 
Uclne two-way anoly31~ of v~rlonce (with interoction term): 
DLCO: Variance ratio on 2,8 df = 4.35 (NS) 
DLNO: Variance ratio on 2,8 df = .14 (HS) 
Ul 
DLNO 
(mmol/min/kpA) 
Sitting Standinc 
56.2 54.0 
54.2 60.2 
52.2 49.4 
54.9 58.6 
55.1 51.3 
54.6 54.1 
1.6 3.3 
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by oxygen re-breathing and also were unable to detect NO. 
Simultaneous resting measurements of DLNO and DLCO 
Fig 27 shows that individuals' values for DLNO exceed their DLCO by 4.3 
fold (SD 0.3) and are related to their DLCO values and the correlation 
coefficient is 0.96. Average DLCO = 11.6 (SD 2.4) and average DLNO 49.1 
(SD 10.2) n = 13. From Table 22 it can been seen that addition of NO to a 
He/CO/air mixture does not appear to affect DLCO nor does adding CO to a 
He/NO/air mixture effect DLNO. Table 23 shows the values from which CO and No 
were calculated for our 13 subjects at rest. The precision of measurements 
for DLCO and DLNO are roughly comparable and are close to a 5% coefficient 
of variation (Table 24). 
The effects of varying oxygen tension, lung volume and posture on DLNO 
Itcan be seen that DLNO is independent of a large variation in alveolar 
oxygen tension (Table 25) in contrast to DLCO. From the values of DLCO 
at two O2 tensions Dm for CO has been calculated (Table 25 and 26). 
Reducing alveolar volume by approximately 40% produced only an 8% fall in 
DLCO but a reduction in DLNO of twice this magnitude (Table 27). The 
difference between the fall in DLNO and DLCO was highly significant (p < .01). 
For 2 subjects, CB and PW no fall in DLCO at lower VA was observed and for 
PW an increase was observed. With a change in posture no significant 
change in DLNO was observed though an increase in DLCO from sitting to lying 
posture. The numbers in this experiment were small however (Table 28) . 
The effect of exercise on DLNO and DLCO 
With increasing levels of exercise (and correspondingly increases in 
oxygen consumption) DLCO increased markedly though the proportionate 
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Fig ?H 
increase in D NO was less (Fig. 28). This increase is statistically 
L 
significiant (p <.001) with a significant (p <.001) linear component. 
Discussion 
As predicted from in vitro measurements we were unable to measure a back 
tension for NO. Indeed even subjects who had recently and regularly been 
exposed to NO and CO (cigarette smoke contained significant quantities of 
both gases) (Stedman 1968) and who showed a measurable CO tension had no 
detectable NO in the alveolar sample. 
.!J. ... 
The single exponential disappearance of alveolar NO with time indicates 
that, in chemical terms, this is a first order process and hence can 
legitimately be described by the diffusing capacity, a constant derived 
from: 
-d (NO) 
dt 
Whilst these observations validate our measurement of D NO they do not by 
L 
themselves indicate what physico-chemical process it reflects since 
alveolar-capillary membrane diffusion (Krogh 1914) removal by the 
capillary blood (Piiper and Scheid 1980) and chemical combination of NO 
and CO with haemoglobin (Gibson 1959) are all Ilfirst order processes \I 
exhibiting semilog decline in alveolar concentration with time. 
In general our D CO values 
L 
are in agreement with published data. 
-1 -1 
Mean 
D CO for our 13 subjects was 11.4 mmol min. KPA measured routinely and 
L 
11.6 measured with f) NO. Piiper and Scheid (1980) give an average of 
-1 L -1 
11.4 mmol min KPA fo r s ingle breath D CO from a survey of 45 
L 
publications. Cotes (1978) quotes coefficients of variation for D CO 
L 
measurements on a given individual of 5% and D CO of 0% which agree with 
m 
our fig ur es . The values for DmCO ag r ee with those expec t e d. The r ed uct ion 
in D CO at lower lung volumes is less than estimated by some though there 
L 
is wide variation (Forster 1964). Close inspection of our results (see 
Table 27) shows that for two subjects no decrease in D was observed at 
L 
lower VA (one in fact increased it) and it is quite probable that these 
subjects held their breath with a closed glottis and so performed a 
Muller manoeuvre. 
Our measurements for f) NO appear to be of similar precision to those for 
L 
D CO. The addition of CO to the inspired mixture does not appear to 
L 
affect measurement of D NO and provides useful "control measurement" on 
L 
each manoeuvre. 
Raising the alveol~' oxygen concentration from 17% to over 
60% has no effect on D NO. Similarly changing posture has little effect 
L 
on D NO. 
L 
During exercise an increase in D NO of similar magnitude to 
L 
D CO was observed but it was considerably less proportionately in view of 
L 
the greater resting value for D NO. An alteration in alveolar volume 
L 
appeared to effect D NO to a greater extent than D CO. It is interesting 
L L 
that D NO ~ltered even in those two individuals who 
L 
maintained D CO 
L 
at 
low long volumes. If, as seems likely, these two performed a Muller 
manoeuvre, inspiring against a closed glottis, it suggests that D NO is 
L 
little affected by such an action. 
Tfl BJ.E ?!J 
PUOLISIIED VALUES roll nATE COIISTAIITS 
forward reactions nate constant 
( 1) O2 + lib. IIb02 
6 -1 -1 3.10 L mol sec 
(2) CO + lib. COlib 1. 2. 5 - 1 -1 10 L mul sec 
(3) NO + lib. NOllb 4.9. ., -1 10 L mol sec -1 
(4 ) NO + IIb02 7 -1-1 ~let lib. + 1103 3.7. 10 L mol sec 
( 5) 202+ S20 4(dlthionlte) 1.3. 
6 -1-1 10 L mol sec 
(6) NO + Il 0 3, I -1 - I 2 2 10 L mol sec 
(7) tlO + lung 3, 5, - I -1 10 sec 
Back reactions lIalf Lives 
(8) IlbCO CO + lib 2.3 hours 
(9) IIbllO NO + lib 5 hou,'s 
(10) 1·let lib. + 1103 = 110 + lib 
IIOTES 
Comments 
Derived fr 'om data for the last 
molecule of lib. using lib. conc 
of 14.6 g dC
' 
= 9l mmol.L. 
(GI h~on 1959) 
Value is for Mb. similar 
flcure anticipated for Ilb. 
(Doyle and lIoek8tra 19R 1) 
(Rurns and Shephard 1979) 
(Gray, Lissl and IIclcklen 1972) 
Mean value derived from our 
data 
DL Q VA =·K = t-'gk = 23.33k 
(Pllper and Scheid 1980) 
In vivo measurement 
(Wald at .1 1975) 
In vivo measurement 
(Sancticr, F,'ceman Rnd Mil]5 196 
Does not occur in mammAlian 
systems 
(KI(>se 1973) 
1. The rilte constants ('0" ,·enctl o n.1 (1)-((,) or'e second order constants. The 
rel<ltlve rate!) o f reClctlon can In gene,'al be cOlllpn,-ed by comparing the macnitude 
of the rate constants. 
2. The rate first o,'der constant of "cClctlon (7) can be compared to (ltl-(6) by 
multiplying by the h,H'",o~lobin concentr'ation In moles = 9. 10~ mols.L-\ • 
The kinetics of reaclions (1)-(3) are more complex (Gibson 1959) 
l' Assuming 1 mol. of hA e moglobin (mwt 66,880) combines with 4 II,ols. of each gas. 
Some recent experimental observations help to understand which processes of 
gas transfer influence DLNO. 
Japanese work argues strongly against a reaction with the conducting airways 
or lung tissue (Yoshida et al 1980; Yoshida et al 1981). The low water 
solubility of NO (Table 9) and its general lack of reactivity at low 
concentrations even to reactive species such as hydrogen peroxide (see 
Table 29) make physiological absorption and chemical reaction with surface 
molecules improbable. 
Using model airway systems and isolating perfused lungs Yosllida et al 
(1981) was unable to demonstrate accelerated disappearance of NO due to 
reaction with lung. Using an inhaled isotope of NO in rats Yoshida et al 
showed rapid alveolar NO uptake and no retention by lung tissues. 
The explanation for my observations on DLNO may be derived from referring 
to two widely accepted models of gas t ransfer. The Roughton Forster model 
1 
DL 
1 + 
DH 
1 
eve 
considered CO transfer as two resistances 1 
DM 
represent-
ing extra erythrocytic diffusion across epithelium, interstitium endothelium 
and plasma and 1 intraerythrocytic entry into the red cell and displace-
eve 
ment of oxygen from oxyhaemoglobin. Since NO is relatively insoluble in 
water (Table 9) and reacts virtually irreversibly with haemoglobin the 
Roughton Forster model could be applied to NO. In vitro the rate of com-
bination of NO with oxygen and reduced haemoglobin is about 400 times as 
fast as CO (Gibson 1959) (Doyle & Hoexstra 1981). Accordingly 1 will be 
eNO 
very small relative to 1 and DLNO should approach D NO. 
aeo m 
D CO was calculated 
m 
in a previous section for five subjects. NO diffusivity (water solubility 
~) exceeds that for CO by 1.8. D NO calculated from D CO would be 
m m 
a pprOXimately 34 mmol s /min/kpA for these five subjects. In fact measured 
was 51 mmols/min/kpA. Given the approximations used in calculating 
the figure might be in reasonable agreement. If DLNO approximated 
to D NO this would explain the lack of effect of hyperoxia and greater effect 
m 
of lung volume compared to DLeo. 
133 
nernative mode L ot a lveolar gas transfer .is that of Piiper and Scheid 
,In 8 
(I ()HO) (s ee sec:LiO II 'J( ii). They considered llIa s transfer of gas fro/l1 an 
I Ji se d illvcolar 1I111L ac ross a tissue membrane to a moving capillary i c.e<1 -
To l,ill c Ollduct.ance \vhi c h in c lud es gas diffusion a nd r eac tion 
,' Lit bluud (!'~III <i:-;:;; Lr<:I Il s lel Jtvided by c' lv eo l ar ai.r/end capi.llary 
. l 0 
Q' (3 ( I ~ f.> ) From sec bon 3(;.i) He ded uc e d 
. tens .Lo n t.; '" -e • gil S 
that NO uptake s hould be dillusi.on .Limite d. NOIv I) is a co(;l!Josi t e of 
I ( : I·l°;ili(~ (jJ r eoc cion. S ince the cli[[usivity of NO excee ds dirl Usco n a n e. . c. 
thfll or CU IJ\' (JIll \' 1 . 0 21 fo ur fold ;!,reaL~'r val ue lor DLNO C()lIljJorect to 
lJCO IlIu sL re s uJt irUll1 ,1 di. f[erence in tlte kinetics of g(]S r e<:l ct ·LOIl \vith 
J. 
haemo glob i II. 
I t therefore spems l ikely that 0 NO either reflects membrane transfer or 
L 
~mbination with haemoglohin or both. Th e failure of hyperoxia to affect 
D NO <:0I1Irl sugR,est that D NO W8S independent of 
L L 
equation indicating that D NO largely reflected 0 
L m 
the " V" part of the 
c 
Certainly the values 
i ~r the ra t e of combination of NO with haemoglobin (Gibson 1959) and 
oxyhaemoglobin (Doyl e and Hoekstra 1981~ show that these reactions are 
~o ord ers of magnit ude more rapid than the equivalent for CO (Table 29), 
On the other heno, the reaction rate of NO with the red cell at 
~ysiological r8nges of 0 tension ha s never been measured and it is 
poss ibl e t h i'1t through th e red cell membrane becomes 
se l f -limi ting . f., 1 t8rnati ve ly the r eact i o n kinetics of NO combining with 
haemoglobin cOlll rl bl' independent of O . Study of the effect of changing 
Hb concentr8t ion s s hollld give further insight and this is the subject of 
the next section. 
VlIllll1TLON IN DLCO W[TII CIlIING I NG III1EMOGLOBIN CONCENTllllTlON 
DLCO(mmol/mln/kpA) 
15 
r. = .86 P ( .001 ~CO= .75(SD.14)Hb-.42(S01 . 22) 
10 
A 
4 
A 
5 
A 
A 
A 
A A 
5 10 15 Hb 
Fjg 29 
VAlUATION IN D .. NO WITH CHANGING HAEMOGLOUIN CONCENTHATION 
DlNO (mmol/min/kpA) 
o 
50 
40 
30 
20 
10 
0LNO = 3.S (SO.S)c+ 4.22 (505.0S) r=0.9 P ( .001 
o 
o 
5 
o 
Fig 30 
o 
o 
10 15 Hb (g/dl) 
ii) The Effect of Anaemia on NO and CO Uptake 
Method 
To deLermine the effect of anaemia on DLNO and DLCO ten c;lronically 
anaemic p~tients were recruited. All suffered from chronic renal tailure 
and were elther on maintenance dialysis or following renal transplant. 
The majority were in-patients. Each provided informed consent and the 
study had the approval of the hospital Ethics Committee. Each was asked 
whether or not he smoked and whether he suffered from recent lung 
disease. Each performed a series of lung function tests (vitalography), 
total lung capacity (by body plethysmography) and a combined DLCO, DLNO 
manoeuvre as described. The most recent haemoglobin concentration was 
recorded. Three volunteers (normal controls) were also included. 
Results 
Figs. 29 and 30 show that DLNO, like DLCO, varies with haemoglobin 
concentration. Figs. 29 and ]0 show that in fact the ratio of DLNO to 
DLCO is very similar in anaemic patients to that in normal controls. 
Lung function results were within 2 SDs ot predicted. 
Discussion 
The marked variation in DLNO with changing Hb indicates that the Hb 
concentration exerts a significant influence on NO uptake. The close 
relationship of values for DLCO and DLNO at low Hb concentrations 
indicates that the reaction with the red cell affects NO uptake at least 
as much as CO uptake. It is intriguing therefore that NO uptake is 
independent of oxygen concentration and two explanations are offered. 
One is that the kinetics of CO uptake are as described: 
135 
(- d (CO)/dt) 
(02) (Roughton, Forster and Cander, 1957) 
whereas those for combination of NO with Hb 02 are K (NO) (Hb 02) (Doyle 
and Hoekstra, 1981) where M' and K are rate constants. It can be seen 
that the oxygen concentration will only affect CO uptake. An alternative 
explanation is that the rate of NO reaction with Hb is extremely rapid 
but passage into the red ce:l becomes limiting. Changing the Hb 
concentration which necessarily involves changing the number of red cells 
will therefore limit the uptake of NO. 
The observ8tion that for a gas whose combination with Hb is the most 
rapid known and whose back reaction does not occur is still limited by 
the chemical rate of combination with haemoglobin, is strong support for 
alveolar capillary difftlsion not being limiting and supports recent work 
by other Authors using a variety of techniques (Gehr et aI, 1978; Burns, 
1979) . 
These observations give further insight into the toxicology of NO. 
1) It appAars that smokers generally have undetectable NO in their 
alveoli but after inhaling smoke a peak concentration of less than 10 
ppm is observed (see Chap tel' 6) which is rapidly cleared at a half 
lifA of 2 seconds. Such exposure is unlikely to cause lung toxicity 
by comparison with animal work. 
2) The rate of uptake appears to exceed that for reaction with oxygen 
and oxygen centred free radicals (see Chapter 5). Accordingly little 
NO or nitrosamine will be generated "on site". 
2 
3) The similarity of CO and NO uptake is strong support for the blood 
being the fate of inhaled NO. 
4) The above discussion and, in particular, the similarity of behaviour 
with varying Hb concentration does suggest that in general D NO and 
L 
D CO measure a similar aspect of lung function. Measurement of D NO 
L L 
in a clinical context therefore is unlikely to give any further 
information than and is likely to remain considerably less 
practicable than measurement of D CO. 
L 
If when NO is inhaled it reacts not with the lung tissue but is rapidly 
taken into the blood a further possibility for toxicity arises. NO could 
reduce the oxygen carrying capacity and cause cardiac and vascular 
insufficiency in a similar way to that suggested for CO. Furthermore, 
estimates of NO product in the blood might form an exposure index similar 
to carboxyhaemoglobin. These questions are addressed in the next 
chapter. 
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EXPERIMENTAL: COMPARISON BETWEEN BLOOD METHAEMOGLOBIN AND 
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·CHAPTER 6 
EXPERIMENTAL: COMPARISON BETWEEN BLOOD METHAEMOGLOBIN AND 
CARBOXYHAEMOGLOBIN LEVELS IN SMOKERS 
i) Survey of smokers 
Introduction 
There is strong evidence that when nitric oxide is inhaled it reacts with 
oxyhaemoglobin to produce methaemoglobin. This evidence comes from 
experiments where blood haemoglobin solutions have been reacted with 
known volumes of NO (Doyle and Hoekstra 1981) from experiments where 
animals have been exposed to NO (Toothill 1967) and from human volunteer 
NO exposure studies (Case, Schol ey and Dixon 1975) (von Nieding, Wagner 
and Krekeler 1973). No study has previously examined methaemoglobin 
concentrations in smokers. No study has previously examined 
methaemoglobin formation in blood exposed to cigarette smoke. 
Methaemog lobin in smokers may be important for two reasons. Firstly, it 
is incapable of carrying oxygen and raised levels may reduce oxygen 
delivery contributing to ischaemic heart disease in a similar way to that 
suggested for carbon monoxide. Secondly, since NO is said to produce 
methaemoglobin in molar equivalent concentrations (Doyle and Hoekstra 
1981), measuring metHb concentrations in smokers might allow 
quantification of NO expos ure. This would be particularly helpful since 
the results of exposure to NO vary from rapid death to no effect 
depending entirely on concentration (see Chapter 1). 
Method 
To compare metHb concentrations in smokers and non-smokers 672 patients 
(336 smokers) attending an out-patient department for routine 
venepuncture were studied during office hours over a 2 week period. Each 
subject was asked whether or not they smoked and 5 ml of blood was drawn 
and immediately placed in an EDTA bottle (Sequestrene, Labco, Marlow, 
Bucks, England). Each sample was analysed for COHb, MetHb and Hb using 
CALIBRATION PLOT FOR METHAEMOGLOBIN ON IL282 an automated instrument (IL282 Co Oximeter, Instrument Laboratories, 
Andover, Mass, USA) (Dennis and Valeri 1980). Analysis was performed 
within 3 minutes of venepuncture to minimise error (Kiese 1973) • 
• 
10 
• 
Calibration of instrument 
-
" ... 
The instrument was calibrated daily using a solution of predetermined Hb 
• ~ 
0 concentration (Caldye, Instrument Laboratories, Andover, Mass, USA) since 
H 
I-
w: 
-
0:: 
I- only the Hb channel requires calibration (see Chapter 3, section 3 and 
Z 
w 
-
lJ 
Z 5 0 Dennis and Valeri 1980). To assess reproducibility five replicate 
u 
m 
• T 
I· measurements were made on a series of single 5 ml samples drawn from 20 
~ 
• 0 
ILl 
non-smokers. To assess linearity at low Hb levels a lysate of 
, rr 
::J 
If) • c( 
loJ approximately 10% metHb was made by adding potassium ferricyanide to a 
:=: 
.-
.,;- suspension of lysed red cells in 0.1 M phosphate buffer containing 
• . . i 
5 10 detergent (Nonidet) (BDH Chemicals, Poole, England) • The solution was 
PRUHCTED I~ETH8 UlNCGJTHA T ION (~) 
then serially diluted with a lysate of low metHb (0.2%) content. The 
concentrations were checked in the IL282 prior to dilution. Statistical 
comparison was by 2 sample Z test (Snedecor and Cochran 1967). 
Fig 31 
Results 
Fig. 31 shows that the instrument gives a linear response down to 
methaemoglobin levels of less than 1%. Tests of reproducibility showed 
standard deviations on the series of 20 samples ranging from 0 to 0.8%, 
,4-0 
TABLE 30 
Hean values (SO) of methaemoglobin and carboxyhaemoglobin in patients studied. 
HetHb 
COHb 
Hb 
n 
\; = 3.19 
t:; = 3.33 
Non-smokers 
0.67 (0.33)% 
0.65 (0.62 • 0.67)% 
0.09 g/100 ml 
0.87 (0 . 47)% 
13.3 (1 .7 ) g/100 ml 
336 
P = 0.0014 
P < 0.001 
Smokers 
0.60 (0:23)%* 
0.58 (0.56 • 0.61)%t (Geometric mean 
(95% confidence 
intervals» 
0.08 g/100 ml 
3.26 (2.2)% 
13.8 (1.6) g/100 ml 
336 
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Fig 32 
an average of 0.1%. This is well within the 0.5% standard deviation 
specified by the manufacturers and agrees with 0.4% maximum variation for 
triplicate measurements noted by other authors (Dennis and Valeri 1980). 
From Table 30, as expected, carboxyhaemoglobin levels in smokers 
substantially exceeded those in non-smokers. From the figures in the 
table the mean value of methaemoglobin in smokers did not exceed that in 
the non-smokers. In fact, the value in the non-smokers was statistically 
significantly greater. Fig. 32 shows the distribution of methaemoglobin 
values in smokers and non-smokers . It appears approximately "normal" 
although there is some skewness towards high values in the non-smokers • 
This minor departure is unlikely to invalidate the Z test which is robust 
to minor departures from normality and inequality of variance in the two 
groups (Snedecor and Cochran 1967). Transformation to the logarithm 
(Table 30) can be shown to equalise the variance and in fact gives an 
even larger, ie more significant, value for Z. If we set the smallest 
difference in methaemoglobin level between smokers and non-smokers as 
0.1% (maximum resolution of the instrument) then the power of detecting 
such a difference using the unlogged data is 98% (Cohen 1969). 
Discussion 
The failure to detect elevated metHb levels in smokers could be due to NO 
following a different metabolic path in smokers compared to human 
volunteers in other situations. Alternatively alveolar exposure 
concentration in smokers could be lower than in the human acute 
inhalation studies (Case, Scholey and Dixon 1975) (von Nieding, Wagner 
and Krekeler 1973). It seems improbable that NO follows a different 
metabolic path in cigarette smo~e since elevated metHb has been found 
after exposure to automobile exhaust (Case, Scholey and Dixon 1975). 
Exhaust contains CO, CO , hydrocarbons and active oxidants and therefore 
2 
I 
I . 
I 
I 
I 
I 
has similarities to tobacco smoke (indeed for certain varieties of pipe 
tobacco smoke the similarity appears remarkable to the untrained nosel). 
To test the hypothesis that cigarette NO is converted to metHb but in 
lower concentration the following pilot experiment was carried out. 
ii) Study of Blood Acutely Exposed to Cigarette Smoke 
Introduction 
Though it is known that NO reacts with NO to yield metHb (Doyle and 
Hoekstra 1981) the formation of rnetHb in blood following cigarette smoke 
exposure has not been studied. 
Method 
A Gauloise International filter cigarette was smoked by aspirating 35 ml 
puffs at 1 minute intervals using a glass syringe via a Cambridge filter. 
This brand was chosen because of its very high NO yield (403 mcg) and 
high average NO concentration (960 ppm) (see Chapter 4). It was smoked 
"by hand" so that the aspirated smoke could be slowly expelled from the 
syringe and directed into 5 ml of whole blood. The blood had recently 
been obtained by venepuncture and was anticoagulated by thorough mixing 
in an EDTA bottle (Sequestrene). It was then decanted into a 500 ml 
conical flask. The filtered cigarette smoke was then bubbled through the 
blood by slowly emptying the syringe by hand over 58 seconds. A total of 
8 cigarettes were smoked in this way and the blood sample analysed for 
COBb and MetHb using the IL282 after each cigarette. 
Result 
The CO yield of a Gauloise International is 16 mg (Department of Trade 
and Industry League Table 1983). Using the formula CO yield mg 
0.0045 x puff number x puff vol x BP x conc 
T 
143 
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Fig 33 
(Rothwell and Grant 1974) assuming T = 293°k gives an expected CO 
concentration of 4% and the average NO concentration is therefore 40 fold 
lower. Fig. 33 shows that there is a linear increase in COHb and metHb 
with number of cigarettes "smoked". The increase for COHb exceeds that 
for metHb by about 16 fold. 
Discussion 
This result shows that if a series of cigarettes are smoked through blood 
there is a steady increase in metHb suggesting that metHb is indeed 
formed. The increase however, is far smaller than for COHb. This could 
explain why elevated metHb was undetectable in the sample of smokers • A 
40 fold greater rise in COHb than metHb should be expected on the basis 
of their relative concentratior.s in the smoke. It is possible that the 
greater affinity of NO for Hb (Gibson 1959) is partly responsible for the 
greater than expected metHb concentration though it is possible that 
other species in the smoke (eg oxidants) also result in metHb formation • 
Taken together these experiments are consistent with the view that 
cigarette NO does indeed react with the blood but the concentration of NO 
in the alveolus is so low that it does not normally cause elevation of 
metHb. Certainly the results of Chapters 4 and 5 suggest that it is 
lower than the 3 ppm average alveolar NO that caused metHb elevation in 
Case et al study in 1975. These levels of NO are unlikely to generate 
much NO (see Chapter 4) nor are they prone to cause structural or 
2 
physiological damage (see Chapter 1). 
There seems no evidence from these two experiments that metHb derived 
from cigarette smoke can ever reach levels to interfere with blood oxygen 
transport. 
14t 
The experiments so far have studied the behaviour of NO in comparison 
with CO in a relatively controlled laboratory setting. In the next two 
Chapters an attempt is made to link the laboratory analyses with clinical 
disease on a large scale popu13tion basis. 
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CHAPTER 7 
EPIDEMIOLOGICAL: THE RELATIONSHIP BETWEEN CARBON MONOXIDE YIELD OF 
CIGARETTES AND CARDIORESPIRATORY DISEASE 
Introduction 
Up to 1982 no epidemiological study had looked for an association between 
smokers' cigarette CO exposure and their risk of heart or lung disease. 
In 1981 the carbon monoxide yields of old UK cigarettes became available 
following the public response to Sir Richard Doll's appeal for old 
cigarettes for analysis (Wald, Doll and Copeland 1981). The Whitehall 
Study was a prospective study of 18,403 Civil Servants aged 40 to 64 that 
commenced in 1967-9 (Reid etal 1974). Among the data recorded at entry 
were details of cigarette brand, number smoked per day and inhalation 
habit. From records of the brands smoked and from the results of the CO 
analyses of the old cigarettes it has been possible to estimate cigarette 
CO exposure for most of the smokers in the study and relate it to their 
risk of heart and lung disease. 
The Whitehall Study 
This was a screening study carried out by trained nurses or technicians 
over a 2~ year period (1967-9) of all non-industrial male Civil Servants 
working within approximately 2 miles of Whitehall in London. Subjects 
were identified via Personnel Officers and a personal letter sent to each 
subject. Response rate averaged 77% ranging from 58% among messengers 
(many physically disabled) to 87% among senior grades. Each man was 
questioned about age, job, residence, family history, relevant past 
medical history and also a standardised questionnaire on smoking and on 
symptoms of diabetes. A standard questionnaire on cardiorespiratory 
147 
disease was also administered (Reid et al 1974). Height and weight 
(clothed), skin fold thickness were measured and vitalography (FEVI and 
FVC) was performed using a Garthur vitalograph. Three technically 
satisfactory records were taken and the mean FEVI and FVC of the two 
records with the highest FVCs was used in the analysis. 
Electrocardiography was undertaken with a Mingograph 31B using multipoint 
electrodes. Five technically adequate complexes were recorded for each 
of the six limb leads; a preliminary enquiry showed that of those who had 
suggestions of ischaemia in a full 12 lead record, approximately 75% 
would show ischaemic changes in the limb leads. Records were coded 
independently by technicians using the Minnesota code (Rose 1965). Blood 
sugar after a glucose load and cholesterol were estimated. Details were 
sent (with the patient's consent) to their general practitioner. Two 
cohort studies were set up. A group of 1,470 men who were believed to be 
at high risk of coronary heart disease or disabling bronchitis were 
identified and entered into a study of anti-smoking measures. Those with 
blood glucoses of 110- 195 mg/l00 ml were entered into a study of 
treatment of diabetes. Of more immediate relevance to the present work, 
all the 18,043 men entered into the study and examined were followed for 
a 10 year period with their mortality recorded at a central registrary 
and the cause of death relayed to the office holding the examination 
data. 
Method 
Cigarette analysis 
At the time of the initial questionnaire and examination of the study 
(1967-9) the yields of tar and nicotine for the cigarettes smoked by 
smokers in the study were available from analyses carried out by the 
Tobacco Research Council. Unfortunately the cigarettes donated by the 
l~ 
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TABLE 31 
CO YIELDS 1965 - 1972 (rug) 
FILTER 65 66 67 60 69 70 71 72 
/PLl\IN 
plain 14 16 16 16 16 16 
plain 15 16 15 15 
plain 15 15 15 15 
plain 19 20 20 17 
plain 20 20 20 20 
plain 20 20 19 
plain 21 20 20 20 20 
filt e r 17 15 15 
filt e r 16 16 15 15 
fil te r 10 19 19 19 
filter 22 19 19 19 19 
filter 29 29 22 22 
filt e r 25 - 17 - 17 
public and subsequently analysed by the Laboratory of the Government 
Chemist for tar, nicotine and CO are incomplete and not all brands are 
represented for a given year. The CO yields used are therefore those for 
1967-70 if possible, if not for the closest available year. If values 
for more than one year between 1967 and 1970 "/ere available the average 
was taken. The years used and the number of brands were 1964 (1), 1965 
(0),1966 (2),1967 (4), 1968 (2), 1969 (4),1970 (4), 1971 (7), 1972 
(1). The justification for using brands outside the years 1967-70 is 
that within a given brand yields changed little between 1965 and 1972. 
Table 31 is derived from the Government Chemist's analyses for all brands 
for which at least 3 years of CO yield are represented. The constancy of 
yields for the majority of brands implies that taking yields for other 
brands outside the range of the study was justifiable. The only brands 
for which yields changed markedly are Benson and Hedges King Size 
(excluded from the analysis) and Rothmans King Size for which the 1968 
value was available. Over all, carbon monoxide yields were therefore 
available for cigarette smoked by 68% of the smokers in the study. Of 
those excluded, smokers of handrolled cigarettes formed a substantial 
proportion (13.6%) of all smokers. The cigarettes donated by the public 
had not of course been stored under standard conditions, nor were large 
numbers available for analysis (Wald, Doll and Copeland 1981). To 
estimate any bias so arising the tar and nicotine yields of these 
cigarettes were compared to values obtained by analysis of a larger 
number of cigarettes performed by the Tobacco Research Council for the 
years of interest (1967-70). 
Statistical analysis (NeIder and Wedderburn 1972) 
The study population was divided into 3 categories according to CO yield. 
Analysis was based on linear rr:o)delling using "log odds" as the dependent 
t4~ 
TABLE 32 
Comparison of smokers with known and unknown carbon monoxide 
yzelas oJ cigarettes 
Age (years) 
Systolic blood pressure (mm Hg) 
Plasma cholesterol (mmolfl) 
Blood glucose (mmol/l) 
No of cigarettes/day 
"Inhalation" (~o) 
Height (m) 
Body mass index Ckg/mZ) 
Suspect ischaemia (0.0) 
Phlegm (%) 
FEV 1 (l) 
Known 
carbon monoxide 
(n = 4910) 
51·7 
134·7 
5·10 
1·95 
16 ·9 
80·0 
1·75 
24·4 
16 ·5 
34·1 
3·01 
Unknown 
carbon monoxide 
(n = 2360) 
52·1 
135·4 
5·12 
1·95 
14·3 
77·6 
1·75 
24 ·3 
16·1 
33·9 
3 ·01 
Some means may be based on fewer subjects because of missing values. All 
figures have been standardised for grade of employment. 
TABLE 33 
-Percentage distribution (and numbers) of 4910 cigarette smokers 
accoraing to number of cigarettes smoked and carbon monoxide yield 
Carbon monoxide yield: 
Cigarettes smoked per day 
~18 mg > 18-20 mg >20mg Total 
1-9 24·8 (237) 58 -7 (560) 16'5 (157) 100·0 (954) 
10-19 30'2 (536) 57'0 (1012) 12·7 (226) 99-9 (1774) 
~20 35'6 (776) 53'2 (1161) 11-2 (245) 100·0 (2182) 
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variable for the mortality and symptom data. FEV1 was entered as the 
dependent variable via standard multiple regression analysis. Mortality 
rates, odds ratios and chai square for linear trend were calculated with 
the fitted models. 
Results 
Table 32 compares the smokers now analysed with those smokers in the 
original Whitehall Study who were excluded because the CO values of their 
cigarettes were not known. The present study group has a deficit of men 
from lower employment grades, chiefly because they were the main users of 
handrolled cigarettes. Table 33 shows the relation of daily cigarette 
consumption to CO yield. High yield brands were more popular among light 
smokers, 16% of whom chose a brand yielding more than 20 mg compared with 
only 11% in heavy smokers. Furthermore, men who were in the lower 
employment grades, or who reported that they inhaled, tended to smoke low 
CO brands. Fig. 34 shows the dispersion of CO yields and their relation 
to TRC tar yi e lds . When the correlation was weighted for numbers 
choosing that brand it was low (+0.05) for tar and (+0.01) for nicotine . 
None of these correlations were statistically significant. On the other 
hand, contemporary TRC analysis and the recent reanalysis of both tar and 
nicotine showed excellent correlation (r == 0.90 for tar and 0.86 for 
nicotine: n == 22 (unweighted)). The mean differences (results of recent 
analysis - those of contemporary analysis) were small: == 0.9 (SD 0.3) mg 
for tar and - 0.08 (SD 0.003) mg for nicotine. This implies that for 
these constituents the old packs of cigarettes were representative and 
deterioration in storage was negligible. 
During the ten years of follow up 635 men died. The underlying cause was 
given as coronary heart diseas e (lCD 410-414) in 255 and lung cancer (lCD 
15"0 
TABLE 35 
Prevalence oj suspected myocardial ischaemia and 10 year mort alicy 
rates by carbon monoxide yield oj cigarettes 
Carbon monoxide y ield: 
x~ for 
Outcome ~ 18 mg :> 18-20 mg .- · 20 mg linear 
(n = 1535) (n=2709) In = 626j 'rend • 
Prevalence of suspected 
ischaemia ( '~, ) 15·6 16 ·4 18 ·0 1·78 
10 year CHD mortality ( ')-;,,) 
Total 5·39 4·99 3 ·59 2·55 
With ischaemia 10 31 9-45 8 ·32 O' .39 
\'(,'ithout ischaemia 4-49 4'01 2-47 3 ·20 
Prevalence of phlegm ( t;~,) 33'2 34·0 339 0·22 
10 year 1 ung cancer 
mortality (~.~) 1·39 1·88 1·90 1·38 
10 year other non CHD 
mortality I.' :;, ) 5 ·46 5 ·93 5 ·32 0 '03 
10 year all causes 
mortality ( Oi .:' 12·21 12·8 1 10 ·80 0 ·22 
CHD = Coronary heart disease. 
All rates are ~tandardised for age and employment grade to the total \"X'hitehall study 
population. 
*Requires Z~ ( Idf) ~ 3 '&4 for p '-: 0 ·05. 
Table includes only subjects with known ischaemia status. 
TABLE 36 
TABLE - 10 year mortality from coronary heart disease by carbon monoxide 
yield of cigareCtes and reported inhalation habit. Reslllrs are percentage mortality 
(and numbers of deaths) 
Carbon monoxide yield; z~ for 
Reponed inhalation linear 
~ 18 mg . IH-20 mg ·20 mg trt:nd .. 
Yes 6 -12 (79) 4·98 (107) 3·01 (14) 6-83 
No 3-03(11) 5 -55 (36) 5 ·59 (8) 2-52 
All rates are standardised for age and grade of employment to the lOtal Whitehall 
study population. 
*Require Xl (Id£) ~ 3·84 for p <: a-os j Zl ~ 6·63 for p .-.: 0·01. 
162) in 90 (8th revision). Table 34 shows the relations between CO 
yields Rnd various measures of smoking related disease, standardised for 
a~e and employment rate. None of the trends are significant with the 5% 
level. The prevalence of suspected coronary heart disease tended to 
increase as carbon monoxide yield increased. The trend for mortality on 
the other hand was in the opposite direction, the strongest negative 
e.o ~r;) NN E 00 
0 00 
N ~~ 
trend being among men free of suspected myocardial ischaemia (symptoms or 
ECG changes). CO yield was not evidently associated with the production 
,.. 0'" 
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-0 
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of phlegm or other causes of death. Table 34 summarises mortality 
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] relations in the form of odds ratios (see Chapter 3, section 5) after 
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controlling for age, employment grade, daily number of cigarettes and tar 
yield. All the models gave goodness of fit statistics indicating 
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adequate fit to the ohserved data. The 95% confidence intervals include 
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" U 1 so that no significant effects emerge. Nevertheless, the data would 
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suggest that smoking higher CO cigarettes is associated with a 32% 
VI 
>Dr--
'?''?' reduction in risk of death from coronRry heart disease and a 49% increase 
NN 
in risk of death from lung cancer. The association with total and other 
mortality shows no consistent pattern (Table 35). When the data is 
divided into self reported "inhalers" and "non-inhalers" the results are 
striking. Among the inhalers the coronary heart disease mortality rate 
in the low CO group is twice that of a high CO group and this effect is 
highly significant (Table 36). The opposite (but non-significant (p < 
0.05)) effect is seen for self reported non-inhalers. For lung cancer 
mortality among those who reported inhaling the risk was 75% higher in 
the high CO group but this trend was not significant In 
non-inhalers, however, the highest rates were in the low CO group but 
numhers were small. There is a highly significant positive association 
between FEVl and CO yield of cigarettes (see Table 37). Adjustments for 
amount smoked, tar yield and employment rate halved the magnitude of the 
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Fig 34 
trend but it still remained consistent. 
Discussion 
The data from this analysis do not support the view that CO is the cause 
of heart disease in smokers. Although CO appears to exert a weak 
influence on the prevalence of clinical evidence of established coronary 
heart disease (angina, history of possible infarction and ischaemic type 
ECG changes) the effect on coronary heart disease mortality is quit e the 
opposite. This negative effect becomes significant among self reported 
inhalers (who have an increased risk of coronary heart disease 
(Higenbottam, Shipley and Rose 1982)). Similarly there is little 
evidence to suggest that high CO cigarettes were associated with an 
increased risk of chronic airflow obstruction since these smokers 
exhibited the highest value for FEV1. The estimated risk of lung cancer 
was 50% greater among those who chose high yield cigarettes though this 
increase was only seen amon~ inhalers. This unexpected observation 
raised the possihility that CO may be a factor in bronchial carcinoma. 
It is possible that our results exclude a role for CO in heart disease. 
On the other hand, because the risk of heart disease is affected by other 
risk factors it is possible that an effect due to CO could be obscured. 
Some evidence for sllch "confounding" of risl< factors is suggested by low 
CO yielding brands being favoured by heavier smokers who inhaled in the 
lower employment grades . The negative association with prevalence of air 
flow obstruction is expected since there is no evidence that CO in parts 
per million dos es damages hmgs. This s uggestion of a positive 
association with lung cancer is intriguing; epidemiological evidence (Lee 
al1d Garfinkel 1981) favours a link with tar. On the other hand reference 
to Fi~. 34 shows a very poor correlation of CO with tar, especially when 
the correlation is weighted (see previous section). It therefore seems 
impossible that this was a "tar effect". Various gas phase constituents 
such as acroline and hydrogen cyanide are somewhat better correlated with 
CO yield than tar (Young, Robertson and Rickert 1981) and it is possible 
that a gas phase carcinogen yield is correlated with CO. Though the 
effect of CO on lung cancer did not reach statistical significance 
(unlike that for CHD) there wer'e three fold fewer lung cancer deaths than 
CHD deaths and larger numbers would have narrowed the confidence 
intervals. It seems too large an effect to ignore and well worthy of 
further study. 
Unfortunately, due to the understandable reluctance of the Laboratory of 
the Government Chemist to s acrifice its unique collection of old 
cigarettes for further analyses by private individuals, it was not 
possible to estimate the Whitehall population's NO exposure. Instead 
published mortality statistics were used to examine the population 
effects of cigarette NO exposure. 
next chapter. 
These studies are described in the 
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CHAPTER 8 
EPIDEMIOLOGICAL: THE RELATIONSHIP BETWEEN NITRIC OXIDE YIELDS OF 
CIGARETTES AND CARDIORESPIRATORY DISEASE 
Introduction 
The cigarette NO yields of Cha pter 4 form a substantial data base for 
comparing disease risk between countries. There is a very large range, 
a lmost 50 f old, between the lowest yielding UK and the highest yielding 
French cigarette. This difference is far greater than that observed for 
CO or tar and will correspondingly increase the power of statistical 
analysis. Furth e rmore, in a given country all types of smoker will be 
represented. The problem of diffe rentiating disease association with 
cigarette type from association with type of smoker is therefore avoided. 
Chapter 5 NO yields r e fer to a limited range of 1983 UK, US and French 
brands. De a th from smoking r e l a t e d dis e a se occurring now will de pend on 
total life exposure to cigarette smoke (Doll and Peto 1981). To estimate 
lifetime s moke NO exposure requires knowledge of NO yields of cigarettes 
throu ghout life a nd numb e rs smoked. Can these be estimated? I believe 
this is possible if the following assumptions are made. 
1) Cigarette NO yields are e ither high (US and French) or low (UK). 
Whilst within a country changes in yield may have occurred, they will 
not be suffi c ient to chang e a country1s "average cigarette yield" 
from high to low or vice v ersa (Chapter 4). 
2 ) Nitrosami ne yields will f o llow NO yields since both are derived from 
nitrate (Neurath, Dunger and Pein 1978). 
3) Since the world cigarette market can be divided into four tobacco 
types (US blend/UK type/dark (eg French)/Turkish (Colby 1978)) then 
average yields of cigarettes in many countries can also be classified 
as high or low NO (because of their small world brand share, Turkish 
cigarettes were excluded). 
4) The number of smokers and their average cigarette consumption in a 
country can be approximated by the total tobacco sales + by the 
population. This should predict the burden of cigarette related 
disease (Doll and Peto 1981). 
5) Mortality data from different countries may be used to measure 
disease incidence. However, due to differences in certification 
practices ICD classes may need to be combined to include all deaths 
(Reid and Fletcher 1971). 
6) People who die from smoking related disease now are generally in 
their forties at the youngest. In many countries smoking has rapidly 
increased in popularity since World War II so that current cigarette 
sales figures may not acc'~rately reflect smoking consumption of 
earlier cohorts. Sales figures for their early adult years might be 
a better predictor (Doll and Peto 1981). 
The analysis was performed on data from 21 developed countries. 
Mortality from coronary heart disease, carcinoma of the bronchus and 
chronic airflow obstruction was studied. 
15b 
Method 
Mortality data 
In all cases male deaths/100,000/annum were adopted. 
i) Coronary heart disease 
The age chosen was 35-44 since death certification should be more 
reliable than in older cohorts. Mortality in 1975 was studied since 
at the time of analysis this was the last year for which complete 
data for all countries was available. The cohort was born in 
1931-1940. The year chosen for tobacco consumption was 1955 when 
the cohort was aged 15-24, the years when most smokers start to 
smoke regularly. Since in 1955 in most countries the vast majority 
of smokers were male, mortality analysis was performed on males. 
ICD (8th revision) was used. 
ii) Carcinoma of the bronchus 
The age chosen was also 35- 44 to maximise reliability of 
certification. Cigarette consumption for 1955 was chosen for a 
similar reason to i. Similarly male mortality was analysed (ICD 
A81). 
iii) Chronic airflow obstruction 
The age of cohort chosen '#as 55-64 in 1975 because too few deaths 
occur in the younger age cohorts for useful analysis. The cohort 
was born in 1911-1920 and hence would have been 15-24 in 1935. 
However, due to the profound effect of the war on the smoking habit 
in many countries, a post-war (1950) rather than pre-war figure was 
adopted. Male mortality only was analysed. To account for 
international differences in death certification, ICD 8th revision 
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categories A93 (bronchitis, emphysema and asthma) and A96 (other 
lung diseases) were combined. 
To examine the trends in mortality before and after 1975 figures for CHD, 
Ca bronchus and chornic airflow obstruction for 1970 and 1980 were also 
examined. 
Cigarette consumption data 
This was obtained from data published by the tobacco industry (Lee 1976). 
The index "manufactured cigarettes/adult" was used, obtained by dividing 
total sales/annum by total adult population. In general the year 1955 
was chosen, apart from the chronic airflow obstruction analysis, but to 
estimate trends in consumption, data figures for 1950 and 1960 were 
plotted. 
Results 
Coronary heart disease mortali1~ 
Fig. 35 shows the relationship between 1975 CHD deaths and 1955 cigarette 
consumption. The relationship is statistically significant (r = 0.655, n 
= 21, P < 0.001) and the gradient is 0.019 and intercept 11.6. It can be 
seen that the rates for CHD for Norway, Finland, Australia and New 
Zealand are above the regression line and those for West Germany, France, 
Greece, Switzerland and Japan below. Thus two high and two low NO 
cigarette countries have above average and five high NO cigarettes have 
below average rates for CHD. 
Bronchial carcinoma mortality 
Fig. 36 shows the relationship between 1975 Ca bronchus deaths and 1955 
cigarette comsumption. The correlation is not significant (r = 0.353, n 
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= 21, P > 0.05) but I have drawn in the least mean squares regression 
line since it helps highlight the countries that have particularly high 
or low mortalities. Four high NO cigarette countries (Italy, France, 
Belgium and USA) have greater and four high cigarette NO countries 
(S\'ieden, Switzerland, Japan and Denmark) have lower bronchial carcinoma 
mortalities. All the low NO yield countries appear to have average 
mortalities. The particularly high mortalities of Belgium and France of 
the French type cigarette countries is notable. 
Chronic airflow obstruction mortality 
Fig. 37 shows the relationship between 1975 chronic bronchitis deaths and 
1950 cigarette consumption. Again the relationship is not statistically 
significant (r = 0.273, n 21, p > 0.05) but the least mean squares 
regression line again dilineates high and low mortality countries. Four 
high NO and three low NO countries have an unexpectedly high chronic 
airflow obstruction mortality while five high NO countries have low 
chronic airflow obstruction mortality . 
Trends in cigarette consumption 
Fig. 38 shows that in general cigarette consumption considerably 
increased from 1950 to 1960 in all countries so that the actual year 
chosen should little affect the analysis. The increase in consumption in 
Ireland, Finland, Sweden and Norway was tending to flatten out, whereas 
in Canada, Australia, Switzerland and West Germany, dramatic increases 
continued. However, otherwise countries tended to "keep rank". 
Trends in mortality 
Fig. 39 shows that between 1970 and 1980 the rates for all 3 cigarette 
related diseases were in general declining in the US, UK and France. The 
dramatic reduction in UK chronic airflow obstruction deaths and US 
ischaemic heart diseases are especially noteworthy. The only exception 
to the declining rate is UK ischaemic heart disease which was still 
increasing, albeit at a slower rate, during 1976 to 1980. 
Discussion 
In general there appears to be a tendency for cardiorespiratory disease 
mortality to increase with national cigarette consumption but only for 
coronary heart disease was this trend was statistically significant. 
There were marked deviations from this trend but in no disease could 
these deviations be explained on the basis of NO yield. Thus for CHD 
there were high NO countries below the regression line and, in fact, two 
low NO countries were above it. Though for bronchial carcinoma 4 high NO 
countries did appear to have a relatively high risk, this trend was 
balanced by a reduced risk in four others. Again for chronic airflow 
obstruction the high NO countries are equally balanced in terms of risk 
and, in addition, the risk is particularly high in three low NO 
countries. 
Comparing mortalities in different countries is naturally open to 
criticism. For example even c 'Juntries such as the US and UK where high 
standards of epidemiology and medicine are practiced there are marked 
differences between the way American and British doctors classify 
respiratory disease (Reid and Fletcher ·1971; Reid et al 1964). Thus 
Norwegian and American physicians favour the diagnoses of emphysema and 
the British favour bronchitis (Reid and Fletcher 1971). In other 
countries, such as France, inexact terms such as cardiac failure may be 
used, not stipulating whether the cause is ischamic heart disease or not 
(Uemara K and Pisa Z 1985). It is generally recommended that categories 
IbO 
of disease are combined so that these problems are minimised (Reid and 
Fletcher 1971; Uemara and PisH 1985). Thus I combined ICD A93 and A96 
(8th revision) to give an index of chronic airflow obstruction. This 
includes all lung disease except tuberculosis, pneumonia, influenza, 
pulmonary emboli, trauma and carcinoma of the bronchus. Inevitably 
asthma deaths, pulmonary bronchiectasis and other lung diseases unrelated 
to smoking will be included, but since their incidence is so much smaller 
than chronic airflow obstruction, their influence should be minimised. 
Despite these adjustments differences in diagnostic habit may well bias 
the results. 
How easy is it to justify the other five assumptions in the first 
paragraph? The UK preference for flue cured virginia tobacco, the US for 
the US blend and the French for dark tobacco have existed since the 
beginning of the century (see Chapter 1) and it seems likely that the 
major differences in NO yield have existed over this time. With the 
change from small plain to large filter cigarettes changes in NO yield 
are likely (see Table 17). Further increases in cigarette NO yield may 
have occurred with changes in tobacco processing technology (Surgeon 
General 1979). It is difficult to verify how nitrosamine yields vary with 
different blends but until widespread analyses are done it seems 
reasonable to assume they will follow NO yields. Similarly it would be 
helpful to confirm that cigarettes from the other 18 countries had been 
correctly classified into high or low NO. However, the dramatic 
difference in yield between the high and low NO brands coupled with the 
marked preference of a country for one of the principal cigarette tobacco 
types, suggests this assumption is reasonable. Attempting to estimate 
the lifetime cigarette consumption of cohorts dying in recent years is 
difficult and the year chosen for predicting consumption is arbitrary. 
Ibl 
However, j.t appe ars that ove r a 10 year period little alteration in rank 
occurred indicating that the year chosen is not critical. 
If the mortality analysis is restricted to the UK, US and France over the 
period of 1979-80 it can be seen that mortality for all three diseases is 
declining. Set against a background of increasing cigarette consumption 
up to the 1970s (see Table 1) and with probably increased NO yields of 
cigarettes in each country, it seems impossible that it is the NO 
directly (or via nitrosamine production) 
responsible for these three diseases. 
I b'2. 
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CHAPTER 9 
DISCUSSION OF THE WORK AS A WHOLE 
This section summaries the salient findings of other workers and my own 
experiments hence justifying the final conclusions. 
Cigarette smoke analysis 
The purpose of cigarette NO analysis in this study was firstly to confirm 
that fresh smoke did not contain N02 and secondly to determine how 
rapidly N02 was produced as smoke aged. A second reason for NO analysis 
was to construct a league table of contemporary NO values. 
Absence of N02 in the smoke 
The similarity of signal produced when nitric oxide and total oxides of 
nitrogen are analysed confirms the vital observation of others 
(Barkermeyer and Seehofer, 1968) that fresh unaged cigarette smoke 
contains little N02. This is directly predicted from a knowledge of NO 
chemistry. At 600°C (the tip of a burning cigarette end) (Baker, 1981) 
N02 is completely broken down to NO and oxygen (Cotton and Wilkinson, 
1980). This is a particularly important observation. NO is directly 
2 
toxic to the lung producing a variety of structural and biochemical 
changes including emphysema. NO, on the other hand, exerts its toxicity 
by reducing the blood oxygen carrying capacity. From animal work it 
appears that continuous exposure to an inspired NO concentration of 
2 
about 10 ppm is needed to produce emphysema. It seems impossible for the 
negligible amount of NO in fresh smoke to cause this condition. Smoking 
2 
necessarily causes intermittent exposure and secondly the important 
process of diluting the smoke during the act of smoking greatly reduces 
the concentration of NO that will reach the airways. If NO is to cause 
2 
lung damage it must be derived from NO after the puff is drawn. 
Rate of production of NO during smoke ageing 
2 
In the whole smoke disappearance of NO appears to conform closely to the 
rate of oxidation of NO in air whether the standard cigarette machine or 
a continuous suction method is used to generate the smoke sample. I did 
not quantitatively analyse for NO in the aged smoke because it is well 
2 
established that the product of NO oxidation in whole smoke is NO • 
2 
Indeed the Saltzman method for chemically quantifying NO in smoke relies 
2 
on all the NO being oxidised to NO (Norman and Keith, 1961). 
2 
Application of the kinetics of NO in air to the concentration in a 
cigarette shows that in concentrated fresh smoke of 1000 ppm up to 50 ppm 
NO might be generated in the (up to) 8 seconds the smoke is in the 
2 
respiratory tract. However, the average sized fresh puff (44 ml, see Table 
2) will be mixed with 750 ml of fresh air, hence diluting the smoke 15 
fold. At 60 ppm only 1 ppm of NO would be generated during the act of 
2 
smoking. 
In the gas phase however, after removal of particulates, disappearance of 
NO is rather faster and appears to follow first order kinetics. This 
observation explains some anomalous findings by previous workers. Sloane 
and Kiefer (1969) found that oxidation followed pseudo second order 
kinetics. On the other hand, Williams (1980) measured more rapid loss of 
NO than predicted by the kinetics. If the data of Vilkins and Lephardt 
(1975) are plotted on a semilog graph they also appear to follow first 
order kinetics. It appears from their paper that NO is the initial 
2 
product but that further nitrogen containing species are produced as the 
smoke ages further. Though the reaction rate is faster in the gas phase 
compared to whole smoke, the production of NO is still not rapid at low 
2 
concentrations. The half life is 4.3 minutes, therefore, in eight 
seconds at an alveolar concentration of 60 ppm only 1.3 ppm of NO will 
2 
be generated. 
The chemical mechanisms underlying the difference between the phases are 
not fully elucidated by my data. Obviously in the gas phase something is 
present that reacts with NO to produce NO faster than oxygen can. 
2 
Oxygen centred free radicals are the only agents that react with NO 
faster than oxygen that are also known to be present in cigarette smoke 
(Pryor et al, 1983). Other highly reactive oxidants such as hydrogen 
peroxide and ozone are not known to be present in the smoke.The possible firs 
order kinetics of NO disappearance in gas phase is further support for 
free radical participation (Cox and Tyndall, 1981). Careful scrutiny of 
Pryor's methods (1983) shows that he separates out the particulate matter 
before analysis. In fact, he admits that traces of particulates may 
"quench" the gas phase free radicals. The continued rapid disappearance 
over 8 to 10 minutes that I observed implies that the free radicals are 
continuously regenerated since they are usually believed to be very short 
limited species (Pryor et al, 1983). These two observations, firstly, 
that fresh smoke does not contain NO and is not likely to generate it 
2 
during smoking and, secondly, that whole smoke does not contain oxygen 
centred free radicals, are significant. The oxidant theory proposes that 
emphysema results from unopposed proteolytic destruction of collagen and 
elastin in the lung parenchyma. Proteolysis in turn is said to be due to 
inactivation of the active site of antiproteases by oxygens (Carp and 
Janoff, 1978). It is believed that some of the oxygens are in the smoke 
while others are derived from inflammatory cells (Carp and Janoff, 1978). 
Oxides of nitrogen (Dooley and Pryor, 1982) and oxygen centred free 
\b~ 
radicals (Pryor et aI, 1983) a~e believed to be the most active gaseous 
oxidants in smoke. If, as my work suggests, they are not present in the 
smoke that a smoker draws then they are unlikely to contribute to 
emphysema. However, whilst these experiments make generation of nitrogen 
dioxide and free radicals in the smoke unlikely, it is possible that 
contact with the lung helps accelerate their formation. This subject is 
discussed in a later section. 
NO analysis of contemporary brands 
NO analysis of contemporary brands shows a range of concentration for 
almost two orders of magnitude from 10 to 1000 ppm. For most cigarettes 
(particularly in the UK) the concentrations are considerably lower than 
1000 ppm thus reinforcing the view that NO levels in smoke are 
insufficient to generate toxic levels of NO in the alveolus during 
2 
smoking. It is important to emphasise the dilution of smoke that occurs 
during the act of smoking. Continuous inhalation of 1000 ppm of NO or of 
3 to 6% CO, which are the expected concentrations in the undiluted fresh 
puff, would be fatal in a few minutes. It is highly likely that the same 
consideration applies to many other ingredients in the smoke. However, 
because of the approximately 15 fold dilution which occurs during smoking 
and the short (up to 8) second dwell time that the smoke is in contact 
with the alveoli, acute toxicity does not occur. 
The yields of NO by weight Va17 from 50 to 400 mcg if the single ultra 
low tar cigarette is excluded. My data appear to agree reasonably with 
other laboratories for precision and accuracy. As might be expected for 
a gas phase agent deliveries do not appear lower for filter than plain 
cigarettes. Though there is a suggestion from the data that UK 
ventilated filter cigarettes yield lower values than ordinary cellulose 
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acetate filter varieties, this is not apparently the case for US and 
French cigarettes. On the other hand, the US and ' French brands chosen 
were the most popular varieties and did not include any less popular 
ultra low tar cigarettes. A recent survey of US low tar (less than 10 
mg) cigarettes however, (Griest, Quincy and Guerin, 1977) gave yields of 
5 to 205 mcg NO with most varieties yielding 100 mcg of NO. These yields 
are substantially below average US plain and filter cigarettes and 
support the idea that yields for ventilated filter cigarettes are lower. 
In general there is a poor correlation between NO yields and either CO or 
tar yield. However, there is a suggestion that CO tar and NO yields of 
the two or three low yielding ventilated filter varieties are lower. The 
poor correlation of NO, CO and tar is not unexpected. NO is produced 
from reduction of nitrates, CO from combustion of carbon containing 
compounds and tar from distilation of leaf. It is thus likely that 
formation proceeds independently as the leaf burns. This poor 
correlation has three important consequences. Firstly, yields of CO and 
NO of old cigarettes cannot be used to predict how NO yields have changed 
over the years. Secondly, tar and CO yields of current cigarettes (for 
example in a league table) cannot be used to predict NO yields. Finally, 
and leading on from these observations, epidemiological studies that have 
shown links between tar yield and disease cannot be explained on the link 
being with NO rather than tar. 
The major determinant of cigarette NO yield is quite clearly the country 
of manufacture and type of tobacco. The highest yielding cigarettes on 
the British market are the US and French type cigarettes. It is notable 
that US Benson and Hedges 100 mm (a UK brand name) is lower yielding than 
most o t her US brands. This marked international variation would appear 
to be a consequence of the rigid preferences the UK, US and French 
markets have for particular tohacco types (Colby, 1978). This in turn 
determines tobacco nitrate (lOVI for Virginia and high for Itdark type lt and 
American blend by virtue of its Burley tobacco component). Tobacco 
nitrate in turn determines NO yield. This marked difference, with three 
fold higher yields for US and French cigarettes compared to UK 
cigarettes , has clear epidemiological implications yet it does not seem 
to have attracted attention previously. Though nitrosamine levels were 
not measured in my study it se~ms reasonable to assume that they will 
mirror the NO yields (Neurath, Dunger and Pein, 1981). 
Comparison between NO and CO uptake from the respiratory tract 
Previous work has shown that inhaled NO is taken up into the blood as 
methaemoglobin. The purpose of this series of experiments was to 
determine the rate at which it occurred and what affected the rate. The 
calculated rate constant could be compared to those for other reactions 
of NO and, hence, the fate of inhaled NO in smoke is predicted. 
Similarly smokers' alveolar NO could be estimated. 
Kinetics of alveolar NO uptake 
Analysis of alveolar air at various times after inhalation shows that NO 
disappears rapidly with a first order process with a half life of about 4 
seconds. This rate is extremely rapid exceeding the alveolar uptake of 
CO by four to five fold. The lir.earity on the semilog plot is the most 
direct evidence for a first order process. In addition, values for the 
rate constant expressed as DL, the diffusing capaci ty, appear 
reproducible over a wide range of inspiratory NO concentrations arguing 
against a concentration dependent uptake of NO and thus a second (or 
higher) order of reaction. 
It is instructive to compare the extremely rapid alveolar removal of NO 
with its known reactions with oxygen or its removal rate in ageing 
cigarette smoke. In cigarette smoke gas phase the half life of NO is 
four minutes. At 60 ppm NO in air the half life of oxidation is just 
over one hour. However, alveolar NO is removed with a half life of four 
seconds. The immeasureable back tension even in smokers suggests that 
unlike CO, this rapid reaction of NO with haemoglobin is irreversible. 
Factors affecting NO uptake 
Expressing the rate constant for NO uptake as D (the diffusing capacity) 
L 
allows easy comparison with other gases, particularly CO. Simultaneous 
measurements of D for CO and NO can be made reasonably rapidly in a 
L 
respiratory physiology laboratory by adapting existing equipment. Such 
measurements can be made on volunteers at rest performing various 
manoeuvres at sub maximal exercise and also in cooperative patients. 
The major limiting step to NO uptake appears to be combination with 
haemoglobin. Thus a three fold increase in Hb from 5 to 15 g/dl produces 
a three fold increase in D NO. By contrast, changing oxygen 
L 
concentration and posture had negligible effects on NO uptake. Changing 
alveolar volume and increasing levels of exercise had measurable but 
small effects on D NO. It is in-t;eresting that modern thinking about D CO 
L L 
also favours combination with haemoglobin being the rate limiting step to 
CO uptake (Davis, 1982). Certainly my data shows that individuals' 
values for D NO and D CO are very closely correlated supporting the idea 
L L 
that the mechanism of transfer from alveolus to blood is similar for the 
two gases. 
Previous work has suggested that the rate of combination of NO with 
reduced haemoglobin (Gibson, 1959) and with oxyhaemoglobin (Doyle and 
Hoekstra, 1981) exceeds by at least an order of magnitude the rate of 
combination for CO or oxygen. The fact that even for such a reactive gas 
combination with haemoglobin is still rate limiting surely suggests that 
the conductance of the alveolar membrane is almost infinite. This view 
is supported by the recent measurements for conductance for 0 using 
2 
morphometric methods (Gehr, Bachofen and Weibel, 1978) and dithionite 
(Burns and Shepherd, 1979). Such reasoning casts grave doubts on 
experiments in which "Dm" for CO is measured. It is suprising that 
alveolar NO uptake is only four times faster than CO uptake if the 
respective rates of combination are 100 fold different as Roughton's 
experiments suggested. A possible explanation is that Roughton's 
experiments were performed using reduced haemoglobin in the presence of 
dithionite which is unlike the in vivo situation. It seems reasonable 
that incorporating the haemoglobin in a red cell markely slows the rate 
of reactions and sets up NO gradients between the pulmonary capillary 
plasma and the red cell interior. 
The apparent independence of D NO of alveolar oxygen tension is 
L 
intriguing. The most plausible explanation is that the reaction kinetics 
of NO in vivo do not include alveolar O. Certainly Doyle and Hoekstra 
2 
found that the combination of NO with HbO to yield methaemoglobin and 
2 
nitrate was fitted by the kinetics 
- d (NO) 
k ( NO ) ( Hb02 ) 
dt 
(Doyle and Hoekstra, 1981) which do not include (0) except via its 
2 
171 
effect on (HbO). By contrast the combination of CO uptake is given by 
2 
- d (CO) m' ( CO) (Hb02 ) 
- m (COHb) 
dt 
(Roughton, Forster and Can~ller, 1957) which includes 0 in the 
denominator • 
2 
Combination with oxyhaemoglobin would seem a far more 
likely reaction in the oxygenated red cell and is supported by the 
finding of methaemoglobin in animals (Greenbaum, 1967) and man (Case, 
Scoley and Dixon, 1975) (von Neiding, Wagner and Kreckeler, 1973) 
following NO exposure. 
Comparison between blood methaemoglobin and carboxyhaemoglobin_ 
cencentration in smokers and non-smokers 
The purpose of these analyses was to determine whether the fate of 
inhaled NO in smokers was methaemoglobin formation and if so whether 
sufficient was formed to impair blood oxygen carriage. 
Though low level, ie 3 to 20 ppm, NO exposure appears to cause elevation 
of methaemoglobin in volunteers (Case, Scoley and Dixon, 1975) (von 
Nieding, Wagner and Kreckeler, 1973) methaemoglobin levels in smokers 
appear no higher than in non-smokers. There are 3 possible explanations 
for this anomaly. It is p ( ssible that when NO is incorporated in 
cigarette smoke it follows a different pathway compared to when inhaled 
in isolation. However, there is no evidence to suggest that other 
products such as NOHb are produced in smokers' blood (Freeman et al, 
1978) . Another possibility is that methaemoglobin metabolism is 
accelerated in smokers compared to non-smokers. This could account for 
the statistically significantly lower methaemoglobin concentration 
\72 
I I observed in s mol<ers "signifi ,~ ant difference" could easily be spurious 
however, since it is rather less than the reading standard deviation of 
the instrument. It could easily be an example of a small difference 
becomin8 spuriously "significant" when very large numbers of subjects are 
studied. The most likely reason for methacmoglobin concentrations not 
being elevated in smokers is that they inhale insufficient NO. For 
example, a smoker vlho inhales perhaps 50 ppm of NO for 10 two second 
"pulses" ear::h time a ci.~arette is smoked is probably exposed to less NO 
than the subjects who continuously inhaled 3 ppm for a period of one to 
two hours in one of the voluntee r studies cited (Case, Scholey and Dixon, 
1975). The final short experiment in which the smoke of eight cigarettes 
is bubbled through blood helps to resolve the issue. A linear increase 
in both methaemoglobin and carhoxyhaemoglobin is observed but the rise in 
carboxyhaemoglobin exceeds the rise in methaemoglobinb y 16 fold. This 
strongly suggests that the average smoker is unlikely to form sufficient 
methaemoglobin for the levelE to he significantly elevated. In passing, 
it is noted that though the cigarette CO levels exceed NO levels by 30 to 
50 fold, the COHb levels are only 1 times greater than the metHb levels. 
This suggests that the affinity of oxyhaemoglobin for NO exceeds that for 
CO. In addition, there is no suggestion from this experiment that 
methaemoglobin rleriveci from NO limits blood oxygen carriage. 
Estimated nitrogen oxide exposure i .n smokers 
The three approaches described abovi allow estimation of smokers' 
alveolar oxide of nitro ge n exposure a nd hence prediction of toxicity . Let us 
take the nlC)xilllu:o: ci~arette NO concentration as 1000 pPI:1 (and most UK br a nd::> 
are considera bly 10\\'er than this). Durin g i.nl181ation the 'pUI.[ volUliie' LS 
' t ( ' lId 1 ) 'fl1e dilution factor diltted by the active inhalatLon ~n1a e VO . ume . 
inhaled volu ~~ le 
pu[ [ Volul,1e 
754 divided by 44 = 17 then pea k alveo lar concentrations o[ 
d I , I ' 'nhaled (Challter 1) Ir 60 ppll1 at a maxi mum are expecte eaC 1 tUle Slilo(e ~s 'L ' 
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fact, this may well be a generous over estimate. Karnik and Coin (1980) 
diluted a 35 ml puff of cigarette smoke to 1 litre in air. Volunteers 
then inhaled 10 of these one litre aliquots at one minute intervals. The 
rise in blood carboxyhaemoglobin (.8%) following simulated smoking of 10 
one litre aliquots was very similar to that following smoking a single 
cigarette (1%). The dilution estimated from their experiment is 
therefore approximately 30 fold. This gives a peak alveolar 
concentration for NO of 30 ppm for a high yielding French or US brand and 
nearer 10 ppm for UK brands. 
The extremely rapid removal of NO into the blood from the alveolus 
indicates that this peak concentration rapidly falls. Thus after two 
seconds in the alveolus 60 ppm will have declined to about 40 ppm and by 
30 seconds the concentration would be less than 1 ppm. Similarly, if the 
NO concentration in the French smoke is 5 ppm maximum this will be 
2 
diluted to .3 ppm in the alveolus. 
It is 
unlikely that further NO will be generated in the alveolus because in 10 
2 
seconds 1 ppm of NO would be formed even were the alveolar concentration 
2 
to remain at 60 ppm. If it is rapidly falling due to removal of NO into 
blood then even less will be produced. Such low exposure has not been 
shown to cause ultrastructural damage in animals. Passing fresh 
cigarette smoke into blood produces a linear rise in methaemoglobin 
indicating that the pigment c an be used to quantitate cigarette NO 
exposure. Since smokers' NO exposure does not produce a rise in metHb it 
must be assumed that exposure is less than 3 ppm for one to two hours. 
Compare Case, Schol ey and Dixon 1975. Such low NO exposure levels have 
not been shown to cause permanent ultrastructural damage in animal 
ex pe r i ments (Hu god, 1979). 
In vitro work on nitrosamines indicates that NO is needed for their 
2 
formation (Challis and Kyrtopoulos, 1976). The minimal amounts of NO 
2 
that I predict would be inhaled would not appear conducive to alveolar 
nitrosamine formation. 
The relationship between cigarette CO yield and cardiorespiratory disease 
I used morbidity and mortality data from the Whitehall study together 
with recent published cigarette CO analysis to study associations between 
CO yield and heart and lung disease. 
The results of this reanalysis require consideration. Carbon monoxide 
yield appeared to exert a weak influence on the prevalence of clinical 
evidence of established heart disease (angina, history of possible 
myocardial infarction and ischaemic type electrocardiographic change). 
However, quite the reverse appears for death from coronary heart disease 
especially among self-reported inhalers. A recent case control study 
(Kaufman et al, 1983) showed no significant increased coronary heart 
disease risk among high CO brand smokers (nor indeed for "tar"). How 
strong is the other evidence incriminating CO as the cause of coronary 
heart disease in smokers? Wald readily admitted that the association of 
carboxyhaemoglobin with vascular disease may reflect smoke exposure 
rather than a role for CO itself (Wald et al, 1973). Astrup's group were 
unable to reproduce their original results suggesting CO causes atheroma 
and retracted the original work (Hu god ~t aI, 1978). Of even greater 
concern, the scientific honesty and integrity of Aronow, the strongest 
preponent of CO exacerbating established CHD, has been questioned 
(Budiansky, 1983). The concept that CO induced hypoxia is the key to 
cigarette related coronary heart disease seems unlikely in view of the 
range of mechanisms in the body for combating chronic hypoxia. Long term 
/7r) 
low level CO expOBtrre may improve oxygen transport by causing a ris~ in 
the haemoglobin concentration (Smith and Landaw, 1978) . Tissue 
adaptation may also facilitate increased oxygen uptake (Wagner et aI, 
1978). Raaily the most dramatic illustration of how mammals can adapt to 
CO is the experi:ae nts of Zebra (1976) e t a1. By increasing ambient CO 
from .05% to .2~% over a 10 day period concentrations of 74% COHb were 
tolerated by laboratory mice. Such levels would be rapidly fatal without 
a period of adaptation. The mechanisms of adaptation include increases 
in haemoglobin and blood volume, changes in the oxygen association curve 
and an increase in heart weight. These serve to increase cardiac output 
and maintain oxygen carrying capacity (Penney, 1984). It seems probable 
that similar adaptive changes occur at lower exposure concentrations. 
The lack of relationship between CO yield and FEV1 is not surprising. 
The evidence that CO has a r~le in lung disease refers to acute high 
level rather than chronic low level exposure. Furthermore, the effect is 
seen on lung parenchyma rather than on the airways (Sone et aI, 1974) 
(Fein et aI, 1980). In addition it is probably misleading to look for an 
association between current smoking habit and lung function since it has 
been found that the closest associations are between respiratory disease 
rates and smoking habits 20 to 25 years previously (Reid and Fletcher, 
1971) • The suggestion of a relationship, even if non-significant, 
between CO yield and Ca bronchus is important and should not be lightly 
dismissed. The prevalent view (Lee and Garfinkel, 1981) is that high tar 
and plain cigarettes are associated with higher cancer risk. Reference 
to Fig 34 shows that not only were the higher CO cigarettes not of higher 
tar yield, they were also not the plain cigarettes. On the other hand, 
CO is not a known carcinogen. It is possible that i.t acts as a "marker II 
for other agents in the smoke. For example acrolein and hydrogen cyanide 
17b 
are better correlated with CO yield than tar (Young, Robertson and 
Richart, 1981). By analogy with domestic stoves and the internal 
combustion engines high CO yields could reflect incomplete combustion and 
perhaps higher yields of carcinogens. 
Overall, and accepting the differences in interpreting this type of 
epidemiological study, there seems no support for the view that a smoker 
who chooses a low CO brand, reduces his risk of disease. It certainly 
seems premature to recommend reductions in CO yield unless these 
reductions are achieved by total reductions in smoke ingredients. 
Indeed, unless evidence contradictory to this study and other recent work 
is produced, should not CO be deleted from the "league table"? 
The relationship between 
cardiorespiratory disease 
nitric oxide yield of cigarettes and 
I used the cigarette NO data of chapter 5 to estimate the likely NO 
yields for cigarettes where UK type, US type or French dark tobacco 
cigarettes are smoked. I then examined the variation in deaths from 
chronic lung disease, coronary heart disease and bronchial carcinoma for 
21 countries. After allowing for international differences in smoking 
consumption I attempted to link disease incidence with estimated NO and 
nitrosamine exposure. 
For coronary heart disease there was a statistically significant 
relationship between deaths in 1975 and cigarettes consumption 20 years 
earlier. However, two low NO countries, Australia and New Zealand had 
"above average II risk of CHD and five high NO countries (West Germany, 
France, Greece, Switzerland and Japan) had rates below average. 
Obviously "confounding" variables could have a major effect on these 
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rates. The residents of Australia and New Zealand might, for example, 
consume more atherogenic dairy produce than their counterparts in Greece 
or Japan. On the other hand, the relationship between cigarette 
consumption and CHD deaths is highly significant and it is tempting to 
assume that this is due to the association rather than an independent 
correlation between both variClbles and a third unknown risk factor. It 
has to be admitted, however, that there is minimal evidence suggesting 
that NO is the cause of CHD in smokers. Indeed, nitrates are commonly 
used in the therapy of ischaemic heart disease and NO has been shown to 
dilate coronary vessels (Gruetter et al, 1980). For bronchial carcinoma 
there appeared to be some relationship between 1975 deaths and cigarette 
consumption 25 years earlier but it was not significant. This is 
surprising in view of the close relationship between individual cigarette 
consumption and bronchial carcinoma risk (Doll and Peto, 1976) and is at 
variance with Doll and Peto's international survey (Doll and Peto, 1981). 
I have found no evidence to link carcinoma mortality with NO yield: four 
high NO countries had above average and four below average NO yield. NO 
has been linked to bronchial carcinoma via nitrosamines which are 
believed to be potent carcinogens (Surgeon General, 1982). Cigarette 
nitrosamine yields in general follow NO yields (Newrath, Dunger and Pein, 
1976) due to their formation during burning. It is thought unlikely that 
they are formed from NO in the absence of NO either in gaseous mixtures 
2 
(Challis and Kyrtopoulos, 1976) or in the lung (Iqbal et al, 1980) 
(Postlethwaite and Mustafa, 1977). 
For chronic air flow obstruction there again appears to be some 
relationship between mortality and cigarette consumption but again NO 
yield has little effect. Though four high NO countries have high 
mortality, they are balanced by five with lower mortality. The main 
171 
evidence linking NO with chronic lung disease is of course via NO 
2 
production. If, as the earlier chapters suggest, little NO is 
2 
generated, then lung damage if; unlikely. 
The methods of this section are of course open to criticism. Can all 21 
countries be classified into "high" or "low" NO? Have they remained so 
over the last 50 years? Do nitrosamine levels really follow NO yields? 
Can cigarette sales for a certain year be used to predict later heart and 
lung disease? Is it realistic to compare disease rates in different 
countries? While these criticisms are not easy to answer for no disease 
is there a clear relationship between NO yield and disease risk •• 
Conclusion 
1) It appears from this work that inhaled NO is not converted to toxic 
NO but is rapidly and harmlessly removed in the blood when cigarette 
2 
smoke is inhaled. There is no evidence that despite their three fold 
higher NO yields, US or French type cigarettes are associated with a 
higher risk of disease. 
2) There appears to be no evidence that smokers who choose a lower CO 
yielding cigarette reduce their risk of heart or lung disease. 
3) Over all the evidence is against a role for CO and NO in the 
development of cardiorespiratory dis~ase in smokers. 
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ABSTRACT. The authors analyzed the blood of a group of 336 smokers and 336 non-
smokers to determine if tobacco smoke, potentially the major source of nitrogen oxide 
pollution for 40 % of the adult population, significantly reduces oxygen carrying capacity 
as a result of methemoglobin formation. Each blood sample was analyzed for carboxyhe-
moglobin, methemoglobin, and hemoglobin using an automated spectrophotometer. The 
mean value of methemoglobin in the smokers did not exceed that in the non-smokers; in 
fact, the level in the non-smokers was significantly greater. As expected, carboxyhemoglo-
bin levels in smokers substantially exceeded those in non-smokers. The authors conclude 
that methemoglobin arising from cigarette smoke exposure does not interfere with the oxy-
gen carrying capacity of the blood in smokers. 
THERE has been much concern recently about the 
hazards of oxides of nitrogen (NOxl as pollutants in the 
indoor and outdoor environment.! The levels encoun-
tered in polluted atmospheres (up to 1300 mcg/m3 = 
0.7 parts per million [ppm]), ! however, are three orders 
of magnitude lower than the concentrations in a puff of 
cigarette smoke (up to 1000 ppm) Y Fresh cigarette 
smoke contains almost exclusively nitric oxide (NO), J,4 
the chief health risk of which is believed to be related 
to its irreversible reaction with hemoglobin to yield 
methemoglobin .s-7 It has been shown that exposure to 
levels of NO of 20 ppm for 15 min8 and to levels of 
about 3 ppm of NOx for 3 hr7 causes a significant rise in 
blood methemoglobin concentration of healthy volun-
teers. We therefore analyzed the blood of a group of 
smokers and non-smokers to determine whether to-
bacco smoke, potentially the major source of NO pol-
lution for 40% of the adult population,2 sign ificantly re-
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duces oxygen carrying capacity as a result of methemo-
globin formation . We studied 336 smokers and 336 
non-smokers undergoing routine venepuncture at the 
out-patient department of a teaching hospital located 
in a non-industrial university city serving a mixed urban 
and rural population. 
METHODS 
When patients who attended the out-patient depart-
ment during office hours (i.e. , 9 A.M . to 5 P.M.) under-
went routine venepuncture, an extra 5 ml of blood was 
drawn and immediately placed in an EDTA bottle (Se-
questrene, Labco., Marlow, Bucks, England). Each sub-
ject was asked whether or not they smoked. Each sam-
ple was analyzed for carboxyhemoglobin (COHb), met-
hemoglobin (metHb) , and hemoglobin (Hb) using an 
automated spectrophotometer (I L 282 Co-Oximeter, 
Archives of Environmental Health 
Instrument Laboratories, Andover, MA}.9 The instru-
ment was calibrated each day using a solution of 
predetermined Hb concentration only (Caldye, Instru-
ment Laboratories, Andover, MA) since only the total 
Hb channel of this instrument requires calibration. 9 
Analysis was performed within 3 min of the blood sam-
ple being drawn since concentrations may be errone-
ous if not analyzed immediately.lo Samples were taken 
during the morning and afternoon over a 2-wk period. 
To assess reproducibility, 5 replicate measurements 
were made per sample for a series of 20 5-ml samples 
drawn from non-smokers. To assess linearity at low 
metHb levels, a lysate of approximately 10% metHb 
was prepared by adding potassium ferricyanide to a 
suspension of lysed red cells in 0.1 M phosphate buffer 
containing detergent (Nonidet [BDH Chemicals, Poole, 
England]). This solution was then serially diluted with a 
lysate of low metHb (0.2%) content. The concentra-
tions were checked on the IL 282 prior to dilution . 
Results for metHb concentration were compared by 
calculating the "Z" statistic. I I 
RESULTS 
Figure 1 confirms that the instrument gives a linear 
response to metaHb levels of less than 1 %. The stan-
dard deviations on the series of 20 samples range from 
o to 0.18% and averaged 0.1 %. This is well within the 
0.5% standard deviation specified by the manufactur-
ers and agrees with the 0.4% maximum variation noted 
for the triplicate measurements by other authors.9 From 
the figures in Table 1, the mean values of metHb in the 
smokers did not exceed that in the non-smokers; in 
fact, the level in the non-smokers was significantly 
greater. As expected, COHb levels levels in smokers 
substantially exceeded those in the non-smokers .1 2 
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Fig. 1. Serial dilution of methemoglobin solution to low 
concentrations. 
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Table 1.- Mean Values of Methemoglobin and 
Carboxyhemoglobin in Patients Studied 
Non-smokers Smokers 
MetHb 0.67 (0.33)% 0.60 (0.23)% 
0.65 (0.62 . 0.67)% 0.58 (0.56 . 0.61}%t 
(geometric mean [95% 
confidence intervals]) 
0.09 g/ l OOml 0.08 g/ l OOml 
COHb 0.87 (0.47)% 3.26 (2 .2)% 
Hb 13.3 (1.7) g/100 ml 13.8 (1.6) g/100 ml 
N 336 336 
NOTE: Numbers which appear within parentheses are standard de-
viat ions, unless otherwise indicated. 
• Z ~ 3.19, P ~ .0014. 
t Z ~ 3.33 , P < .001. 
Figure 2 shows the distribution of metHb values in 
smokers and non-smokers. It appears approximately 
"normal," although there is some skewness toward 
high values in the non-smokers. This is unlikely to in-
validate the "Z" test, which is robust to minor depar-
tures from normality and inequality of variance in the 
two groups. Transformation of the metHb data to the 
logarithm effectively equalized the variance (as shown 
by the similar width of the two confidence intervals on 
the two geometric means in the Table). Performing a 
" Z" test on the log transformed variable can be seen to 
give an even larger value for the "Zff statistic. 
If we set the smallest difference in metHb level that 
we would not wish to overlook at 0.1 % (the maximum 
resolution of the instrument) , then the power of detect-
ing such a difference using the unlogged data and ac-
counting for the slight inequality of variance is 98%.13 
DISCUSSION 
Our failure to demonstrate elevated metHb levels in 
smokers could be due to NO following a different met-
abolic pathway when inhaled in cigarette smoke com-
pared to inhalation in air by volunteers.8 If this is the 
case, it is unlikely that nitrosyl hemoglobin (NOHb) is 
the final product since an earlier study found no differ-
ence in NOHb concentrations between smokers and 
non-smokers.14 While it is possible that highly reactive 
oxygen species, known to be preser'lt in cigarette 
smoke,15 alter NO metabolism in smokers, similar 
species occur in automobile exhaust which neverthe-
less causes elevation of methemoglobin levels.7 A more 
probable explanation for ou r observation is that ciga-
rette smoke contains insufficient NO to affect metHb 
levels. The carbon monoxide (CO) in cigarettes pro-
duces a 5% increase in COHb in smokers compared to 
non-smokers.12 While NO yields for current United 
Kingdom cigarettes are not published, the average 
United States CO yield (17 mg) exceeds the average 
NO yield (350 mcg) by 50 times, 2 and despite the 
greater affinity of NO for hemoproteins compared to 
CO l6 the expected rise in metHb could well be over an 
order of magnitude lower than the rise in COHb and 
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Fig. 2. Distribution of methemoglobin levels in smokers and non-
smokers. 
not detectable by our methodology. It must be remem-
bered that the puff of cigarette smoke is diluted many 
fold by the time it reaches the alveoli, and this fact 
coupled with exposure to cigarette smoke being inter-
mittent rather than continuous may indicate that smok-
ers' NO exposure is actually less than in the volunteer 
studies referred to . . 
We believe our sample of smokers to be representa-
tive of the smoking population since our mean value 
for COHb is in reasonable agreement with values ob-
tained on larger groups of British smokers. 12 While fur-
ther information such as number and brand smoked 
and time since last cigarette would have been of inter-
est, it would have prolonged the time spent with each 
patient and reduced the number in the study with con-
comitant loss of power. We believe it is unlikely that the 
elevated COHb in the smokers would have affected 
332 
their metHb levels. Although high levels of COHb may 
affect estimation of metHb by the modified technique 
of Evelyn and Molloy, 17 this is because of the necessity 
to convert COHb to metHb by ferricyanide in that 
method. Since COHb and metHb are estimated sepa-
rately at their separate absorption maxima, this prob-
lem should not arise with the IL 282. 
The suggestion from our data that levels of metHb in 
non-smokers actually exceed those in smokers is puz-
zling and is not just due to the slightly higher Hb con-
centrations in the smoker, since this difference is also 
seen if metHb concentrations rather than saturations 
are compared. We think it unlikely that there was a 
significant difference in NO exposure from any other 
source or indeed any other cause of methemoglobine-
mia between the two groups. We would urge caution, 
however, in drawing conclusions from a difference 
which, though statistically significant, is less than 0.1 %, 
the minimum resolution of the instrument. 
Overall, however, there is no suggestion from our 
data that metHb formation arising from cigarette smoke 
exposure interferes with the oxygen carrying capacity 
of the blood in smokers. It would be of great interest to 
perform a similar study in the United States or in the 
continent of Europe where cigarette levels may be l 
three-fold higher .18 
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The study population was divided into three categories accordi'ng 
to the carbon monoxide values, and analySis was based on the method 
of Neider and Wedderburn. 9 Mortality rates, odds ratios, and Z2 
tests for trend were calculated with the fitted models. 
Results and comment 
Table I compares the smokers now analysed with those smokers 
in the original Whitehall study who were excluded because the 
carbon monoxide values of their cigarettes were not known. The 
present study group has a deficit of men from lower employment 
grades, chiefly because they were the main users of hand rolled 
cigarettes. During the 10 years of follow up 635 men in the present 
study died. The underlying cause was given as coronary heart disease 
(lCD 410-414) in 255 and lung cancer (ICD 162) in 90. 
Table II shows the relation of daily cigarette consumption to 
carbon monoxide yield. Higher yield brands were more popular 
among light smokers, 16 % of whom chose a brand yielding more 
than 20 mg, compared with only 11 % of heavy smokers . Furthermore, 
men who were in the lower employment grades or who reported that 
they inhaled tended to smoke low carbon monoxide brands: 
The figure shows the dispersion of carbon monoxide yields and 
their relation to tar yields. The correlation was low (+0'05) and not 
TABLE I-Comparisoll of smokers with kllowll alld IIllkllOWIl carboll mOlloxide 
yields of cigarelles 
Age (yea rs) 
Systolic blood pressure (mm Hg) 
Plasma cholesterol (mmol/I) 
Blood glucose (mmol/I) 
No of cigarettes/day 
"Inhalation" (~o) 
Height (m ) 
Body mass index (kg/m') 
Suspect ischaemia ( % ) 
Phlegm ( 'Yo) 
FEV,(l) 
Known 
ca rbon monoxide 
(n = 4910) 
51'7 
134'7 
5·10 
1·95 
16'9 
80 '0 
1'75 
24·4 
16 '5 
34·1 
3'01 
Unknown 
carbon monoxide 
(n = 2360) 
52·1 
135-4 
5'12 
1·95 
14'3 
77'6 
1·75 
24·3 
16'1 
33'9 
3·01 
Some means may be based on fewer subjects because of missing values. All 
figures have been standardised for grade of employment. 
TABLE ii-Percentage distribucioll (alld Ilumbers) of 4910 cigarelle smokers 
accordillg to Illlmber of cigarettes smoked alld carboll mOllOxide yield 
Cigarettes smoked per day 
25 
01 
~ 20 
<l1 
U 
.~ 
§ 15 
.Q 
8 
1-9 
10-19 
;. 20 
0 
0 
0 
0 
0 0 
.; 18 mg 
24'8 (237) 
30'2 (53 6) 
35 '6 (776) 
0 
0 
0 
0 0 
0 
Carbon monoxide yield: 
> 18-20 mg >20 mg Total 
58'7 (560) 16·5 (157) 100·0 (954) 
57'0 (1012) 12·7 (226) 99·9 (1774) 
53'2 (l16J) II) (245 ) 100·0 (2 182) 
• 
• 
• • • 
0 
0 
• 
• • 
~, __ , ~o -----+--, ~~~o-
20 25 , 30 35 
Tar (mg) 
Relation in analysed brands betw:een tar yield (manufacturers' contemporary 
estimates) and carbon monoxide yield (recent estimates on reconstituted 
cigarettes). . ! 
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significant. There was also essentially no association between carbon 
monoxide and nicotine yields (r = + 0'01 ). 
Table III shows the relations between carbon monoxide yield and 
various measures of smoking related disease, standardised for age 
and employment grade. None of the trends are significant at the 5% 
level. 
TABLE lll-Preva lelZce of slIspected myocardial ischaemia m,d 10 year morlality 
rates by carboll mOlloxide yield of cigarelles 
Carbon monoxide yield: 
z' for 
Outcome .; 18 mg > 18-20 mg > 20 mg linear 
(n = 1535) (n = 2709) (n = 626) t rend· 
Prevalence of suspected 
ischaemia (U 0) 15'6 16'4 18 '0 1'78 
10 year CHD mortality (~,, ) 
Total 5'39 4·99 3·59 2·55 
\\lith ischaemia 10'31 9·45 8·32 0'39 
\Vithout ischaemia 4'49 4·01 2·47 3·20 
Prevalence of phlegm (Ov) 33'2 34'0 33·9 0'22 
10 year lung cancer 
mortality ( vI) 1·39 1·88 1·90 1·38 
10 year other non CHD 
mortality (U~ ) 5'46 5·93 5'32 0'03 
10 year all causes 
mortality (U!.) 12·21 12'81 10·80 0·22 
CHD = Coronary heart disease. 
All rates are standardised for age and employment grade to the rotal \VhitehaH s tudy 
population. 
' Requires z' (1 dO ,,3'84 for p < 0'05. 
Table includes only subject s with known ischaemia s tatus. 
The prevalence of suspected coronary heart disease tended to 
increase as carbon monoxide yield increased . The trend for mortality, 
on the other hand, was in the opposite direction, the strongest negative 
trend being among men free of suspected myocardial ischaemia 
(symptoms or electrocardiographic changes). Carbon monoxide yield 
was not evidently associated with the production of phlegm or with 
other causes of death. 
Table IV summarises the mortality relations in the form of odds 
ratios, after controlling for age, employment grade, daily number of 
cigarettes, and tar yield. All the models gave goodness of fit statistics 
indicating adequate fit to the observed data. The 95 % confidence 
intervals all include unity, so that again no significant effects have 
emerged. Nevertheless, the "best estimates" that emerge from these 
data are that smoking the high carbon monoxide cigarette is associated 
with a 32% reduction in the risk of death from coronary heart disease 
and a 49% increase in the risk of death from lung cancer. The 
association with total and other mortality is again irregular. 
TABLE lV-Odds ratios (aud 95% coujideuce intervals) for variolls ca llses of 
10 y ear /IIortality by carboll morwxide yield of cigaretles 
Outcome 
CHD 
Lung cancer 
Other non-CHD 
All causes 
.; 18 mg 
1·00 
1·00 
1·00 
1·00 
Carbon monoxide yield: 
> 18-20 mg 
0 ·99 (0'75; 1'32) 
1·50 (0'91; 2·46) 
1·12 (0'85; 1·47) 
1·12 (0,92; 1'37) 
> 20 mg 
0'68 (0'42 ; 1' 10) 
1'49 (0'72; 3'10) 
0·99 (0'65; 1'5 1) 
0 ·90 (0 '66; 1'22) 
CHD = Coronary heart di sease. 
Controlled for age, grade of employment, cigarettes/day, and tar yield. 
Any effect of carbon monoxide on the cardiovascular system might 
be expected to be seen more clearly among men who inhale. 7 Table V 
analyses coronary mortality (adjusted for age and employment grade) 
according to reported inhalation habit. A striking result emerges: 
there is a strong and highly significant inverse relationship between 
carbon monoxide yield and mortality rate among self reported inhalers, 
the rate in the low carbon monoxide group being more than twice 
as high as in the high carbon monoxide group. Among those who 
denied inhaling the opposite was seen, high carbon monoxide smokers 
having the highest mortality (but not significantly so at the 5% level). 
A similar analysis for lung cancer mortality showed that among 
men who reported inhaling the risk of lung cancer was 75 % higher 
in the high carbon monoxide group, though the trend was not 
significant. In non-inhalers, however, the highest rates were in the 
low carbon monoxide group, but the numbers were small. 
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TABLE v-l0 year marta lilY from corollary hea rt disease by carboll moilOxide 
yield of cigarel/es alld "eported illhalatioll habit. R eslllts are percemage mortality 
(a lid III1/1/bers of deaths) 
Carbon m onoxide yield : Z 2 fo r 
Reported inhalation linear 
.; 18 mg > 18-20 mg > 20 mg trend · 
Yes 6·12 (79) 4·98 (107) 3'01 (14) 6'83 
No 3'03 ( I I) 5'55 (36) 559 (8) 2·52 
All rates are standardised for age and grade of emp loymen t to the total \'\' hilchall 
study population. 
'Require z' OdO " 3'84 for p < 0'05; I.'" 6·63 for p < 0'01. 
There was a highly significant positive association between FEV I 
and carbon monoxide yield of cigarettes (table VI). Adjustment for 
amount smoked, tar yield, and employment grade halved the 
magnitude of the trend but it still remained consistent. 
TABLE VI-Meall va illes of FEV, (lio'es) ill relatioll 10 ca rboll mOlloxide yield, 
adjllsted for (a) age ollly, alld (b) age, IIII/1/ber of cigarel les, employmenl grade, 
tar. Figures in parentheses are sta ndard errors 
Adjustment 
(a) Age onl y 
(b) All factors 
Discussion 
.; 18 mg 
2·96 (0'015) 
2·97 (0'01 5) 
Carbon m onoxide yield: 
> 18-20 mg 
3·04 (0 '012) 
3'01 (0 '01 J) 
> 20 mg 
3·10 (0'024) 
3·04 (0'023) 
We still do not know which components of cigarette smoke 
are responsible for its associated cardiovascular hazard. Carbon 
monoxide in high concentration is a known poison and it might 
be argued that it should be reduced as much as possible. 
Nevertheless, the cardiovascular effects of long term low level 
exposure remain uncertain. Astrup reported that exposure to 
carbon monoxide produced atheroma in rabbits fed cholesterol I II; 
but this may be a poor model for human disease." An association 
between the prevalence of arterial disease and carboxyhaemo-
globin may simply indicate that the latter is a better index of 
exposure to tobacco smoke than reported smoking history." 
'Acute exposure to carbon monoxide could impair oxygen 
transport to the myocardium as a result of the formation of 
carboxy haemoglobin. This may explain why when men with 
established coronary heart disease are acutely exposed to 
carbon monoxide they experience a reduction in exercise 
tolerance.'" It might also explain our observed association 
between higher carbon monoxide yields of cigarettes and 
symptoms of ischaemia. Nevertheless, long term low level 
exposure may improve oxygen transport by causing a rise in the 
haemoglobin concentration," and tissue adaptation may 
facilitate an increase of oxygen uptake. I S Interestingly, a recent 
case control studyI' found no evidence that the risk of myocardial 
infarction in smokers is related to the carbon monoxide yield 
of their cigarettes. 
In our analysis it was possible to separate the effects of 
carbon monoxide yield from the effects of tar and nicotine, 
because the yields of these constituents were not correlated at 
the time of the study (figure). Carbon monoxide yield may 
exert a weak effect on the prevalence of clinical evidence of 
established coronary heart disease (angina, history of possible 
myocardial infarction, and ischaemic type electrocardiographic 
changes). Quite the reverse is seen for death from coronary 
heart disease, when smokers of high carbon monoxide cigarettes 
have 32% less risk of dying than smokers of low yield cigarettes. 
Furthermore, this negative effect is increased and very significant 
among self reported inhalers. This contrasts with our earlier 
observations on tar, where among inhalers the high tar and 
nicotine group had a greater mortality risk than the low tar and 
nicotine group.7 The inverse carbon monoxide associated risk 
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is particularly affected by smoking behaviour (as measured by 
self reported inhalation), perhaps by influencing the site and 
degree of absorption of the constituents of smoke. 
Long term exposure of the lungs to carbon monoxide may 
contribute to the development of lung disease. Acute poisoning 
with carbon monoxide may cause alveolar shadowing on chest 
radiographs, suggesting interstitial changes 3 or alterations in 
alveolar permeability'; but the relation of these acute changes 
to the development of chronic airways disease or emphysema, 
or both, is unknown. In our study smokers of high carbon 
monoxide cigarettes had the best values of FEV 1, which suggests 
that carbon monoxide is not a major factor in chronic obstructive 
bronchitis or emphysema. 
It has been suggested that carbon monoxide yield may 
predict the yield of other gases such as acrolein and hydrogen 
cyanide,I' known to be toxic to pulmonary epithelium.Is 
Nevertheless, it is unwise to take the health correlates of 
carbon monoxide yield as a guide to the effects of other gases 
until we know more about how their concentrations vary 
together in different brands. 
The estimated risk of death from lung cancer was almost 
50% greater in the group smoking high yield cigarettes, though 
this increase was seen only among inhalers. Possibly carbon 
monoxide or some associated gas phase component is responsible, 
although the suspected carcinogens in' cigarette smoke are 
believed to be principally in the tar. l ' 
Wald has recently been unable to find any clear association 
between smokers' estimated carbon monoxide retention and 
the carbon monoxide yield of their cigarettes. 2o Though there 
may be other explanations," his finding raises the possibility 
that carbon monoxide may have mental effects, which, like 
nicotine, influence inhalation and hence carboxyhaemoglobin 
concentrations . Such compensatory behaviour might perhaps 
account for the increased coronary mortality among inhaling 
smokers of low carbon monoxide brands. 
These results provide no evidence to support the view that 
the smoker can reduce his risk by changing to a brand with a 
lower yield of carbon monoxide; indeed, total mortality was 
higher in smokers of low yield brands. The complexity of smoke 
chemistry, the variability of smoking habits, the arbitrary choice 
of cigarette brand, and our ignorance of the mechanisms 
responsible for consequent damage to health combine to make 
it difficult to predict the effects on health of manipulating the 
constitution of cigarette smoke. 
C Borland is supported by a grant from the East Anglian Regional 
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Carbon monoxide yield of cigarettes and its relation to 
cardiorespiratory disease 
COLIN BORLAND, ANDREW CHAMBERLAIN, TIM HIGENBOTT AM, MARTIN SHIPLEY, 
GEOFFREY ROSE 
Abstract 
Estimates of the carbon monoxide yield of their cigarettes 
have been obtained for 4910 smokers (68% of all smokers) 
in the Whitehall study of men aged 40 to 64. In the 10 
years after examination 635 men died. When men 
smoking cigarettes 'Yith high carbon monoxide yield 
were compared with those smoking cigarettes with a low 
yield, and after adjusting for age, employment grade, 
amount smoked, and tar yield, the risk of death was 32% 
lower for coronary heart disease, 49% higher for lung 
cancer, and 10% lower for total mortality; these 
differences were not statistically significant. Among men 
who said that they inhaled the risk of fatal coronary 
heart disease was 51 % lower in the high carbon monoxide 
group (p <0'01 ), while the risk of lung cancer was 75% 
higher. 
These results provide no evidence that a smoker can 
reduce his risk of death by smoking a brand with a low 
carbon monoxide yield; he might even increase it. The 
complex interactions between characteristics of the 
smoker, smoking behaviour, constituents of tobacco 
smoke, and health are again demonstrated. 
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Introduction 
The search for a less hazardous cigarette has depended on 
identifying suspected harmful components of tobacco smoke 
and then reducing their concentrations. Initial interest centred 
on tar, and in the United Kingdom between 1960 and 1980 
the sales weighted average yield for tar in manufactured 
cigarettes fell from 31 to 16 mg'; this decline is tending to 
flatten out. Concern is now moving to carbon monoxide, 
because of its suspected relation to cardiovascular disease 2 
and perhaps also to lung disease3 - 5 ; over a similar period 
its yield fell only from 21 to 16·5 mg. There is growing pressure 
both on manufacturers to reduce the average carbon monoxide 
yield and on the public to prefer lower yield brands. Neverthe-
less, there is no direct evidence on the health consequences of 
such a policy. The experience of the Whitehall study is relevant. 61 
Methods 
In 1967-9 the Whitehall study examined 18403 civil servants 
aged 40 to 64. Each completed a questionnaire, which included 
details of current cigarette consumption and usual cigarette brand, 
and underwent recordings with a dry wedge spirometer. The prevalence 
of coronary heart disease at initial examination was assessed by the 
presence of "angina" and "possible infarction," as defined by the 
standard questionnaire. 6 Electrocardiographic evidence of ischaemia 
was defined by Minnesota codes 1·1-3,4· 1-4, 5'1-3, or 7·1. 
The tar and nicotine yields of cigarette brands were known from 
contemporary analyses performed by the industry, but no such 
data were available for carbon monoxide. Recently, however, the 
Government Chemist has analysed old packs of cigarettes, and from 
this source the carbon monoxide yields were available for the cigarettes 
smoked by 68 % of the cigarette smokers in the study. B The remainder 
smoked hand rolled cigarettes or less popular brands. Contemporary 
analysis and the recent reanalysis for both tar and nicotine showed 
excellent correlation (r = 0'90 for tar and 0 ·86 for nicotine; n = 22) 
and the mean differences (results of recent reanalysis minus those of 
contemporary analysis) were small: + 0·9 (SD 0'03) mg for tar and 
- 0·08 (SD 0'003) mg for nicotine. This implies that for these 
constituents the old packs of cigarettes were representative and 
deterioration in storage was negligible. No such validation was 
possible for the carbon monoxide estimates. 
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Nitric Oxide Yields of Contemporary 
UK, US and French Cigarettes 
COLIN BORLAND AND TIM HIGENBOTTAM 
Borland C (Department of Respiratory Physiology, Addenbrooke's and Papworth Hospitals, Cambridge, UK) and 
Higgenbottam T. Nitric oxide yields of contemporary UK, US and French cigarettes. International Journal of Epidemio-
logy 1987, 16: 31- 34. 
To determine what governs nitric oxide (NO) yields of cigarettes and to obtain a range of yields for contempor'ary 
cigarettes 17 UK, 14 US, B French and 1 Turkish brand were analysed using a chemiluminescent analyser and standard 
smoking machine. The country of origin appeared to be the major factor affecting NO yield. US and French brands 
exceeded UK values by 3-5 fold. Apart from a reduced NO yield in UK ventilated filtered brands, the design of a 
cigarette and its tar, nicotine and carbon monoxide (CO) yield had little effect on NO yield . It is argued that these 
international differences in NO yields reflect differences in the nitrate content of tobaccos traditionally used in 
manufacture in those countries over many years. Despite their probable increased lifetime exposure to NO (and by 
implication nitrosamine exposure) there appears to be little evidence that US and French smokers are at greater risk of 
lung disease than their UK counterparts. 
Nitric oxide (NO) is one of the main constituents of the 
gas phase of cigarette smoke. I.2 Oxides of nitrogen are 
believed to be harmful to the body by causing lung 
damage l and by forming nitrosamines3 which have 
been considered carcinogenic. 4 Despite this potential 
toxicity contemporary data on cigarette NO yield are 
limited to a small number of US brands .s We have 
measured the NO yields of a representative range of 
popular UK, US and French brands of cigarette. One 
brand of Turkish cigarettes has also been studied . This 
has provided us with a comparison of yields of the four 
main types of tobacco blends used in cigarette manu-
facture throughout the world. 6 An attempt has been 
made to correlate cigarette type, tar yield and carbon 
monoxide (CO) yield with that of NO yield . 
METHODS 
Analysis of Nitric Oxide yield 
A purpose built chemiluminescent analyser was used 
(Chem Lab Ltd, Hornchurch, Essex) . The smoke 
sample containing NO is drawn into the device at 
120 ml per minute and carried in a stream of nitrogen 
to the reaction chamber. Here the NO in the sample is 
exposed to ozone generated within the analyser by 
passing a stream of oxygen at 30 ml per minute across 
Department of Respiratory Physiology, Addenbrooke's and Pap-
worth Hospitals, Cambridge. 
Reprint requests to: Dr Tim Higenbottam, Addenbrooke's Hospital, 
Hills Road, Cambridge , CB2 2QQ, UK. 
Interested readers may contact the Authors for brand names and 
yields. 
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an EHT (7000 volts) discharge . Any NO in the sample 
will react with the ozone to produce nitrogen dioxide 
(N02) , some of which is in an excited form. On return 
to the ground state photons of light in the near infra red 
range are emitted7 which can be quantified electrically 
by a photomultiplier. It has been shown that this reac-
tion is quantitative for NO in the smoke sample. 8 A 
series of potentiometers enable a range of 0.4 to over 
1000 parts per million (ppm) to be analysed. 
The analyser was calibrated daily using a mixture of 
NO in nitrogen of approximately 5b parts per million 
(ppm) concentration by volume. The exact con-
centration was expressed on a manufacturer's certifi-
cate of analysis. For the higher yielding US and French 
cigarettes a mixture of 1000 parts per million NO in 
nitrogen was also used for calibration. Linearity from 1 
to 25 parts per million was determined by diluting the 
NO mixture in air. Above 25 parts per million oxida-
tion of NO during the dilution process resulted in non-
linearity. Since many of the French and US cigarettes 
may yield several hundred parts per million linearity at 
higher concentrations was assessed indirectly. A mix-
ture of approximately 300 parts per million NO in 
nitrogen and oxygen was made up and the resulting 
decline in NO was measured against time. Plotting the 
reciprocal of the NO concentration against time was 
shown to be linear and agreed with the predicted slope9 
suggesting that the instrument response was indeed 
linear. 
The Choice of Cigarettes for Analysis 
A selection of 17 UK cigarettes were chosen to include 
not only popular brands lO but also I~ss popular plain 
n 
j 
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cigarettes, very low tar cigarettes and American types 
of cigarettes. They were chosen so as to explore the 
influence of filter and tobacco fype on NO yields in 
cigarettes sold in the UK. The US brands chosen were 
the 14 most popularll in the year prior to the study. The 
8 French cigarettes included all the popular 'Gitanes' 
and 'Gauloise' varieties produced by the French 
tobacco monopoly (SEITA) that are available in the 
UK . All the UKand French cigarettes were obtained 
from 3 tobacconists in a single city in the UK during the 
Spring of 1983. Unlike French cigarettes, US cigarettes 
for the UK market are of different composition than 
those on sale in the US . Accordingly US cigarettes 
were purchased retail from a single tobacconist in the 
US in Spring 1983. 
The Preparation of the Cigarettes and the Smoking 
Procedure 
A single packet of ~ach brand was purchased, opened 
and stored for at least 48 hours under constant humid-
ity at room temperature. 12 These conditions were 
achieved using an air-tight container enclosing a satur-
ated solution of sodium bromide. 
The order of cigarettes and brands smoked was ran-
domized . The cigarettes were smoked sillgly in runs of 
10. Each such run contained a control cigarette which 
was chosen from the UK market as having NO yield 
intermediate between the range of UK and US and 
French brands . 
Smoking was performed using a standard single port 
smoking machine (Heinrich Borgwaldt, Hamburg, 
RG-1) which takes a bell shaped puff of 35 ml of smoke 
every minute. The cigarette was extinguished when the 
burn-line crossed the pencilled butt mark and a single 
clearing puff of smoke was taken . Five cigarettes were 
smoked from each packet for each brand. The exhaust 
from the smoking machine was directed into a 50 ml 
glass syringe which was then immediately aspirated 
into the NO analyser. In this fashion analysis was 
carried out on a puff by puff basis so as to reduce the 
oxidation of NO .9 
Calculation of NO Yield 
The yield on NO per cigarette is simply calculated as 
yield per 35 ml puff = 0.0168 x prrxC parts per mil-
lion where P is barometric pressure in mm Hg (Torr), T 
is temperature in degrees Kelvin and C is con-
centration per puff. The factor 0.0168 is derived from 
Charles' law and Avogadro's law.12 The total yield for 
the cigarette is the sum of the parts per million for each 
puff including the clearing puff. 
Data on Type of Cigarette 
Data for each brand of cigarette were obtained from 
the laboratory of the Government Chemist (UK and 
French cigarettes) and from the Federal Trade Com-
mission (US cigarettes) for a month as close as possible 
to the purchasing date. It included details oil the 
length, filter type, tar, nicotine and carbon monoxide 
yields. " , 
RESULTS 
The range of UK cigarettes that we analysed accounted 
for approximately 57%10 of the market. Approxi-
mately 43% of the market share for US cigarettes was 
also analysed . ll It is difficult to estimate the market 
share of the French Cigarettes since this market is cate-
, gorised by manufacturer ' rather than brand but as all 
the popular Gitane and Gauloise cigarettes available in 
the UK were analysed and since the manufacture of 
these ' two brands held approximately 70% of the 
French market ' we believe that the sample is 
representative. 13 
The table of results (Table I) shows the nitric oxide 
yields for the cigaretteS. There is a major difference in 
yield between UK cigarettes which are low compared 
with the US and French brands. Indeed these two 
countries' cigarettes have a 3-5 fold greater yield of 
NO. The only higher yielding UK cigarettes are US 
and French cigarettes on sale on the UK market. The 
UK cigarettes appear to have a wider range of NO 
yields than do the US or French cigarettes. There was a 
tendency for the UK and US ventilated filter cigarettes 
to have lower NO yields than the plain or filtered 
cigarettes. In general plain and filtered cigarettes have 
similar yields in all three countries . There was very 
poor correlation between NO yield, carbon monoxide, 
tar and nicotine , yields of the cigarettes and this is 
shown by the correlation coefficients. 
DISCUSSION 
This analysis is on a relatively small scale compared 
with those conducted by the official agenciesl4•15 when 
comparing tar, nicotine and carbon monoxide yields. 
We have made no attempt to assess regional variations. 
However the contrast between the countries do .offer 
useful points of comparison. We would not, however, 
suggest our work is sufficiently comprehensive to offer 
reference values for yields of NO. 
Our results compare favourably with the work of 
others. For example Snell obtained a range of 167-
378 mcg for oxides of nitrogen (expressed as N02) 
from 21 US brands in 1976.5 Similarly Newell's data3 
when converted from parts per million to mcg's give a 
range of 219-628 mcg for dark tobacco cigarettes (for 
NITRIC OXIDE YIELDS OF CONTEMPORARY CIGARETTES 33 
TABLE 1 Yields of UK, Frellch alld US Cigarettes. 
Design 
F' 
F' 
F' 
F 
F 
F 
F 
F 
F 
F 
VF 
F 
P 
F 
P 
VF 
VF 
Length 
(mm) 
84 
83 
84 
84 
84 
94 
83 
84 
70 
83 
84 
70 
69 
74 
65 
84 
84 
NO yield 
(mcg) 
Mean (SD) 
Tar 
yield 
(mg) 
UK Cigarettes 
222 (30) 
218 (18) 
196 (13) 
135 (19) 
96 (6) 
95 (16) 
89 (13) · 
88 (20) 
85 (4) 
76 (9) 
74 (5) 
71 (12) 
60 (9) 
56 (4) 
55 (10) 
43 (10) 
10 (4) 
15.5 
15.5 
16 
17 
17 
13 
15 
15 
16 
16.5 
8.5 
14.5 
24 .5 
15 
17.5 
4 
1 
r = 0.34 
• US brands on UK market 
F 
P 
VF 
F 
P 
F 
F 
VF 
F 
F 
P 
VF 
F 
F 
F 
VF 
P 
F 
F 
VF 
F 
F 
F 
P = Plain. 
F= Filter. 
100 
70 
90 
83 
69 
70 
70 
70 
70 
85 
85 
100 
100 
85 
100 
85 
80 
85 
100 
85 
gO 
85 
85 
VF = Ventilated Filter. 
Turki sh Cigarettes 
191 (18) 
French Cigarettes 
409 (44) 
403 (35) 
379 (32) 
376 (29) 
363 (43) 
358 (43) 
353 (26) 
320 (37) 
22 
12 
10 
24 
12 
12.5 
10 
12 
r = 0.43 
US Cigarettes 
384 (91) 14.7 
379 (54) 24.3 
376 (21) 10.7 
371 (18) 14.3 
361 (22) 15.1 
321 (47) 14.2 
317 (32) 9.0 
316 (39) 20 .1 
312 (29) 16.6 
295 (13) 16.0 
292 (45) 10.7 
283 (l2) 16.4 
274 (27) 16.9 
230 (7) 8.2 
r = 0 .31 
Nicotine 
yield 
(mg) 
1.3 
1.3 
1.3 
1.4 
1.4 
1.2 
1.4 
1.3 
1.4 
1.4 
0.9 
1.3 
2.4 
1.2 
1.4 
0.5 
0.2 
0.25 
1.4 
1.0 
0.5 
1.2 
0.6 
0.6 
0.6 
0.6 
0.69 
1.02 
1.56 
0.79 
0.97 
1.01 
0.95 
0.70 
1.28 
1.12 
1.06 
0.79 
1.06 
1.07 
0.58 
0.39 
CO yield 
(mg) 
15.5 
15 
15 
17 .5 
17.5 
15 
15 
15 
14 
15 
9.5 
13.5 
14 
15 
11 
4 
0.5 
0.55 
17 
16.5 
17.5 
19.5 
19 
19 
13.5 
19 
0. 19 
13.8 
16.4 
11.2 
14.5 
16.3 
16. 1 
12.9 
12.2 
15.3 
15.5 
11 .2 
14.9 
15.2 
19.6 
0.29 
example French type), 50 mcg for flu-cured Virginia 
(UK type) and 194 and 267 mcg for 2 US brands. We 
were struck by the marked differences in nitric oxide 
yields between the countries. We would suggest that 
the largest single factor affecting NO yield appears to 
be the country of manufacture with French and US 
type cigarettes exceeding the UK cigarettes 3-5 fold. 
The single Turkish brand analysed had a yield above 
the upper limit of the UK range. 
The design of the cigarette appears to playa lesser 
role in determining the NO yield. Plain cigarettes do 
not have a higher yield than filter cigarettes. In general 
particularly amongst the UK brands ventilated filter 
cigarettes had lower yields than either the filter or the 
plain varieties but there were important exceptions 
amongst the US and French brands. There was little 
correlation between NO, CO, tar or nicotine yields 
except that the very low tar yielding ventilated filter 
brand had the lowest NO, CO and tar yields of all the 
cigarettes . 
Previous work suggests that the nitrate content of 
tobacco used in blending each brand is the cause of 
these marked variations in NO yield. It has been shown 
by radiolabelling experiments that the NO yield in 
smoke is derived principally from tobacco nitrate. 16 
This in turn depends on the type of tobacco used, its 
mode of cultivation and the process · of curing the 
tobacco leaf. Flu-cured Virginia tobacco (as used in 
UK cigarettes) and sun-cured oriental tobacco (as used 
in Turkish cigarettes) and sun-cured oriental tobacco 
(as used in Turkish cigarettes) have lower nitrate yields 
than dark air-cured tobacco (as used in French cigaret-
tes) or the Burley tobacco which is one of the four main 
constituents of US brands.6.t7.18 The national prefer-
enceJor particular blends of tobacco within the ciga-
rette brands seems to be longstanding. The UK has had 
a preference for Virginia tobacco since the last cen-
tury.19 Similarly the US preference for a blend of Bur-
ley, Maryland, Virginia and Oriental dates from the 
early years of the 20th century.6 It seems likely there-
fore that these marked international differences in the 
NO yield of cigarettes has existed for many years and 
are not simply a recent trend. However there has been 
a slight increase in recent years in the NO yield of US 
cigarette brands. This is thought to be due to the pro-
cess of adding different parts of the tobacco plant to 
provide the filler for the cigarette and so reducing the 
cost and tar yield. 20 A further difference between ciga-
rettes made of different tobaccos is that nitrosamine 
yields from Burley and dark tobaccos are higher than 
comparable yields from Virginia and Oriental 
tobaccos. 3 As nitrosamines are derived from NO and 
nitrate 16 it is to be expected that nitrosamine yields will 
closely parallel the NO yield . 
It appears likely therefore that smokers in the US 
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and in France have been exposed to considerably 
higher NO and possibly nitrosamine yields than 
smokers in the UK. This has probably been occurring 
for many years. The consequences of these different 
exposures are difficult to gauge mainly because of 
marked differences in the mortality rates from smok-
ing related diseases which have partIy resulted from 
international differences in the popularity of smoking 
cigarettes. 2t An additional difficulty in assessing the 
consequences in terms of health risk is that many of the 
diseases are classified differently in different coun-
tries .22 Despite these difficulties Doll and Pet02t have 
calculated lifetime cigarette smoke exposure from 
available sales figures and have shown a striking rela-
tionship between estimated consumption and the mor-
tality rates from bronchial carcinoma for a range of 
developed countries. There is no suggestion from their 
figures that the US or French cigarette carry with them 
any higher risk of lung cancer as assessed per cigarette 
smoked than does the UK counterpart. Similarly other 
workers have noticed comparable mortality rates of 
bronchitis per cigarette smoked in the UK and US .23 
Furthermore if we restrict our observations to the UK 
our table shows that the small plain cigarettes that were 
popular some 30 years ago have a lower NO yield 
compared to today's popular King size filter cigarettes. 
One could perhaps suggest that despite an increase in 
the average NO and nitrosamine exposure there has 
been no increase in mortality from either chronic bron-
chitis or lung cancer in the UK. Indeed the reverse has 
been observed.24 This circumstancial evidence would 
seem to suggest that NO yields of cigarettes may not be 
important in determining the mortality risks from lung 
cancer and chronic lung disease. 
Further work is obviously required to estimate the 
hazards associated with the NO yield of cigarettes. 
However our data would not support the idea that 
. removing NO from cigarettes would necessarily reduce 
the risks to the smoker. 
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SUMMARY 
There remains uncertainty about the rate of oxidation 
of nitric oxide (NO) in cigarette smoke. Using a single-
port smoking machine and a chemiluminescence NO 
analyser we have investigated the rate of NO disap-
pearance during cigarette smoke ageing over 10 minutes 
for gas phase and whole smoke. 
The disappearance of NO in whole smoke conformed 
to the (pseudo) second order kinetics observed for oxi-
dation of NO in air. In the gas phase however the rate 
of disappearance was more rapid and appeared to fol-
low first order kinetics. The possible mechanisms for 
this difference in behaviour are discussed. 
ZUSAMMENF ASSUNG 
Die Oxidationsgeschwindigkeit von Stickoxid (NO) in 
Zigarettenrauch ist weiterhin unklar. Unter Verwen-
dung einer Einkanal-Rauehmaschine und eines NO-
Chemolumineszenz-Analysators wurde die Geschwin-
digkeit der NO-Abnahme wahrend der Alterung von 
Zigarettenrauch in der Gasphase und im Gesamtrauch 
,., Received : 26th July 1984 - accepted: 7th March 1985. 
liber einen Zeitraum von zehn Minuten untersucht. 
Die Abnahme von NO im Gesamtrauch stimmte mit 
der bei der Oxidation von NO in, Luft zu beobachten-
den Kinetik (pseudo)zweiter Ordnung liberein . Die 
Schwundrate in der Gasphase war jedoch groBer und 
sehien einer Kinetik erster Ordnung zu entsprechen. 
Die dies em unterschiedlichen Verhalten moglicherweise 
zugrundeliegenden Mechanismen werden diskutiert. 
RESUME 
Il regne encore une certaine incertitude quant it la vi-
tesse d'oxydation de l'oxyde d'azote (NO) dans la fu-
mee de cigarette. On a utilise une machine it fumer it un 
seul canal avec analyseur de NO par chimiluminescence 
pour etudier la vitesse de disparition de ce gaz pendant 
10 minutes de vieillissement de la fum ee, tant pour la 
phase gazeuse que pour la fumee totale. 
Le processus de disparition du NO dans la fumee totale 
est bien Merit par Ie modele cinetique differentiel du 
(pseudo) second ordre, eorrespondant it l' oxydation du 
NO dans l'air. Cependant la vitesse de disparition dans 
la phase gazeuse est plus rapide et semble suivre un 
modele cinetique differentiel du premier ordre. Les 
mecanismes possibles pour expliquer ces differences de 
comportement sont discutes. 
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Figure 1. 
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INTRODUCTION 
Fresh cigarette smoke contains up to 1000 parts per 
million (ppm) of nitric oxide (NO) per puff (1). This 
yield is largely dependent on the nitrate content of the 
tobacco used in manufacture (2) and hence is higher for 
"U.S. blended" and "dark air-cured" varieties than for 
cigarettes manufactured from "Bright (Virginia)" or 
"Oriental" tobacco (3). On ageing the smoke NO is in-
itially oxidised to nitrogen dioxide (N02) (4) and sub-
sequently reacts to form methyl nitrite (5). The reaction 
of NO with oxygen to yield N02 is known to be third 
order: 
The recommended value for k derived from an exten-
sive review of experimental values is 
1.2 X 109 exp(530/ T"') cm6 mol- 2 S- I (6) . 
There is a disagreement among previous investigators 
regarding the value of k for the oxidation of NO in cig-
arette smoke. Sloan and Kiefer (2) found a similar value 
to that recommended (6) whilst Williams (7) obtained a 
rather higher figure. We have investigated the rate and 
order of this reaction in undiluted whole smoke and in 
gas phase and present a possible mechanism for the dif-
ferent kinetics observed which may explain the differ-
ent rate constants found by earlier workers . 
EXPERIMENT AL 
Cigarettes 
A popular U.K. king-size (85 mm) (all flue-cured) mid-
dle tar (18 mg) filter cigarette was used. Packets were 
purchased retail, opened and stored in an airtight con-
tainer at constant humidity over a saturated sodium 
bromide solution for at least 48 hours prior to smoking 
(8). Previous determinations we have made for this 
brand gave a mean yield of 135 micrograms (Ilg) NO 
which is at the top end of the range for current U.K. 
cigarettes. 
Smoking Machine 
A standard single-port restricted smoking machine was 
used (Heinrich Borgwaldt, Hamburg: RM 1/ G-R58). A 
single cigarette was inserted in the filter holder, lit and 
smoked in the standard fashion, i.e. 35 ml bell-shaped 
puff of 2-second duration taken once per minute (8) . 
The third puff, empirically found to have the most re-
producible concentration of nitric oxide, was then di-
" absolute temperature (kelvin). 
rected into a 50 ml glass syringe where ageing occurred 
for 0 to 10 minutes. The cigarette was then extin-
guished. Following ageing the concentration of nitric 
oxide remaining in the syringe was measured. For de-
terminations of the reaction rate in the gas phase, a 
35 mm Cambridge filter (T39Z """) was inserted into the 
filter holder on the smoking machine. For determina-
tion on the whole smoke the filter was omitted, but the 
machine was regularly cleaned to remove deposited tar; 
in addition the exhaust from the machine was directed 
into a second 50 ml syringe since in practice it was 
found that tar deposited on the inside of the barrel of 
the syringe prevented aspiration of the sample into the 
analyser. This syringe was normally emptied into the 
first immediately prior to analysis. For both gas phase 
and whole smoke the 3-way tap was turned to permit 
aspiration of the sample once the ageing period had 
elapsed (see Figs. 1 and 2). 
Nitric Oxide Analysis 
Nitric oxide was analysed by a purpose-built instru-
ment,'"H, for estimation of NO in the gas phase of to-
bacco smoke. The sample was aspirated at a rate of 
120 mll min and exposed to ozone generated from oxy-
gen within the device by EHT + discharge. Some N02 
is formed in an excited state and emits photons of light 
in the near infra-red which are detected by a photomul-
tiplier (9) . The resulting signal is amplified and condi-
tioned and plotted on a pen recorder (Vitatron 
2001 ++). To prevent any deposition of particulate mat-
ter within the analyser the sample was passed through a 
Cambridge filter in a low dead space holder prior to 
sampling (see Figs. 1 and 2). 
Number of Analyses 
Two replicates were made for both gas phase and 
whole smoke for ageing periods of 0 to 10 minutes in 
1-minute intervals. The order of ageing interval was 
randomised. 
Oxygen Analysis 
In a separate experiment the oxygen concentration for 
the third puff of the same brand of cigarette smoked in 
an identical fashion was determined. Oxygen analysis 
was performed by mass spectrometer (MGA 200 +++) 
calibrated for oxygen in air and in a mixture of oxygen 
(14%), argon (8%), carbon dioxide (8 % ), the remain- : 
der nitrogen. A sample was aspirated directly from the ' 
syringe via a filter and 5 replicates were performed for 
',,", Evans Adlard & C o. Ltd., Winchcombe, Cheltenham, Glos. , England . 
,',,',,', ChemLab Instruments Ltd. , Hornchurch, Essex, England. 
+ electrical high tension. 
++ Fisons Scientific Apparatus, Loughborough, Leics. , England. 
+++ Centronic Ltd., C roydon, Surrey, England. 
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Figure 3. 
1/[NO] vs. time for varying ageing periods. (Predicted slope 
using k = 7.3 X 109 cm6 mol-2 s-' and O2 concentration of 14.4% 
(Tables 1 and 2) .) 
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whole smoke and separated gas phase immediately after 
taking the puff and after a 10-minute ageing period. 
RESULTS 
The rate of oxidation of nitric oxide is third order and 
when oxygen is greatly in excess it will become 
(pseudo) second order (2): 
The integration and rearrangement of the above reac-
tion equation results in: 
1 1 
-- = 2 k [02] t + --[NO], [NO]o 
where [NO]o is concentration at time 0 and [NO], after 
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Figure 4. 
Nitric oxide concentration (log vs. time). Line represents least 
mean squares regression slope. 
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interval t. Thus a graph of l/[NO] vs . t should be lin-
ear with slope 2 k [02], and if [02] is known k may be 
determined (2). 
Disappearance from Whole Smoke 
Figure 3 shows that for ageing in whole smoke the dis-
appearance of NO closely conforms to the predicted 
slope given the initial NO concentrations using the rec-
ommended rate constant of 7.3 X 109 cm6 mol- 2 S - 1 for 
the mean temperature of 293 K and barometric pressure 
of 767 mm Hg recorded during these experiments and 
using the mean oxygen concentration of 14.4% meas-
ured. 
~ 
, 
Table 1. 
Concentration (%) of oxygen in puff [mean (standard deviation) 
of 5 estimations on each phase and time interval] . 
Time (minutes) 
o 10 
Whole smoke 
Gas phase 
14.2 (0.9) 
14.6 (0.3) 
14.5 (0.6) 
14.1 (0.3) 
Table 2 . Values for rate constants. 
1. Rate constant k for third order reaction - d[~tO] = 2 k [NOj2 [02] Source 
[k] = cm6 mol- 2 s-' [k] = 12 mol- 2 min- ' 
8.6 X 109 5.2 X 105 our data (whole smoke) 
8.0 X 109 4.8 X 105 unspecified phase (2) 
7.3 X 109 4.4 X 105 recommended at 22 ·C (6) 
4.3 X 10'0 2.6 X 106 our data (gas phase) 
0.83 0.50 
to X 10'0 to X 106 gas phase (7) 
2.8 1.65 
. d[NO] 
2. Rate constant k for first order reaction - -d-t - = k [NO] 
[k] =s-' 
2.7 X 10-3 
7.0 X 10- 3 
Disappearance from Isolated Gas Phase 
Disappearance of NO from the gas phase proceeds 
considerably faster than either the predicted slope or 
that observed for the whole smoke. In comparison, 
Figure 4 shows that the disappearance from gas phase 
is best fitted by a logarithmic decay curve, i.e. first or-
der kinetics giving a rate constant of 2.7 X 10-3 S-I. 
Experimentally Determined Rate Constants 
Table 1 shows the experimentally determined oxygen 
concentrations for the third puff. Table 2 shows the 
rate constants derived for whole smoke and gas phase 
assuming (pseudo) second order kinetics together with 
values obtained by earlier observers (2, 7). The close 
agreement between our value for whole smoke, that of 
Sloan and Kiefer (2) and the recommended value (6) is 
apparent. On the other hand our value for gas phase 
agrees with that of Williams (7). In addition, if we as-
our data (gas phase) 
estimated from gas phase (5) 
sume first order kinetics, the rate constant we have de-
rived for gas phase agrees reasonably well with that we 
have estimated from Vilcins and Lephardt (5) if the ab-
sorbance decay for NO in their figure is plotted against 
time on a semilog graph. 
DISCUSSION 
Our results and those of others who have studied the 
disappearance of NO in the isolated gas phase (5, 7) 
suggest that the oxidation proceeds faster than pre-
dicted. It would seem unlikely that the increased loss 
we observed could be due to leakage or apparatus dead 
space because of the similarity of our experimental sys-
tem for each phase. Similarly the filter on the entry 
port of the analyser should prevent particulates causing 
a falsely elevated signal when whole smoke was ana-
lysed. The similarity of the t = 0 values for NO for gas 
phase and for whole smoke provides further evidence 
against this possibility. 
The results also show clearly that the oxidation of NO 
in the gas phase is faster than in whole smoke. We do 
not believe that this phenomenon is confined to flue-
cured Virginia cigarettes since similar results (see Ta-
ble 2) have been reported for U.S. cigarettes. In fact, we 
have ourselves observed a similar difference in reaction 
rates with a U.S. blended cigar.ette and with a French 
(dark tobacco) type cigarette. 
Our observations imply a catalytic oxidation process 
which does not occur in the presence of particulates 
and in the following footnote '" we offer a possible ex-
planation. 
Peroxy radicals are known to react rapidly with nitric 
oxide, 
ROO, +NO--RO· +N02 , 
and clearly such reaction schemes in which the free 
radicals are not consumed can explain the first order 
oxidation of nitric oxide observed in the gas phase in 
this work, since the kinetics of the reaction with the 
hydroperoxy radical for example are believed to be sec-
ond order (11). However, we have observed rapid oxi-
dation over a period of 10 minutes which is much 
longer than the time scale expected for the removal of 
the free radicals involved. This can be reconciled if it is 
remembered that the removal reactions of these radicals 
can generate molecules such as peroxy nitrates which 
decompose slowly at room temperature to yield free 
radicals which can oxidise nitric oxide (Fig. 5). If, as 
our results suggest, the particulate 'material impedes 
rapid oxidation of the nitric oxide by free radicals then 
the measurements made of the latter species in the gas 
phase in isolation (10) may be erroneously high when 
considering the smoke as a whole. Electron spin reson-
ance studies give the gas phase concentration of oxy-
gen-centred free radicals as 5 X 10 14 spins per 35 ml 
puff = 2.3 X 10- 11 mol cm-) (10). Using the second or-
der rate constant of 6.5 X 1012 cm) mol- I S-I (11) for 
the reaction of nitric oxide with a hydroperoxy radical 
gives a first order rate constant for nitric oxide disap-
pearance of 1.5 X 102 S-I. This figure is rather greater 
than we have determined experimentally and may sug-
gest that another reaction in the sequence is rate limit-
ing. We accept, however, that further studies are re-
quired before the kinetics of the gas phase reaction can 
be conclusively characterised. It would, for example, 
increase the precision of the rate constants obtained if 
the change in nitric oxide concentration could be moni-
tored continuously, rather than on an intermittent ba-
sis. However, the implication from our data that partic-
ulate matter "quenches" highly active oxygen-contain-
ing species is significant. Since these latter species are 
alleged to be toxic, experiments in which animals, en-
zymes and cell suspensions are exposed to isolated gas 
phase may yield results not applicable to whole smoke. 
,', The fact that oxidation in the gas phase is more rapid than oxidation by oxy-
gen requires the presence of high ly reactive oxidant species. Oxygen-contain-
ing free radicals are known to be present in cigarette smoke (10) and could re-
combine on the surface of smoke particles, explaining the slower disappear-
ance in the whole smoke. 
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Similarly, unless conditions exist in the respiratory tract 
where separation of gas phase and particulates occurs, 
oxygen-centred free radicals may not reach levels suffi-
cient to cause toxicity. 
Figure 5. 
Possible reaction mechanisms in the NO ageing process 
(R represents an alkyl group). 
1. NO + HOO ' • HO' + N02 
2. HO' + RCH3 RCH 2 ' + HP 
3. RCH2 ' + O2 RCH2OO' 
4. RCH2OO' + NO RCH2O' + N02 
5. RCHP' + O2 RCHO + HOO' 
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